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A feasible approach to the restoration of injured bone tissue is the use of tissue 
engineering strategies to deliver mesenchymal stem cells (MSCs) to the site of 
regenration in degradable, in-situ gelling, bio-active hydrogels. Although inert 
Polyethylene glycol (PEG) hydrogels provide flexibility in controlling the cell 
microenvironment, their use for in vivo applications in tissue regeneration is limited by 
their persistence (nondegradability) in the site of regeneration. In an attempt to produce 
inert hydrolytically degradable matrices for encapsulation of MSCs, hydrogels based on 
star PEG macromonomers chain-extended with short hydroxy acid (HA) segments 
(SPEXA) were synthesized and characterized with respect to gelation kinetics, water 
content, degradation rate and mechanical properties. HA monomers included glycolide, 
lactide, p-dioxanone and ε-caprolactone. The degradation rate of SPEXA hydrogels was 
strongly dependent on HA type and number of HA repeat units. SPEXA gels chain-
extended with the least hydrophobic glycolide completely degraded within days, lactide 
within weeks, and p-dioxanone and ε-caprolactone degraded within months. Further, 
there was a biphasic relationship between HA segment length and gel degradation. There 
was a significant decrease in gelation time of SPEXA macromonomers with HA chain-
extension for all HA types due to micelle formation. Meso-scale simulations revealed 
formation of micellar structures within the SPEXA precursor solutions for all HA types. 
 The micellar SPEXA hydrogels supported osteogenic differentiation, collagen 
production, and mineralization of MSCs. We further investigated the effect of
vi 
concentration and hydrophobicity a BMP-2 protein derived peptide on osteogenic 
differentiation of mesenchymal stem cells (MSCs) encapsulated in a PEG based 
hydrogel. The dose-osteogenic response curve of the BMP-2 peptide was in the 0.0005-
0.005 mM range, and osteoinductive potential of the BMP-2 peptide was significantly 
less than that of BMP-2 protein even at 1000-fold higher concentrations. There was a 
higher osteogenic differentiation of encapsulated hMSCs when the BMP-2 peptide was 
dissolved in the hydrogel matrix as compared to the peptide conjugated to the hydrogel 
network. The BMP-2 peptide with a positive index of hydrophobicity had a critical 
micelle concentration (CMC) and formed aggregates in aqueous solution. Results 
revealed that osteoinductive potential of the BMP-2 peptide is correlated with its CMC 
and the free peptide concentration in aqueous medium and not the total concentration. 
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The clinical needs for bone tissue regeneration are diverse and include 
applications arising from skeletal defects caused by fracture, trauma, infection, 
neurosurgical procedures, resection of tumors and spinal deformities. [1-3] There are 
more than 280000 and 700000 hip and vertebral fractures in the USA annually.[4] 
Approximately 500000 and 2.2 million bone grafting procedures are performed inside the 
US and worldwide respectively each year.[5] The total number of spinal fusion 
procedures in the U.S. was 673,000 in the year 2012. [6] 
The gold standard for bone implantation is use of grafts harvested from the 
patient‟s body (Autologous grafts). However, autologous bone grafting needs an 
additional surgery for harvesting the bone from the donor site. Furthermore, the donor 
site may undergo morbidity, infection and pain after operation. [7] The use of cadaveric 
bone (allograft) suffers from a risk of disease transmission [8]. Further, the use of 
devitalized allografts was associated with 60% graft failure over 10 years due to the 
absence of bone osteoprogenitor cells within the graft.[9] It is well established that the 
presence of stem cells or osteoprogenitor cells has a significant role in bone 
regeneration.[10, 11] A 63% reduction in bone formation was reported when the stem 
cell containing periosteum and bone marrow were removed from a live bone graft in a 
murine segmental femoral bone graft model. [9] In addition, a significant increase in the 
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bone formation and neuvascularization were observed with immobalizing MSCs on the 
surface of allografts or directing MSCs to the surface of allografts in-vivo.[12, 13] 
However, MSCs had a limted viability and an extensive migration from the site of 
regeneration when they were incorporated into the grafts without a three dimensional 
carrier similar to the stem cell carrier matrix in the natural bone. [13] 
Bone is a composite matrix consisting of a mineral and a gel phase.[14, 15] The 
mineral phase provides the mechanical strength as well as osteoconductivity while the gel 
phase, with a significantly lower stiffness than the mineral phase, plays a critical role in 
maturation and differentiation of stem cells and progenitor cells.[14, 15] Multiple 
bioactive ligands within the gel phase interact with stem cells to initiate the cascade of 
differentiation and mineralization.[16] For instance, the interaction between RGD, a 
ligand in collagen I and fibronectin proteins, and cell surface receptors, facilitates cell 
spreading and focal adhesion to the ECM which is critical for cell differentiation.[17] 
Also, a peptide corresponding to residues 73-92 of the knuckle epitope of the BMP-2 
protein is shown to have an osteo-inductive potential. [18] Differentiation of stem cells to 
bone cells in the natural bone is regulated by an optimal matrix stiffness (mechanical 
cues) and optimal spatio-temporal distribution of bio-active ligands (biological cues) 
within the soft gels. [19]  
An exciting approach to bone tissue engineering is to deliver progenitor cells to 
the regeneration site in natural or synthetic hydrogels modified with the bioactive lignds 
(see Figure 1.1). This allows the encapsulated cells to secrete the desired extracellular 
matrix (ECM).[20] In that approach, the gel degrades gradually, providing space for the 
new bone formation and eventually displacing the gel with the patient‟s own bone tissue.  
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Cell-laden bioactive hydrogels can be used alone for minimally invasive non-load 
bearing applications or combined with supportive structures for load bearing applications. 
Hydrogels are hydrophilic polymeric networks that retain a significant fraction of water 
in their structure in physiological solution. Nutrient molecules and proteins diffuse 
through hydrogels and cells immobilized in hydrogels display higher biological 
activity.[21-25] Due to these unique properties, hydrogels are very attractive as a matrix 
for cell encapsulation and delivery to the regeneration site in regenerative medicine.[26-
30] 
 
Figure 1.1. Schematic representation of cell-laden hydrogels for tissue regeneration. A 
fluorescent image of live MSCs (green dots) encapsulated in a PEG based hydrogel is 
shown at right.  
Minor variation in the sequence distribution of natural gels can significantly affect 
the fate of encapsulated cells. With many cell-binding ligands and regulatory factors, it is 
difficult to adapt the properties of natural matrices to a particular application in 
regenerative medicine.[31] For instance, differentiation of mesenchymal stem cells 
(MSCs) shifted from osteogenic to chondrogenic lineage by changing the matrix from 
collagen type I to type II.[32, 33] Moreover, due to their low stiffness, natural gels are 
limited in practical applications by soft tissue compression.[34-36] Therefore, there is a 
need to synthesize novel hydrogels with tunable physical, mechanical, and biological 
4 
properties for a wide range of applications in regenerative medicine such as MSC 
implantation for treatment of skeletal defects and spinal fusion, chondrocyte implantation 
in cartilage regeneration or as cardiac patches to treat heart infarction. 
Synthetic polyethylene glycol (PEG) based hydrogels are used extensively for cell 
encapsulation to elucidate the effect of physiochemical, mechanical, and biological 
factors in the microenvironment on cell fate in vitro.[36-39]  PEG hydrogels, due to their 
inert, hydrophilic and immunogenic nature, provide enormous flexibility in designing and 
controlling the cell microenvironment.[40, 41] Unlike small-molecule monomers that 
cross the cell membrane, the flexible PEG macromonomers crosslink to produce 
hydrogels with high compressive modulus without adversely affecting the viability of the 
encapsulated cells.[42-46] 
Although inert PEG hydrogels provide flexibility in controlling the cell 
microenvironment, their use for in vivo applications in tissue regeneration is limited by 
their persistence (non-degradability) in the site of regeneration.[30] In that regard, design 
and synthesis of PEG hydrogels with hydrolytically degradable hydroxyl acid (HA) links 
would substantially increase their use as cell delivery matrices in tissue regeneration.[47-
49] We hypothesized that degradation and stiffness of PEG-HA gels are dependent on the 
length and characteristics of the HA segment as well as functionality, molecular weight 
and concentration of the PEG-HA macromonomer. To test the hypothesis, hydrogels 
based on star PEG macromonomers chain-extended with short HA segments (SPEXA) 
were synthesized and characterized with respect to gelation kinetics, degradation rate, sol 
fraction, mechanical properties and water content.[35, 50-52] Star PEG macromonomers 
have lower radius of gyration and shear viscosity, and higher density of functional groups 
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than the linear PEGs,[25, 53] leading to the formation of gels with higher crosslink 
density and modulus.[54-57] HA monomers included least hydrophobic glycolide, 
lactide, p-dioxanone, and most hydrophobic ε-caprolactone. Further, MSCs were 
encapsulated into the developed gels and their viability and differentiation to the 
osteogenic lineage were measured.[35, 51] In addition, Dissipative Particle Dynamics 
simulation method [58, 59] was used to simulate aggregation, micelle formation and the 
distribution of reactive groups in SPEXA hydrogel precursor solutions.[35, 51, 60] 
Experimental and simulation results demonstrated that SPEXA hydrogels with a wide 
range of degradation rate, gelation kinetics and mechanical properties can be synthesized 
with adjusting the hydrophobicity and length of the HA segment, functionality and 
molecular weight of the PEG and concentrations of the macromonomer and initiator. 
Further, results revealed the formation of micellar structures within the hydrogels‟ 
precursor solution at the nano-scale that affects the gelation kinetics, degradation rate and 
macroscopic properties of the hydrogels.[59]  
It is well established that bone morphogenic protein (BMP-2) plays a dominant 
role in osteogenic differentiation of MSCs and formation of the new bone tissue.[16, 61] 
BMP-2 has been used extensively in certain clinical applications such as sinus 
augmentation, spinal fusion, and alveolar ridge augmentation to accelerate bone 
regeneration and reduce the chance of graft failure.[62, 63] Due to its short-half-life and 
diffusion of the protein away from the site of regeneration, doses much higher than the 
endogenous amount are used in clinical applications.[62, 64] High doses of BMP-2 
protein in vivo cause undesired side effects such as bone overgrowth, immune response, 
and tumor formation.[65] For example, the probability of an adverse side effect with the 
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use of BMP-2 in spine fusion may be as high as 40%.[65] An attractive approach to 
reduce the protein‟s side effects in bone tissue engineering is to use peptides derived from 
the bioactive segements of BMP-2.[66] In order to design a BMP-2 peptide incorporated 
hydrogel for osteogenic differentiation of MSCs there is a need to know how peptide 
concentration, peptide aggregation and peptide grafting affect the bio-activity of the 
peptide within the hydrogel. The effect of concentration and hydrophobicity of a BMP-2 
peptide on peptide aggregation and differentiation of MSCs encapsulated in an inert 
polyethylene glycol (PEG) hydrogel was investigated through experiments and 
simulations.[67] Results demonstrated that the osteo-inductive potential of the BMP-2 
peptide within the PEG hydrogel is correlated with the peptide hydrophobicity and 




BACKGROUND AND LITERATURE REVIEW 
2.1. OSTEOGENIC DIFFERENTIATION OF STEM CELLS IN BONE  
Mesenchymal stem cells (MSCs) are multipotent stem cells that have self-renewal 
ability and also can differentiate to osteoblasts, chondrocytes or adipocytes. It is well 
established that MSCs and osteoprogenitor cells play a vital role in bone regeneration 
during development and bone healing. A 50% loss of bone graft strength and a 60% graft 
failure were observed after 10 years of the decellularized allograft implantation. [9] 
Further, a 63% reduction in bone formation was reported when the stem cell containing 
periosteum and bone marrow were removed from a live bone graft in a murine segmental 
femoral bone graft model. [9] In addition, a significant increase in the bone formation and 
neuvascularization were observed with immobalizin MSCs on the surface of the 
allografts or directing MSCs to the surface of allografts in-vivo.[12, 13] Stem cells and 
progenitor cells do not reside within the calcified part of the bone. Bone MSCs in adults 
mainly reside within the perivascular region of the bone marrow whereas osteoprogenitor 
cells exist in bone marrow, endostum and periostium. [68, 69] MSCs differentiate to 
osteoprogenitors in bone marrow. Osteoprogenitor cells undergo differentiation into 
preosteoblasts and osteoblasts in the osteoblastic region of the bone marrow as well as the 
soft osteogenic layer of the periosteum (see Figure 2.1). [19] The osteoblasts develop to 
osteocytes which participate in bone remodeling and bone regeneration. Osteoprogenitor 
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Figure 2.1. Schematic representation of the bone and periosteum micro-structures. 
Osteogenic differentiation of osteoprogenitor cells to bone cells occurs within the soft 
osteogenic layer of the periosteum. 
 
cells in periosteum and bone marrow concurrently give rise to osteoblasts during bone 
repair. [15] Differentiation of stem cells to the bone cells in periosteum and endosteum is 
regulated by an optimal matrix stiffness (mechanical cues) and optimal concentration of 
growth factors (biological cues) at the site of differentiation. [19] While bone is 
composed of a stiff inorganic-organic composite matrix with elastic modulus of 17 GPa, 
the thin periosteum with an elastic modulus of 1.9 MPa is four orders of magnitude less 
stiff. [70, 71] Furthermore, the inner osteogenic layer of the periosteum, that hosts the 
differentiating of osteoprogenitor cells, is softer than the outer fibrous layer (see Figure 
2.1). The process of bone remodeling in adults is compareable with intramembranous 
ossification in infants, in that they both initiate from the differentiation of stem cells to 
osteoblasts in soft un-calcified matrices.[72]  It is well established that the stiffness of 
extracellular matrix (ECM) affects the fate of stem cells. [73, 74] For instance, MSCs 
encapsulated in a semi-synthetic alginate based hydrogel undewent osteogenic 
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differentiation when the matrix elastic modulus was in the 11-30 kPa range while the 
adipogenic differentiation occurred in softer matrices with elastic modulus of 2.5-5 kPa. 
[75]  The osteogenic differentiation of MSCs increased when the elastic modulus of cell-
laden PEG gels increased from 0.2 to 59 kPa. [76] In addition, MSCs underwent 
neuronal, myogenic and osteogenic differentiation when they were cultured on gels with 
low (0.1-1 kPa), intermediate (8-15 kPa) and high (25-40 kPa) elastic modulus 
respectively. [73]  
In addition to the matrix stiffness, an optimal spatio-temporal distribution of 
growth factors plays a key role in differentiation of stem cells/osteoprogenitor cells to 
bone cells during bone remodeling or bone development. Although several growth factors 
including fibroblast growth factor (FGF), transforming growth factor-β (TGF-β), insulin-
like growth factor (IGF) and vascular endothelial growth factor (VEGF) contribute in 
development and remodeling of a vascularized bone tissue, bone morphogenic proteins 
(BMPs) play a dominant role in osteogenic differentiation of MSCs. [16, 61] In 
intramembranous ossification, clustered MSCs in a soft matrix differentiate into 
osteoblasts by localized secretion of BMPs.[72, 77] In a developed bone tissue, migration 
of MSCs from bone marrow toward endosteum and secretion of BMPs promote bone 
formation. [78] Several clinical studies have shown that the rate of healing increases and 
the failure rate decreases with incorporation of BMP-2 and BMP-7 proteins in fracture 
repair or spinal fusion procedures. [62, 63, 79] All in all, the cascade of bone formation 
initiates with osteogenic differentiation of MSCs promoted by mechanical cues and 
growth factors specifically BMPs within a soft matrix.   
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2.2. CROSSLINKING OF POLYMER CHAINS AND GELATION 
As mentioned before, hydrogels are crosslinked networks of hydrophilic 
polymeric chains. If monomers (or macromonomers) of a polymerization reaction show a 
functionality higher than 2, crosslinking between macromonomers will form branched 
structures (see Figure 2.2). If the expected number of chains in each succeeding 
generation of branched structures is greater than the number of chains in the preceding 
generation, crosslinking may result to formation of an infinite network (see Figure 2.2). 
Starting from a randomly chosen primary molecule “A”, the probability that “A” belongs 
to an infinite network is dependent on the total number of crosslinks on a molecule “B” 
which is crosslinked to molecule “A”. If   is the average number of crosslinks on “B” 
excluding the one that primarily connects A to B, the crosslinking is finite when 1  
because each generation tends to be smaller than the preceding one. Infinite networks can 
be formed only if 1 .  
 
Figure 2.2. Schematic representation of crosslinking the multi-functional 
macromonomers (left) to form branched structures (middle) and an infinite network 
(right).  
Therefore, the critical condition for gelation is 1 .[80] At the critical point of gelation 
( 1 ), the number average molecular weight of the chains ( nx ) has a finite value but 
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the weight average molecular weight of chains ( wx ) is infinite. So the molecular weight 
distribution has an infinite breadth at the gelation point.[80] 
2.3. APPLICATIONS OF HYDROGELS 
Hydrogels have been used commercially to fabricate oscular contact lenses. [81] 
Furthermore, hydrogels based on poly(2-hydroxyethyl methacrylate) (pHEMA) 
copolymerized with methacrylic acid (MAA) and N-vinyl pyrrolidone (NVP) were used 
as ophthalmic drug carriers for treatment of glaucoma. [82, 83] In cancer treatment, 
biodegradable hydrogels based on PEG and PLGA were used for delivery of Paclitaxel to 
tumors and they were shown to be effective in localizing drug concentration and 
decreasing the systemic drug concentration. [84] In addition, pH, temperature or 
magnetic sensitive PEG based hydrogels have been used in cancer treatment. [85, 86] 
 Hydrogels, due to their high water content and high diffusivity of nutrients and 
biomolecules, can be potentially applied as carrier matrices for delivery of cells to the site 
of regeneration in cell based therapies and tissue regeneration.[21, 24, 28, 87, 88] Since 
injectable cell-laden hydrogels can be formed in-situ, they can be used for filling 
irregularly-shaped defects through minimally invasive procedures.[89] After injection 
and in situ hardening, the hydrogel matrix guides the development of seeded cell into the 
desired tissue.[24]. The mechanical properties of tissue engineering hydrogels can be 
tuned to prevent deformation or rupture and at the same time keep the cells viable. [44] In 
addition, resorption of biodegradable hydrogels provides volume for tissue formation and 
gradually displaces the hydrogel with cell secreted matrices.[48] Hydrogels have been 
used for encapsulation of different cell lines and regeneration of different tissues. For 
instance, PHEMA and PVA hydrogels were used for engineering of corneas. [90] MSCs 
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were encapsulated in a number of hydrogels including collagen, chitosan, alginate PEG 
and polypeptides for osteogenic differentiation.[30, 75, 91-93] Neural Stem Cells (NSCs) 
were encapsulated in alginate hydrogels and underwent neuronal differentiation when the 
the gel elatic mosulus was 180 Pa within the range of brain tissue modulus (100-1000 
Pa).[94] Different hydrogels including PEG/agarose [95], collagen [96], PEG [97] 
chitosan [98] and hyaluronic acid/chitosan [99] were used for encapsulation of 
chondrocyte cells for cartilage tissue engineering. Co-cultures of Endothelial Colony 
Forming Cells (ECFCs) and Mesenchymal Stem Cells (MSCs) encapsulated in Gelatin 
Methacrylate hydrogels with a compressive modulus of 2 kPa underwent vasculogenic 
differentiation and generated extensive capillary like networks in-vitro. [100] 
2.4 NATURAL VS SYNTHETIC HYDROGELS 
Only those hydrogels that are biocompatible, support cell-matrix interactions and 
provide free volume for the newly formed tissue through degradation can be utilized as 
supporting matrices in regenerative medicine.[101, 102] Consequently, natural hydrogels, 
derived from the components of extracellular matrix (ECM) that degrade enzymatically, 
are frequently used as delivery matrices in clinical applications. Collagen gel, one of the 
main parts of mammalian tissues, is the most widely used natural hydrogel.[103] 
Collagen gel is formed from physically crosslinked collagen fibers self-asembled from 
triplehelic collagen molecules.[104] Gelatin is a thermosensitive gel formed from 
physically crosslinked gelatin protein molecules which are deformed collagen molecules 
with distorted secondary and tertiary structures.[105] Modified collagen and gelatin were 
also chemically crosslinked to make more robust hydrogels. [100, 106, 107] Fibrin gels 
were formed by the enzymatic polymerization of fibrinogen, a natural component of the 
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body, in the presence of thrombin.[103] Alginate is a biomaterial derived from brown 







[108] In addition to alginate, other polysaccharide based natural hydrogels including 
chitosan, hyaluronic acid and agarose have been extensively used in tissue engineering 
applications. [20, 109] With many cell-interactive ligands and regulatory factors, it is 
difficult to tailor the properties of natural hydrogels to a particular application in 
regenerative medicine.[31] Moreover, due to their low stiffness, natural gels are limited 
in practical applications by soft tissue compression.[34-36] Therefore, there is a need to 
synthesize hydrogels with adjustable physical, mechanical, and biological properties for a 
wide range of applications in tissue engineering.  
Hydrogels based on several synthetic hydrophilic macromers including 
poly(hydroxyethyl methacrylate) (pHEMA), poly(ethylene glycol) (PEG), poly(vinyl 
alcohol) (PVA), polyurethane , polyacrylate and polypeptides have been synthesized and 
characterized.[20, 103, 110] pHEMA hydrogels have excellent biostability and are being 
used in fabrication of contact lenses.[103] Degradable pHEMA hydrogels were also 
synthesized with incorporation of oligomeric polycaprolactone (PCL) crosslinkers.[111] 
Polyethylene glycol (PEG) hydrogels are inert, non-immunogenic, and compatible with 
stem cells and can be conjugated with multiple bioactive peptides to modify the cell 
microenvironment and regulate cell fate.[112-114] Furthermore, the stiffness of PEG 
hydrogels can be changed in a wide range with altering the concentration of highly 
soluble PEG macromonomers in the aqueous precursor solution or using multifunctional 
PEG macromonomers. [35, 115] However, PEG hydrogels are non-degradable which 
limits their use as a supporting matrix in regenerative medicine. Degradable PEG based 
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hydrogels were synthesized via copolymerization of PEG macromonomer with 
hydrolytically degradable monomers or incorporation of hydrolytically or enzymatically 
crosslinkers within the hydrogel. [52, 116]  PVA hydrogels have been synthesized using 
glutaraldehyde, acetaldehyde or formaldehyde as crosslinking reagents.[117] Chemical 
crosslinking of PVA macromonomers were also performed using electron beam or γ 
irradiation.[117] Physically crosslinked PVA hydrogels were developed by freeze-
thawing the PVA aqueous solutions or by annealing the dried film. [118, 119] 
Furthermore, cytocompatable PVA based hydrogels for cell encapsulation were 
fabricated by photo-crosslinking of modified PVA chains. [120, 121] Self complementary 
β-sheet forming peptides and amphiphilic peptides have been used to synthesize 
physically bonded fibrous gels. [122, 123] The properties of peptide based gels were 
influenced by the hydrophobicity and flexability of the aminoacids within the peptide 
structure. [124, 125]. 
2.5. PHYSICALLY CROSSLINKED HYDROGELS 
Physically crosslinked hydrogels are composed of macromonomers crosslinked 
through non-covalent bonds including hydrophobic, ionic or hydrogen bonds. Physically 
bonded macromonomers are capable of phase transition in response to external stimuli 
such as temperature, pH and ionic strength. Collagen and gelatin are thermo-sensitive 
natural gels and undergo gelation at physiological temperature. [105, 106] Aqueous 
solutions of Poly(N-isopropylacrylamide) (PNIPAAm) form thermo-sensitive physical 
gels with increasing the temperature above 32
°
C  that is the Lower Critical Solution 
Temperature (LCST) for the aforementioned polymer solutions. [126, 127] The number 
of water molecules bound to isopropyl side chains of PNIPAAm decreases and inter-
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molecular hydrophobic interactions increases with increasing the temperature above 
LCST that causes micro-phase separation and gelation.[128] Solutions of micelle forming 
block copolymers such as PEO-PPO-PEO or PEO-PLGA-PEO were shown to have 
reversible thermogelling properties.[129] Triblock copolymers containing a hydrophilic 
middle block and two hydrophobic blocks at the chains ends such as PPO-PEO-PPO or 
PCL-PEO-PCL underwent micelle formation with bridge and loop conformations in the 
aqueous solutions and formed gels with increasing the temperature due to the 
hydrophobic effect.[126]  
Hydrogels based on Polyacrylic acid or macromonomers with amine group on the 
backbone are examples of pH responsive gels. The weak acidic or basic side groups on 
pH sensitive macromonomers undergo a transition from neutral to charged, leading to a 
structural transition from collapsed to extended chains with increasing or decreasing the 
pH respectively. [128, 130] β-sheet forming and surfactant like peptides were desi                        
gned to form physical gels through hydrogen bonding and hydrophobic interactions. For 
example, peptides with alternating Arginine-Alanine-Aspartate (RAD) residues with 16 
amino acids (RADA)4 and (RARADADA)2 with 1-10 mg/mL peptide concentration 
formed fibrous gels with 10-20 nm fiber diameter in physiological medium or in salt 
solution [123]. The self-assembly of aforementioned peptides to nanostructured gels was 
governed by inter-molecular hydrogen bonding between peptides‟ backbone in β-sheets, 
ionic interactions between the charged side chains on one side of β-sheets and 
hydrophobic interactions between hydrophobic side chains at the other side of β-sheet 
[123, 131, 132]. Solutions of a peptide with an alkyl tail of 16 carbon atoms and a head 
composed of 4 consecutive cysteines, 3 glycines, a serine and a segment of arginine-
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glycine-aspartic acid (RGD) underwent self-assembly to form nanofibrous gels upon 
decreasing pH below 4 [122].  
2.6. COVALENTLY CROSSLINKED HYDROGELS 
 Crosslinks can be generated by chemical reactions and formation of covalent 
bonds between macromonomers. Covalently crosslinked gels are significantly stiffer than 
those that are physically crosslinked [88, 133]. In addition, degradability of covalently-
crosslinked gels can be controlled independently of gelation by the molecular weight and 
ratio of hydrophobic/hydrophilic domains [134-136]. Covalently crosslinked hydrogels 
have been synthesized using different types of reactions including conventional free 
radical reaction, Michael-type conjugation and click reaction.[110] The free radical 
reaction for synthesis of hydrogels can be initiated using redox or photo-initiators. [56, 
137, 138] Synthetic or natural polymers modified with acrylate or methacrylate groups at 
the chain ends or fumarate groups on the backbone have been crosslinked via redox 
initiated free radical polymerization. For instance, acrylated PEG-PLA, oligo 
polyethylene glycol fumarate, PEG-PLA famarate and methacrylated chitosan were 
crosslinked using ammonium persulfate (APS, redox initiator) and tetramethylethylene 
diamine (TEMED, radical catalyst). [139-142] Advantages of photo-initiated reactions 
over redox-initiated ones include spatial and temporal control on the crosslinking reaction 
and faster gelation time. [143] Different photo-initiators including 2,2-Dimethoxy-1,2-
diphenylethan-1-one (IRGACURE 651) [137], 1-[4-(2-Hydroxyethoxy)-phenyl]-2-
hydroxy-2-methyl-1-propane-1-one (IRGACURE 2959) [35, 144, 145] and 
eosin/triethanolamine [146] were used for photo-crosslinking of macromonomer to 
synthesize hydrogels. Free radical photo-initiation was performed under visible light 
17 
[147] , UV [35, 52] or argon laser [146]. Acrylated or methacrylated PEG [148, 149], 
poly(ethylene oxide-co lactide-co glycolide) [52], poly(ethylene oxide-co lactide ) 
fumarate [150], methacrylated gelatin[151], methacrylated hyaluronic acid[152] and 
methacrylated alginate[152] were used for synthesis of photo-crosslinked hydrogels. 
Acrylate or methacrylate functionalized macromers were crosslinked to thiol or amine 
functionalized macromers through Michael addition.[110, 153, 154] Furthermore, click 
chemistry was applied to synthesize hydrogels from PEG based macromers 
functionalized with acetylene and azide functional groups. [155] 
2.7. MICELLAR HYDROGELS 
A-B-A triblock copolymers can form micellar gels in selective solvents [156, 
157]. These micelles are responsive to pH and temperature depending on the nature of 
“A” and “B” blocks. The formed micelles pack into an ordered phase at high 
concentrations (higher than 20 wt%) and form a gel when the “A” block is solvophilic 
[156, 158]. However, when the “B” block is solvophilic, gelation takes place by bridge 
formation between the micelles [159, 160]. Micelle formation in A-B-A triblock 
copolymers is illustrated schematically in Figure 2.3. At low concentrations, the block 
copolymers are freely dissolved in the solvent. As the concentration exceeds the critical 
micelle concentration (CMC), the solvophobic “B” blocks aggregate and form the core of 
the micelles and the solvophilic “A” blocks form the shell or corona.[161] Each 
macromer chain adopts one of four possible conformations: bridge, loop in which two 
chain ends are in the same micelle, tethered in which one chain end is free and free chains 
(see Figure 2.3.b and 2.3.c). The probability of bridge formation as well as total number 
of bridges increase with increasing the macromer concentration[162]. The increase in 
18 
macromer concentration beyond a finite percolation threshold leads to the formation of a 
transient micellar network cross-linked by inter-micellar bridges (see Figure 2.3.c). Each  
 
Figure 2.3. (a) Schematic diagram of an A-B-A triblock copolymer with solvophilic 
block B (green) and solvophobic block A (brown); (b) conformation of chains in A-B-A 
triblock copolymer chains in solution and formation of micellar structure by aggregation 
of solvophobic A blocks; (c) formation of a physical network in a solution of A-B-A 
triblock copolymers by aggregation and micelle formation of solvophobic A blocks. 
Solvophilic (B block) and solvophobic (A block) segments of the copolymer are shown 
in green and brown, respectively.(reprinted from [161]) 
 
bridge in a transient network has a finite residence time in the micelle. The stability of 
physical cross-links increases with increasing the solvophobicity and length of the 
solvophobic segment. A transient network of micelles is mechanically reinforced and 
permanently stabilized by the formation of covalent bonds within the core of the micelles. 
The confinement of the crosslinking reaction inside the micelle cores imparts unique 
features to the hydrogel. In the case of degradable hydrophobic segments, degradation of 
the hydrogel network is confined to the micellar domains. Furthermore, the cytotoxic low 
molecular weight molecules are not exposed to the live cells with positioning within the 
hydrophobic micelles‟ cores. [51]   
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2.8. HYDROGEL SWELLING AND MESH SIZE 
Hydrophilic macromonomers are individually soluble in water or other selective 
solvents. However, the solubility of hydrophilic macromers decreases with formation of 
crosslinks and increasing the average molecular weight of the chains. When the degree of 
crosslinking exceeds the critical point of gelation, the resulting polymeric network can 
not be dissolved in water or selective solvents but it swells (see Figure 2.4). The degree 
of swelling (or water content) of a hydrogel is controlled by two opposing forces, namely 
thermodynamic force of mixing between polymer-water and elastic force of the extended 
polymer chains. The force of mixing tends to increase the water content of the gel by 
attractive interactions between water molecules and the network chains [80].  
 
Figuure 2.4. Schematic representation of the swelling of a crosslinked network and the 
mesh size.  
 
The elastic force of the polymeric chains on the other hand tends to decrease the 
water content of the gel due to the extension of favorable random coil chain 
conformation. The difference in the chemical potential of the gel penetrating solvent is 
given by: [80, 163] 
elasticmixing   0,11                                                                            equation 2.1
 
where 1 is the chemical potential of solvent within the polymeric gel, 0,1 is the 
chemical potential of the pure solvent, mixing is the change of chemical potential caused 
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by mixing and  elastic  is the change of chemical potential due to the presence of elastic 
retractive forces of the polymer chains. At equilibrium, the difference between the 
chemical potential of the solvent inside and outside of the gel (left hand side of the 
equation 1) is zero. In other words, force of mixing and elastic force of extended chains 
become equal at equilibrium. Several factors including molecular weight, hydrophobicity, 
functionality and flexability of the macromonomers, degree of crosslining, nanostructure 
of the gel and temperature affect the swelling of hydrogels.[55, 164] Specifically, the 
swelling of hydrogels decreases with increasing the hydrophobicity of the chains and 
degree of crosslining (crosslinking density) through influencing the force of mixing and 
the elastic force of the chains respectively. [163]  
The molecular weight between crosslinks ( cM ) can be found from equation 2.2 
which is derived via incorporation of thermodynamic of mixing and theory of rubber 





























                                                    
equation 2.2 
where nM is the number average molecular weight of the chains,  is the specific volume 
of the polymer, 1V is the molar volume of solvent, s,2 is the polymer volume fraction in 
the swollen state and 1 is the Flory-Huggins interaction parameter between the polymer 
and solvent.  The mesh size of a gel, the average distance between two adjacent 
crosslinks (see Figure 2.4), can be obtained following determination of cM from equation 

















                                                                                        
equation 2.3 
where nC , rM and l  are the Flory characteristic ratio, molecular weight of the repeating 
unit and length of the bond along the polymer backbone respectively. The degree of 
swelling and mesh size of the hydrogels are particularly important variables for 
controlling the diffusion rate of nutrients, oxygen, growth factors and waste products into 
or out of the cell-laden hydrogels in tissue engineering applications. [165, 166]  
2.9. MECHANICAL PROPERTIES OF HYDROGELS 
Mechanical properties of tissue engineering hydrogels need to be optimal to 
prevent deformation or rupture of the construct and at the same time keep the cells viable 
while tailoring them to a specific lineage.[167] It is well established that the stiffness of 
3D matrix affects fate of the encapsulated cells. For instance, MSCs encapsulated in 
alginate hydrogels underwent adipogenic differentiation when the elastic modulus of the 
matrix was 2.5-5 kPa whereas they went through osteogenic differentiation in the gels 
with elastic modulus of 11-30 kPa.[75]  
When a constant stress is applied on a hydrogel, an instantaneous strain is 
followed by an increasing strain over time.[168]  Since hydrogels exhibit both viscous 
and elastic behaviors they are classified as viscoelastic materials. The time dependant (or 
frequency dependant in dynamic tests) response of hydrogels to an external force is 
related to the time needed for macromolecular motions. At short time scales, polymeric 
chains cannot be relaxed under an external force whereas at longer times polymeric 
chains have time to become relaxed.[168]  The elastic behavior of hydrogels can be 
elucidated using the rubber elasticity theory which was developed by Treloar and 
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Flory[80] and modified by Peppas and Merrill[163]. The elastic behavior of a water 













































                                                              equation 2.4 
Where  is the stress,  , R , T ,   and r,2 are the polymer density, gas universal 
constant, absolute temperature, elongation ratio and the polymer volume fraction before 



































                                                                              equation 2.5 
According to equation 2.5 the modulus of hydrogels is inversely correlated with 
molecular weight between crosslinks ( cM ). Therefore, the shear modulus of the 
hydrogels increases with increasing the density of crosslinks (decreasing cM ). The 
crosslink density can be enhanced with increasing the macromonomer concentration, 
macromonomer functionality or incorporation of multi-functional crosslinkers in the 
solution.[52] It is worth mentioning that intra-molecular reactions lead to the formation 
of loops that do not contribute to the network elasticity [150, 162]. Therefore, an increase 
in the probability of intra-molecular crosslinking through a decrease in macromonomer 
molecular weight or macromonomer concentration negatively affects the mechanical 
properties of hydrogel networks.[35]  
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2.10. DEGRADATION OF HYDROGELS 
Although hydrogels provide flexibility in controlling the cell microenvironment, 
their use for in vivo applications in tissue engineering is limited by their persistence in the 
site of regeneration.[30] Therefore, hydrogels for tissue engineering applications need to 
be degradable with a degradation rate matched with tissue formation (ECM production) 
and remodeling. ECM production is limited by free volume when rate of matrix 
degradation is slower than that of ECM production. Conversely, ECM production is 
limited by cell adhesion when rate of matrix degradation is faster than that of ECM 
production. [102, 169] The essential role of matrix degradation in determining the cell 
fate has been shown for different cell lines. For example , the C2C12 mouse myoblast 
cells encapsulated in a degradable alginate gel  had a higher extent of differentiation into 
myotubes and lower proliferation  than those encapsulated in a non-degradable gel [170]. 
Similarly, MSCs encapsulated in a non-degradable hyaluronic acid (HA) gel did not 
spread and underwent adipogenic differentiation whereas those MSCs  encapsulated in a 
degradable HA gel spread and differentiated to the osteogenic lineage [171].  
Natural hydrogels are mostly enzymatically degradable. For instance, 
myofibroblast cell-laden fibrin gels were degraded after 2 days in the absence of inhibitor 
for enzymatical degradation. [172] Hyaluronic acid based hydrogels are degradable by 
hyaluronidase enzyme.[173] Gelatin based hydrogels were completely degraded over 6 
hours in collagenase solution. [100] Alginate gels were degraded by alginase enzyme 
released from PLGA microspheres and the gel degradation rate increased with increasing 
the alginase loading concentration.[174]  
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Synthetic hydrogels can be made degradable with incorporation of enzymatic, 
hydrolytic or photolytic degradable segments into the macromonomer chains or 
crosslinkers. [175] For instance, Matrix Metalloproteinase (MMP) sensitive peptide was 
incorporated into the non-degradable PEG hydrogel using Michael addition reaction to 
make the gel enzymatically degradable. [176, 177] Fibroblast cells were shown to 
migrate within the MMP-sensitive PEG gels whereas the migration was limited within 
the non-degradable PEG gels or when the enzymatic degradation was inhibited. [176] 
Degradable PEG based gels were synthesizd with incorporation of poly(α-esters). For 
example, Copolymerization of PEG with poly(lactide) (PLA) has been used to impart 
degradability to PEG macromers. The degradation and water content of the copolymers 
could be adjusted by the fraction of hydrophobic lactide segments,[88, 178] but solubility 
of the copolymers in aqueous solution decreased with increasing lactide content.[56] 
Hydrogels synthesized from PEG and Ɛ-caprolactone co-polymers were shown to be 
hydrolytically degradable, but the degradation rate was limited by the hydrophobicity of 
Ɛ-caprolactone and formation of micellar aggregates in the solution.[179] Hydrogels 
based on PEG macromers co-polymerized with 5-15% (wt) glycolide underwent 
complete degradation over 2 to 8 days.[51] Due to a relatively fast degradation rate and 
hydrophilicity of the glycolide monomer, that has been extensively used with lactide or 
caprolactone for adjusting the degradation rate and water content of hydrogels.[52, 180, 
181] In addition to poly(α-esters) , other hydrolytically degradable polymers including 
poly(ester amide)[182], polyphosphoester [183, 184], poly(amino-ester urethane) [185] 
were used to synthesize degradable hydrogels. Furthermore, photodegradable hydrogels 
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were synthesized with incorporation of a nitrobenzyl-ether-derived moiety into the PEG 
based hydrogels.[186]    
Tissue engineered constructs often times require multiphase hydrogels with 
different but complementary microenvironments. For example, osteogenic differentiation 
of MSCs requires a supporting matrix with high compressive modulus and slow 
degradation [187] whereas vasculogenic differentiation of progenitor endothelial cells 
necessitates a low modulus, relatively fast-degrading matrix [100, 188]. This presents a 
need to develop synthetic hydrogels with tunable degradation and stiffness for wide-
ranging applications in regenerative medicine.  
2.11. BIOACTIVE MODIFICATION OF HYDROGELS 
It is well established that cell-matrix interactions within a cell-laden hydrogel play 
a significant role in regulating cell function.[189, 190] In natural ECM, cell adhesive 
proteins such as laminin and fibronectin bind to the integrin cell surface receptors.[189, 
191] It has been shown that cell-matrix attachment is crucial for cell proliferation and 
differentiation.[192] Furthermore, soluble or tethered growth factor proteins, present in 
the natural ECM, modulate cell functions including proliferation, migration and 
differentiation.[193]  
Natural gels such as collagen, gelatin and fibrin possess cell-adhesive ligands. 
Despite this, it is difficult to adjust the properties of natural gels for a specific application 
in tissue engineering. [31] Further, the use of natural gels in regenerative medicine is 
limited due to their poor mechanical properties. [194] The properties of synthetic 
hydrogels including the matrix stiffness can be tuned for a specific application in 
regenerative medicine. However, synthetic hydrogels need to be modified with bioactive 
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ligands for optimal cell-matrix interactions. [195] A number of cell-adhesive peptides 
derived from laminin, fibronectin, elastin and collagen proteins have been incorporated 
into the synthetic inert hydrogels.[195] For example, when Arg-Gly-Asp (RGD), a 
laminin and fibronectin derived adhesive peptide, was added to PEG hydrogels the 
adhesion and mieralization of encapsulated osteoblest cells significantly increased. [17] 
The viability of human mesenchymal stem cells (hMSCs) was significantly higher in 
RGD modified PEG gels compared with non-modified PEG gels. [196]  The viability and 
insulin secretion of β-cells significantly increased when acrylate terminated IKLLI and 
IKVAV cell-adhesive peptides were conjugated to the cell-laden PEG hydrogel. [197]  
In addition to the cell-adhesive ligands, growth factors or growth factor derived 
peptides have been incorporated into the synthetic hydrogels to direct the stem cells into a 
specific liniage. A conjugation of SVVYGLR osteopontin derived peptide to the PEG 
based hydrogel, stimulated the formation of new blood vessels by encapsulated human 
umbilical vein endothelial cells (HUVECs). [198] Similarly, the vasculogenic 
differentiation of MSCs seeded on a PEG hydrogel increased when the osteopontin 
derived peptide was grafted to the hydrogel. [199] The collagen and glycosaminoglycan 
production by hMSCs increased significantly when KLER, a chondro-inductive decorin 
derived peptide, was incorporated into the PEG cell-laden hydrogels.[200]  MSCs seeded 
on PEG hydrogels modified with RGD and an osteo-inductive BMP-2 protein derived 
peptide, KIPKASSVPTELSAISTLYL, showed 5 and 12 fold increase in ALP activity 
and calcium content after 14 and 21 days respectively. [113] The aformentioned BMP-2 
derived peptide tethered to alginate gels induced new bone formation after 4 weeks in a 
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A novel approach to tissue regeneration is the use of injectable in situ 
crosslinkable hydrogels as a carrier for the delivery of therapeutic agents and cells [28, 
203]. Less invasive injectable gels coupled with minimally invasive arthroscopic 
techniques are an attractive alternative to implantation of pre-formed polymers for 
treating irregularly shaped or inaccessible defects [27, 87, 204, 205]. Furthermore, 
diffusivity of nutrients [206, 207] and proteins [166, 208] in hydrogels is 4-5 orders of 
magnitude higher than solid polymers, thus providing a supportive matrix for 
differentiation, proliferation, and maturation of seeded cells into the desired tissue [209]. 
In addition, hydrogels can be reinforced with calcium phosphate nanoparticles to produce 
injectable cements for hard tissue applications [28, 210, 211].  
Biodegradable polymers are widely used as a supportive carrier in tissue 
engineering and drug delivery [49, 212-215]. Among them, poly(lactide-co-glycolide) 
(PLGA) is the most widely used biodegradable polymer because its degradation products 
(lactic and glycolic acid) are resorbed through metabolic pathways [216, 217]. PLGA and 
poly(ε-caprolactone) (PCL) polymers have been copolymerized with poly(ethylene 
oxide) (PEO) to produce amphiphilic macromers that form thermally-induced physical 
gels [136, 218, 219]. Studies concerning the effect of macromer structure on water 
content and modulus [218, 220] demonstrate that physically crosslinked gels are 
significantly weaker than those that are chemically crosslinked [88, 133], limiting them 
for use in non load-bearing biomedical applications. In addition, degradability of 
chemically-crosslinked gels can be controlled independent of gelation by the molecular 
weight and ratio of hydrophobic/hydrophilic domains [134-136]. To control the hydrogel 
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water content (and therefore mechanical strength), degradation rate and the rate of 
crosslinking, our laboratory has previously developed a poly(lactide-co-ethylene oxide 
fumarate) (PLEOF) macromonomer consisting of low molecular weight poly(L-lactide) 
(LMW-PLA) and PEG blocks linked by unsaturated fumarate units [88, 205]. The water 
content of the PLEOF hydrogel could be adjusted by the ratio of hydrophilic PEG to 
hydrophobic PLA blocks and by PEG molecular weight [88]. Degradation rate of the 
network could be controlled by the ratio of PLA to PEG blocks or by the molecular 
weight of PLA segments [88]. However, due to steric hindrance of the fumarate groups 
along the chain and their lower reactivity (compared to acrylates and methacrylates) [88, 
221, 222], the gelation kinetics depended strongly on UV initiator and small molecule 
monomer concentrations [88]. It is well established that the viability of cells encapsulated 
in synthetic gels is largely determined by the fraction of small-molecule initiators and 
monomers that cross the cell membrane [42, 223].  
Terminal reactive groups at chain ends are less sterically hindered compared to 
those along the macromonomer chain. The reactivity of acrylates is an order of 
magnitude higher than fumarates [88, 141, 205]. In addition, star macromonomers have 
lower shear viscosity than linear ones at the same molecular weight [224], resulting in the 
onset of gelation at higher conversions and a higher extent of crosslinking. We 
hypothesized that a multi-arm star amphiphilic poly(ethylene oxide-co-lactide-glycolide) 
based macromonomer each arm terminated with an acrylate group would significantly 
increase the rate of crosslinking, thus reducing the minimum required concentration of 
initiator/monomer to produce robust networks. The objective of this work was to 
synthesize a novel star poly(ethylene oxide-co-lactide-glycolide acrylate) (SPELGA) 
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macromonomer and investigate the effect composition had on gelation kinetics and 
degradation of the hydrogels. In this work, SPELGA macromonomer was synthesized by 
ring-opening polymerization of lactide and glycolide monomers using hydrophilic 
pentaerythritol ethoxylate or poly(ethylene glycol) initiators, followed by acrylation of 
the chain ends with acryloyl chloride. The structure of the synthesized macromonomers 
was characterized by 
1
H-NMR and GPC. The kinetics of photopolymerization of the 
SPELGA macromonomers in aqueous solution was investigated by rheometry. The 




Lactide (LA; >99.5% purity by GPC) and glycolide (GL; >90% purity) monomers 
were purchased from Ortec (Easley, SC) and Boehringer Chemicals (Ingelheim, 
Germany), respectively. The ring opening polymerization initiators 4-arm pentaerythritol 
ethoxylate (PEE800; 15/4 EO/OH; Mn=797 Da; purity >98%) and 4-arm poly(ethylene 
glycol) (4PEG5K; nominal molecular weight of 5 kDa; purity >98%) were purchased 
from Sigma-Aldrich (St. Louis, MO), respectively. The initiators were dried by 
azeotropic distillation from toluene prior to the reaction. Triethylamine (TEA), tin (II) 2-
ethylhexanoate (TOC), N-vinyl-2-pyrrolidone (NVP), and acryloyl chloride were 
purchased from Sigma-Aldrich. Methylene chloride (MC; VWR) was dried by distillation 




3.2.2. SYNTHESIS OF SPELGA MACROMONOMER 
Star poly(ethylene oxide-co-lactide-glycolide) (SPELG) macromer was 
synthesized by ring-opening polymerization of LA and GA monomers with star 4PEE800 
or 4PEG5K initiators, following a procedure similar to the synthesis of low molecular 
weight poly(L-lactide) [205, 225, 226]. The schematic diagram for the synthesis of 
SPELG with 4PEE800 is shown in Figure 3.1. TOC was used as the polymerization 
catalyst and LA/GL ratio was 100/0 for SPELGA-5K and 100/0, 75/25, 50/50 for 
SPELGA-800. In a typical procedure for the synthesis of 100/0 SPELGA, 30g LA 
(0.2084 mol) and 0.0116 mol  initiator (7 ml 4PEE800 or 58 g 4PEG5K) were added to a 
three-neck reaction flask equipped with an overhead stirrer. The reaction flask was 
submerged in an oil bath and gradually heated to 110-120ºC to melt the monomers while 
under steady flow of nitrogen. After melting, 3 ml TOC as the polymerization catalyst 
was added to the reaction mixture with stirring. The reaction was allowed to proceed for 
6 h at 135ºC. Upon completion, the product was dissolved in DCM and precipitated in ice 
cold methanol, ether, and hexane to fractionate the PLA product and remove the 
unreacted monomer and initiator [225]. The solvent was decanted and the star SPELG 
product was vacuum dried (<5 mmHg) to remove any residual solvent and stored at -
20ºC. With TEA as the reaction catalyst, the chain ends of the star SPELG were acrylated 
by the reaction of acryloyl chloride with the hydroxyl end-groups of the SPELG (see 
Figure 3.1). Prior to this reaction the SPELG macromer was dried by azeotropic 
distillation from toluene to remove residual moisture. The polymer was cooled under 
steady flow of nitrogen and dissolved in dried DCM. The reaction flask was immersed in 




Figure 3.1. Reaction scheme for the synthesis of SPELGA macromonomer. The 4-arm 
PEG, lactide-co-glycolide segments, and terminal acrylate groups are shown by black, 
red, and blue colors, respectively.  
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5.6 ml acryloyl chloride and 9.7 ml TEA, each dissolved in DCM, were added drop-wise 
to the reaction with stirring. The reaction was allowed to proceed for 12 h under nitrogen 
flow. After completion of the reaction the solvent was removed by rotary evaporation and 
the residue was dissolved in anhydrous ethyl acetate to precipitate the by-product 
triethylamine hydrochloride salt. Next, ethyl acetate was removed by vacuum distillation; 
the macromonomer was re-dissolved in DCM and precipitated twice in ice cold ethyl 
ether. The macromonomer was dissolved in dimethylsulfoxide (DMSO) and further 
purified by dialysis to remove any unreacted acrylic acid. The SPELGA product was 
dried in vacuum (<5 mmHg) to remove residual solvent and stored at –20°C.  
3.2.3. MACROMONOMER CHARACTERIZATION 
The chemical structure of the SPELGA macromonomer was characterized by a 
Varian Mercury-300 
1
H-NMR (Varian, Palo Alto, CA) at ambient conditions with a 
resolution of 0.17 Hz as described [205]. The sample was dissolved in deuterated 
chloroform (Sigma-Aldrich, 99.8% deuterated) at a concentration of 50 mg/ml, and 1% 
v/v trimethylsilane (TMS; Sigma-Aldrich) was used as the internal standard. The 
molecular weight distribution of the macromonomer was measured by GPC [205]. 
Measurements were carried out with a Waters 717 Plus Autosampler GPC system 
(Waters, Milford, MA) connected to a model 616 HPLC pump, model 600S controller, 
and a model 410 refractive index detector. The columns consisted of a styragel HT guard 
column (7.8 x 300 mm, Waters) in series with a styragel HR 4E column (7.8 x 300 mm, 
Waters) heated to 37C in a column heater. The Empower software was used for 
determination of number ( nM ) and weight ( wM ) average molecular weights and 
polydispersity index (PI). The sample (20 l) with a concentration of 10 mg/ml in 
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tetrahydrofuran (THF) was eluted with degassed THF at a flow rate of 1 ml/min. 
Monodisperse polystyrene standards (Waters) with peak molecular weights (Mp) of 0.58-
19.9, 66.35, and 143.4 kDa and polydispersities of <1.1 were used to construct the 
calibration curve. 
3.2.4. SPELGA GELATION 
The SPELGA macromonomer was crosslinked in aqueous solution by free-radical 
UV polymerization with 4-(2-hydroxyethoxy) phenyl-(2-hydroxy-2-propyl) ketone 
(Irgacure 2959; CIBA, Tarrytown, NY) photo-initiator [88, 141, 211]. The photo-initiator 
was dissolved in distilled deionized (DI) water at 50ºC. The SPELGA macromonomer 
was dissolved in DI water by vortexing and heating to 50ºC to aid dissolution. The 
initiator solution was added to the SPELGA solution, this mixture was then vortexed and 
loaded on the Peltier plate of the rheometer. To make 10, 15, and 20% SPELGA 
precursor solution, 30, 45, and 60 mg of the macromonomer solution was added to 270, 
255 and 240 ml of the initiator solution, respectively. In samples with NVP added as a 
crosslinking agent, the initiator was first dissolved in the desired amount of NVP before 
addition to the macromonomer solution. The sample was irradiated with a BLAK-RAY 
100-W mercury long wavelength (365 nm) UV lamp (Model B100-AP; UVP, Upland, 
CA) [88]. The notation “SPELGAa-Lb-Mc-Nd-Ie” is used to identify the composition of 
the samples, where a, b, c, d and e represent initiator molecular weight, lactide fraction 
and macromonomer molecular weight, NVP and initiator concentrations (wt%), 
respectively. The results are for SPELGA, NVP and initiator concentrations of 25 wt%, 0 
mol%, and 0.16 mol%, respectively, unless otherwise specified. 
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3.2.5. RHEOLOGICAL MEASUREMENTS 
Rheological measurements were carried out at 37°C on an AR-2000 rheometer 
(TA Instruments, New Castle, DE) equipped with a parallel plate geometry (acrylic plate 
transparent to UV light; 20 mm diameter; TA Instruments) [88]. A sinusoidal shear strain 
profile was exerted on the sample via the upper geometry at a constant frequency of 1 Hz. 
The deformation amplitude was kept at 1% to remain within the linear viscoelastic 
region. The polymerizing mixture was injected on the Peltier plate and the upper 
geometry was lowered to a gap of 500 µm. The sample was irradiated with a long 
wavelength UV lamp (Model B100-AP; UVP, Upland, CA) as described above. The 
elapsed time between mixing/injection and the start of data collection was ≤1 min for all 
experiments. The storage modulus (G‟) during the gelation process was monitored by the 
rheometer. The intensity of the transmitted UV light was measured by a BLAK-RAY 
long wave ultraviolet radiation meter (Model J-221; UVP). The transparency of the 
acrylic geometry to long wave (365nm) UV light was confirmed by comparing the 
intensity of the transmitted light through the geometry to the incident light (transmitted 
intensity was >95%). The measured UV intensities at distances of 10, 30, 35, and 40 cm 
from the lamp were 46,000, 5,300, 4,000, and 3,000 µW/cm
2
, respectively. We have 
previously shown that a UV intensity of 46,000 µW/cm
2
 applied 10 cm from the sample 
and exposure time of 1800 s results in the highest extent of crosslinking [88]. Therefore, 
all gelation results are with UV intensity, distance, and exposure time of 46,000 μW/cm
2
, 
10 cm, and 1800 s, respectively. In the text,”modulus” is defined as the storage shear 
modulus of the sample after 1800 s of UV radiation. 
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3.2.6. MEASUREMENT OF SWELLING RATIO AND SOL FRACTION 
After crosslinking, samples with dimensions 20 mm diameter × 300 µm thickness 
were removed from the Peltier plate to measure their swelling ratio and sol fraction. 
Samples were dried at ambient conditions for 12 h followed by drying in vacuum for 1 h 
at 40°C and the total dry weights ( iW ) were recorded. Next, dry samples were swollen in 
DI water for 24 h at 37°C and swelling medium changed every 6 h. After swelling the 
surface water was removed and the swollen weight ( sW ) was recorded. Then, the swollen 
samples were dried as described above and the dry weight ( dW ) were recorded. The 
















S             equation 3.2  
3.2.7. MEASUREMENT OF DEGRADATION 
The SPELGA precursor solution was degassed, transferred into a PTFE mold 
(3cm × 5cm × 750µm), covered with a transparent glass plate fastened with clips, and UV 
crosslinked as described above. After crosslinking the sample was removed from the 
mold and disks were cut from the gel using an 8 mm cork borer. Degradation was 
measured as a function of time in primary culture media (5 ml per sample) without fetal 
bovine serum (FBS) at 37°C under mild agitation. To prepare the primary media 13.4 g 
of Dulbecco‟s Modified Eagle Medium (DMEM; 4.5 g/l glucose with L-glutamine and 
without sodium pyruvate; Mediatech, Herndon, VA) was dissolved in 900 ml of DI water 
containing 3.7 g sodium bicarbonate and 10 ml antibiotic and antimycotic agent (1% v/v). 
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At each time point samples were removed from the media, rinsed with DI water to 
remove excess electrolytes, and dried under vacuum. The dry sample weight was 
recorded and compared with the initial dry weight to determine fractional mass remaining 




H-NMR spectrum of SPELGA800-L50 is shown in Figure 3.2. The 
chemical shifts with peak positions at 1.6 and 5.2 ppm were attributed to the methyl (-
CH3) and methine ( CH ) hydrogens of the lactide units in SPELGA, respectively [227]. 
The shift centered at 4.8 ppm was attributed to the methylene hydrogens (=CH2) of the 
glycolide units in SPELGA. The shifts centered at 3.6 and 4.3 ppm were attributed to the 
methylene hydrogens (=CH2) of the 4-arm initiator (4PEE800 or 4PEG5K) attached to 
the ether (-CH2-O-CH2-) and ester (-CH2-OOC-) groups of lactide/glycolide units, 
respectively [227]. The chemical shifts with peak positions from 5.85-6.55 ppm were 
attributed to the vinyl hydrogens of the acrylate groups (-CH=CH2) at chain ends; the 
latter shifts were absent in the spectra of unacrylated SPELG (see the inset of Figure 3.2). 
The relative intensities of the NMR shifts of SPELGA macromonomers are presented in 
Table 3.1. The ratio of the shifts centered at 1.6 and 5.2 ppm (lactide hydrogens) to that at 
4.8 ppm (glycolide hydrogens) was related to the molar ratio of LA/GL. The ratio of the 
shifts centered at 1.6, 5.2, and 4.8 (lactide+glycolide hydrogens) to those at 3.6 and 4.3 
ppm (4-arm initiator hydrogens) was related to nM  of SPELGA. The ratio of the shifts 
centered at 5.85-6.55 ppm (acrylate hydrogens) to those at 3.6 and 4.2 ppm (initiator 
hydrogens) was related to the average number of acrylate groups per macromonomer. 




Figure 3.2. NMR spectra for SPELGA800-L50. The inset is the spectra of SPELG800-
L50 before acrylation.  
calculated from the NMR data are given in Table 3.1. For SPELGA800-L50 and 
SPELGA800-L75 with feed LA/GL ratios of 1.0 and 3.0, respectively, the actual ratios 
from the NMR data were 1.2 and 3.4. The actual LA/GL ratio was slightly higher than 
the feed indicating that the reactivity of lactide monomer with the growing chain was 
slightly higher than that of glycolide. The number of acrylate groups per macromonomer 
for SPELGA800-L50 and SPELGA800-L75 were 3.2 and 3.6, respectively. 
nM , wM , and PI of the synthesized SPELGA macromonomers which were 
measured by GPC are presented in Table 3.2. nM , wM , and PI of SPELGA800 were 
independent of LA/GL ratio. SPELGA5K, due to higher PEG chain length, had the 
highest molecular weight and lowest PI. The nM  values measured by GPC were within 
10% of the values calculated from the intensity of NMR shifts. All SPELGA 
macromonomers were dissolved in water, heated to 50ºC and crosslinked into a hydrogel.
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--- 1.0 2.42 1.52 6.03 1.82 1.2 1910 --- 
PLGAA800-
L50 
2.93 3.52 9.73 3.51 18.05 8.03 1.2 2260 3.2 
PLGAA800-
L75 
2.96 5.64 5.41 3.41 15.81 12.61 3.4 2600 3.6 
 
Table 3.2. nM , wM , and PI of the synthesized SPELGA macromers. 
 
Macromonomer 
nM  wM  
PI 
SPELGA800-L50 2490 4460 1.80 
SPELGA800-L75 2650 4900 1.85 
SPELGA800-L100 2640 4400 1.70 
SPELGA5K-L100 6570 9460 1.40 
 
The SPELGA800-L100 with low PEG molecular weight and 100% hydrophobic lactide 
fraction was not used in the subsequent gelation experiments due to its low solubility in 
aqueous solution. SPELGA5K-L100 had the highest solubility in water as measured by a 
turbidity test (data not shown). 
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To determine the effect of UV initiator on crosslinking, the gelation kinetics of 
SPELGA5K-L100-M25-N0 macromonomer were monitored by rheometry and the results 
are shown in Figure 3.3. As the initiator concentration was increased from zero to 0.11, 
0.16, and 0.22 mol%, modulus increased from 1.3±0.3 to 10.0±2.1, 27.1±4.1, and 
23.6±4.7, respectively. G‟ initially increased for up to 0.16 mol% initiator concentration 
and then decreased for >0.16 mol% concentration. Figures 3.4.a and 3.4.b show the effect 
of macromonomer concentration (based on the weight of polymerizing mixture) on the 
modulus and sol fraction of SPELGA5K-L100-N0-I0.16 gels, respectively. SPELGA5K, 
due to its higher solubility in water, was selected to study the effect of macromonomer 
concentration. There was a continuous increase in G‟ with increasing macromonomer 
concentration. G‟ increased from 0.16±0.03 to 0.47±0.12, 3.4±0.4, 5.9±1.0, 6.9±0.9, 
13.4±2.4, and 27.1±4.1 kPa as the macromonomer concentrations increased from 10 to 
12.5, 15, 17.5, 20, 22.5, and 25 wt%, respectively, with 170-fold overall increase in 
modulus. Sol fraction decreased from 17.8±1.1 to 15.6±1.5, 12.2±1.6, 13.8±3.0, 
12.0±1.2, 9.4±0.9, and 7.6±0.9% as the macromonomer concentration increased from 10 
to 12.5, 15, 17.5, 20, 22.5, and 25 wt%, respectively. The sol fraction of the PLEOF 
hydrogel with and without NVP monomer is also shown in Figure 3.4.b. SPELGA 
macromonomers with higher reactivity and lower steric hindrance of the acrylate groups 
had significantly lower sol fraction (S=8-18% in the absence of NVP) compared to 
PLEOF without (S=71%) or with (S=39%) NVP. It is well-established that the 
diffusivity/mobility of the growing chain affects gelation and the extent of crosslinking 
[88, 228]. Therefore, NVP was used to investigate the effect of a small molecule 




Figure 3.3 The effect of UV initiator concentration on shear storage modulus of 
SPELGA5K-L100-M25-N0 hydrogels. The intensity, distance from the sample, and 
exposure time of the UV radiation were 46,000 µW/cm
2
, 10 cm, and 1800 s, respectively. 
Values are the mean of three samples with error bars representing one standard deviation 
from the mean. 
show the effect of NVP concentration on the evolution and plateau modulus of  
SPELGA5K-L100-M25-I0.16 hydrogels, respectively. Addition of only 0.4 mol% NVP 
(0.004 moles NVP per mole of solution) to the polymerization mixture increased the 
modulus 2.2-fold from 27±4 (no NVP) to 60±10 kPa but the modulus did not change 
appreciably for concentrations >0.4 mol%. The gelation time of the samples was <60 s 
for all NVP fractions (50, 35, and 41 s for zero, 0.4, and 0.61% NVP, respectively). 
Based on Figure 3.5.a, addition of 0.4 mol% NVP affected modulus after the gelation 
point, but the curves were almost identical for higher NVP fractions. The effect of 
initiator molecular weight and LA/GL ratio of SPELGA-M15 on modulus is shown in 






























Figure 3.4. The effect of macromonomer concentration on the modulus (a) and sol 
fraction (b) of SPELGA5K-L100-N0-I0.16 hydrogel. The open square and open circle in 
(b) are the sol fractions of PLEOF hydrogels crosslinked without (17.5% 
macromonomer) and with (21% macromonomer) 4.1 mol% NVP crosslinker, 
respectively. The intensity, distance from the sample, and exposure time of the UV 
radiation were 46,000 µW/cm
2
, 10 cm, and 1800 s, respectively. Values are the mean of 
three samples with error bars representing one standard deviation from the mean. 
 
SPELGA800 (11.6±3.0 and 15.4±3.2 for SPELGA800-L75 and SPELGA800-L50, 
respectively). This can be attributed to the higher molecular weight of SPELGA5K 
compared to SPELGA800, resulting in lower density of reactive acrylate groups in the 
sample. 
 The effect of initiator molecular weight and LA/GL ratio on sample mass loss 
and swelling ratio is shown in Figures 3.7.a and 3.7.b, respectively. SPELGA800-L50 
with the highest content of the less hydrophobic glycolide monomer had the highest mass 




Figure 3.5. The effect of NVP monomer concentration on (a) evolution and (b) plateau 
shear storage modulus of SPELGA5K-L100-M25-I0.16 hydrogels.  The intensity, 
distance from the sample, and exposure time of the UV radiation were 46,000 µW/cm
2
, 
10 cm, and 1800 s, respectively. Values are the mean of three samples with error bars 
representing one standard deviation from the mean. 
 
example, after 4 weeks, SPELGA800-L50, SPELGA5K-L100, and SPELGA800-L75 lost 
50.0±7.7, 33.0±1.9, and 23±0.4% mass, respectively. The swelling ratios support the 
mass loss results with SPELGA5K and SPELGA800-L75 showing the highest and lowest 
water contents, respectively. For example, after 4 weeks SPELGA5K-L100, 
SPELGA800-L50, and SPELGA800-L75 had swelling ratios of 645, 43, and 7%, 
respectively, corresponding to water fractions of 87, 30, and 6 wt%. Interestingly, 
SPELGA800 hydrogel showed delayed swelling characteristics, which could potentially 




Figure 3.6. The effect of initiator molecular weight and LA/GL ratio of SPELGA 
macromonomer on shear storage modulus of SPELGA-M15-N0-I0.16 hydrogels. The 
intensity, distance from the sample, and exposure time of the UV radiation were 46,000 
µW/cm
2
, 10 cm, and 1800 s, respectively. Values are the mean of three samples with 
error bars representing one standard deviation from the mean. 
 
and SPELGA800-L75 had only 5.7 and 3.8 wt% water content after 4 weeks of 
incubation; however, their water content increased to 83 and 11 wt% after 7 weeks.  
3.4. DISCUSSION 
SPELGA macromonomers crosslinked in the absence of NVP (see Figure 3.5) 
produced a relatively high modulus hydrogel (27±4 kPa). The results in Figures 3.3 and 
3.5 demonstrate that initiator and NVP concentrations as low as 0.16 and 0.4 mol%, 

































Figure 3.7. The effect of initiator molecular weight and LA/GL ratio of SPELGA 
macromonomer on (a) mass loss and (b) swelling ratio of SPELGA-N0-I0.16 hydrogels. 
The intensity, distance from the sample, and exposure time of the UV radiation were 
46,000 µW/cm
2
, 10 cm, and 1800 s, respectively. Values are the mean of three samples 
with error bars representing one standard deviation from the mean. 
 
initiator and NVP concentrations used in this study were an order of magnitude lower 
than those used for gelation of the linear PLEOF macromonomer [88]. The higher 
reactivity of the acrylates in SPELGA compared to fumarates in linear PLEOF reduced 
the minimum required concentration of the initiator and NVP to produce robust networks. 
It is well established that the viability of cells encapsulated in hydrogels depends strongly 
on the concentration of small molecule initiator and monomer that can cross the cell 
membrane. Therefore, the lower initiator and NVP concentrations required for gelation 
has potential to improve biocompatibility of SPELGA hydrogels for cell encapsulation.  
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The modulus initially increased with initiator concentration for up to 0.16 mol% 
and then decreased at higher fractions. The dependence of propagation rate, 
PR , on 

































                         equation 3.3 
where ACPk ,  and tk  are the rate constant for chain propagation and termination, ACiR ,  is 
the radical initiation rate, ][AC  is the concentration of unreacted SPELGA acrylates,  is 
photo-initiation efficiency,   is molar extinction coefficient, 0
I is incident radiation 
intensity,   is gel thickness, and ][I  is the initiator concentration. Higher initiator 
concentrations below 0.16 mol% increased the rate of propagation, leading to a hydrogel 
with higher network density and higher modulus, as shown in Figure 3.3. At 
concentrations above 0.16 mol%, although the propagation rate continued to increase, 
there was a higher probability of localized formation of multiple radicals on growing 
chains, leading to cluster formation and increased cyclization within those clusters. This 
premise is supported by the decrease in gelation time from 460 s to 100, 50 and <30 s, as 
the initiator concentration was increased from zero to 0.11, 0.16, and 0.22 mole%, 
respectively. The increased cyclization and cluster formation reduced the modulus at 
initiator concentrations >0.16 mol%. Wang and collaborators observed a similar effect 
when UV intensity was increased above a threshold level in UV photocrosslinked 
polyacrylamide gels [230]. Similarly, a reduction in tensile modulus above a certain 
initiator concentration was reported for multi-functional methacrylamide, poly(ethylene 
glycol), and N-vinyl pyrrolidone hydrogels [231]. Results in Figure 3.3 indicate that the 
optimum initiator concentration in the absence of NVP was 0.16 mol%. 
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The addition of NVP monomer increased the hydrogel modulus, as shown in 
Figure 3.5. At any time there are monomers, linear and branched chains and a gel 
network in the polymerization reaction. The four propagation reactions involving the 






















             equation 3.7  
where [NVP] and [AC] are concentrations of unsaturated vinyl groups of NVP and 
SPELGA, respectively, and symbols “~” and “>” denote a linear or branch chain in the 
sol (not part of the network) and the gel, respectively. For example, ~X
*
 is a growing 
chain in the sol with a radical attached to X terminal group, with X being NVP (~NVP
*
) 




 denotes a growing chain in the gel with a 
radical attached to X terminal group. There are also four propagation reactions involving 
unreacted acrylates of those SPELGA macromonomers that are part of a chain in the sol 






















          equation 3.11  
Notation “br” stands for a branch in a chain (not part of the gel). Notations “d.c.” 
and “n.c.” denote a dangling (non-load bearing) and a network (load bearing) chain, 
respectively. In propagation reactions (3.4) and (3.5), a growing radical in the sol (~X
*
) 
reacts with an NVP and SPELGA monomer, respectively, with rate constants kP,Vs and 
kP,As. Reactions (3.4) and (3.5) produce linear or branched polymer chains that dilute the 
hydrogel network. In propagation reactions (3.6) and (3.7), a growing radical in the 
network (>X
*
) reacts with an NVP monomer and SPELGA macromonomer, respectively, 
with rate constants kP,Vg and kP,Ag, forming dangling radical chains in the network. In 
reaction (3.8), a growing radical in the sol reacts with a SPELGA acrylate that is part of a 
chain in the sol (~AC) with rate constant KP,br, thus adding a branch to the chain. 
Reactions (3.9) and (3.10) form dangling chains attached to the gel by the reaction of a 
growing radical in the sol with a SPELGA acrylate in the gel (>AC
*
; rate constant kP,dc1) 
or by the reaction of a growing radical in the gel with a SPELGA acrylate on a chain in 
the sol (~AC, rate constant kP,dc2). In reaction (3.11), a growing radical in the network 
(>X
*
) reacts with a SPELGA acrylate in the network (>AC) with rate constant kP,nc 
forming a network chain, as shown in Figure 3.8. Since the ratio of NVP/SPELGA vinyl 
groups for 0.4, 0.61, and 0.83 mol% NVP is 1.3, 2.1, and 2.7, respectively, reactions (3.4) 
through (3.11) all contribute to the polymerization and gelation. 
Reactions (3.4), (3.5), and (3.8) produce polymer chains in the sol which act as 




Figure 3.8. Schematic diagram to illustrate the cross-propagation reaction of the polymer 
chains in the sol with network-bound SPELGA acrylates to facilitate crosslinking: 
scheme a) SPELGA macromonomer with PEG (blue), LA/GL (green), and acrylate (red) 
groups; the growing polymer chain is shown with a purple dot at the chain end; scheme 
b) a growing chain in the sol (~X
*
) cross-propagates by reaction with a network-bound 
SPELGA acrylate (>AC; reaction 3.9) followed by propagation with SPELGA and NVP 
monomers (reactions 3.6 and 3.7) to form a propagating chain bound to the gel; scheme 
c) the growing chain in the gel cross-propagates with a network-bound SPELGA acrylate 
to form a load-bearing network chain (reaction 3.11). Some SPELGA macromonomers 
(4-arm blue stars) are shown with a smaller size for clarity.  
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reduces the trapping of reactive acrylate groups in localized SPELGA clusters. This 
increases the overall conversion, resulting in a higher storage modulus as shown in Figure 
3.5. Nowers and collaborators observed a similar effect when acrylated poly(ethylene 
glycol) (PEG) was added to epoxy polymerization [232]. Reactions (3.6) and (3.7) are 
propagation reactions between a growing radical on the network with NVP monomer and 
SPELGA macromonomer, respectively. In reactions (3.9) and (3.10), a growing radical 
on the network cross-propagates with a SPELGA acrylate on a chain in the sol, or a 
growing radical in the sol cross-propagates with a SPELGA acrylate on the network to 
form a dangling chain attached to the network. In reaction (3.11), a growing radical on 
the network (>X
*
) reacts with a network-bound SPELGA acrylate to form a load-bearing 
crosslink point (see Figure 3.8), leading to a hydrogel with a higher modulus (Figure 3.5). 
As the NVP fraction is increased beyond a certain value, the delay in the onset of 
diffusion-controlled polymerization counteracts the dilution effect of polymer chains in 
the sol. Ultimately, this leads to no further increase in modulus (see Figure 3.5 for 0.4, 
0.61, and 0.83 mol% NVP). Since the diffusivities of NVP monomer and NVP-rich 
growing chains (reactions 3.4 and 3.6) are relatively higher those that of SPELGA 
macromonomer and SPELGA-rich growing chains (reactions 3.5 and 3.7), the 
propagation reactions (3.6) and (3.7) and the cross-propagation reactions (3.9) and (3.10) 
serve as a bridge between the network-bound SPELGA acrylates to increase the number 
of network density. Therefore, the higher modulus of the hydrogels in the presence of 
NVP can be explained by the dilution effect of polymer chain in the sol to delay the onset 
of diffusion-controlled reaction, and by propagation of NVP monomer and growing 
chains with network-bound SPELGA acrylates to facilitate crosslinking.  
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The average molecular weight between crosslinks,
cM , can be determined by the 







                                              (equation 3.12) 
where  is the macromonomer mass density (1100 kg/m3), 'G  is modulus (Pa), R is gas 
constant (8.31 J/mol K), T is absolute temperature (310 K), and S is sol fraction (see Eq. 
3.2 and data in Figure 3.4.b). Using Eq. (3.12), cM decreased from 97  12 to 43 5 kDa 
as the NVP concentration was increased from 0 to 3.6 wt% for SPELGA5K-L100-P25-
I0.16 hydrogel.  
Degradation of SPELGA gels depends on the gel water content and density of 
hydrolytically degradable ester linkages. The relatively fast degradation of SPELGA800-
L50 can be contributed to the high density of degradable LA/GL units (70% LA/GL and 
30% 4PEE800), higher content of less hydrophobic glycolide monomer (50% by weight), 
and the autocatalytic effect of acidic degradation products [234]. SPELGA5K-L100 with 
76% by weight PEG content had high water content (540 wt% swelling ratio after 1 week 
as shown in Figure 3.7.b) but low density of degradable lactide units (24%), resulting in a 
degradation rate lower than that of SPELGA800-L50. SPELGA800-L75 with a high 
density of more hydrophobic lactide groups and low water content (see Figure 3.7.b) 
exhibited the lowest mass loss with time. 
3.5. CONCLUSION 
A novel star poly(ethylene oxide-co-lactide-glycolide acrylate) (SPELGA) 
macromonomer was synthesized and characterized with respect to gelation, sol fraction, 
degradation, and swelling in aqueous solution. We hypothesized that a multi-arm star 
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amphiphilic poly(ethylene oxide-co-lactide-glycolide) based macromonomer with each 
arm terminated with an acrylate group would significantly increase the rate of 
crosslinking, thus reducing the minimum required concentration of initiator/monomer to 
produce robust networks. Addition of only 0.4 mol% NVP to the polymerization mixture 
increased modulus by 2.2-fold but modulus did not change appreciably for higher NVP 
concentrations. The higher modulus can be explained by the dilution effect of polymer 
chains in the sol, to delay the onset of diffusion-controlled reaction, and by propagation 
of growing polymer chains with network-bound SPELGA acrylates to facilitate network 
formation. It is interesting to note that the minimum NVP concentration of 0.4% was at 
least an order of magnitude less than that used in previous studies for gelation of PLEOF 
macromonomers. Depending on macromonomer concentration, sol fraction ranged 
between 8-18%. The higher reactivity and lower steric hindrance of the acrylates in 
SPELGA compared to fumarates in PLEOF significantly reduced sol fraction and 
minimum NVP concentration to produce robust networks. SPELGA gels with highest 
LA/GL content (SPELGA800-L50) had the highest mass loss but lowest water uptake 
with incubation time which was attributed to the high fraction of degradable units and the 
autocatalytic effect of acidic degradation products. SPELGA gels with highest LA/GL 
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The overall goal of this work was to synthesize inert and non-fouling degradable 
hydrogels as a matrix for cell encapsulation. Hydrogels are hydrophilic polymeric 
networks that retain a significant fraction of water in their structure in physiological 
solution without dissolving. Nutrient molecules and proteins diffusive readily through 
hydrogels and cells immobilized in hydrogels display higher biological activity.[21-25] 
Due to these unique properties, hydrogels are very attractive as a matrix for cell 
encapsulation and delivery to the regeneration site in regenerative medicine.[26-30]   
Polyethylene glycol (PEG) hydrogels are used extensively as a matrix for cell 
encapsulation to elucidate the effect of physiochemical, mechanical, and biological 
factors in the microenvironment on cell fate in vitro.[36-39]  PEG hydrogels, due to their 
inert, hydrophilic and immunogenic nature, provide enormous flexibility in designing and 
controlling the cell microenvironment.[40, 41] Unlike small-molecule monomers that 
cross the cell membrane, the flexible PEG macromonomers crosslink to produce 
hydrogels with high compressive modulus without adversely affecting the viability of the 
encapsulated cells.[42-46] 
An exciting approach to in vivo tissue engineering is to deliver progenitor cells to 
the regeneration site in an inert matrix, such as the PEG hydrogel, and allow the 
encapsulated cells to secrete the desired extracellular matrix (ECM). In this approach, the 
encapsulated progenitor cells, guided by cell-cell interactions and soluble factors, create 
and reorganize their ECM as they go through lineage commitment, differentiation, and 
maturation. Although inert PEG hydrogels provide flexibility in controlling the cell 
microenvironment, their use for in vivo applications in tissue regeneration is limited by 
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their persistence (non-degradability) in the site of regeneration to provide free volume for 
tissue formation and remodeling. In that regard, design and synthesis of PEG hydrogels 
with hydrolytically degradable links would substantially increase their use as a cell 
delivery matrix in tissue regeneration.[47-49] 
Copolymerization of PEG with poly(lactide) (PLA) has been used to impart 
degradability to PEG macromers. However, due to the hydrophobicity of lactide, these 
copolymers form thermo-responsive physical gels in aqueous solution with orders of 
magnitude lower modulus than the covalently crosslinked PEG hydrogels.[150, 235] The 
degradation and water content of the copolymers could be adjusted by the fraction of 
hydrophobic lactide segments,[88, 178] but solubility of the copolymers in aqueous 
solution decreased with increasing lactide content.[56] Furthermore, the covalently 
crosslinked copolymer gels had significantly lower modulus compared to PEG hydrogels 
due to entrapment of reactive groups in micellar domains.[56, 59, 236, 237]  
We hypothesized that degradation and crosslink density of PEG-PLA gels and 
viability of encapsulated cells is strongly dependent on the number of lactides per 
macromonomer. We further hypothesized that PEG macromers with short lactide 
segments could produce mechanically robust hydrogels with tunable degradation rate. 
Previous molecular dynamic simulations demonstrated that the micelle size and reactivity 
of PEG-acrylates with short lactide segments depended strongly on the lactide segment 
length.[59]   
The objective of this work was to synthesize star 4-arm poly(ethylene oxide-co-
lactide) acrylate (SPELA) macromonomers and investigate the effect of number of 
lactides per macromonomer on gelation time, modulus, sol fraction, water content, and 
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degradation and to compare the results with the linear poly(ethylene oxide-co-lactide) 
acrylate (LPELA). Star PEG macromonomers have lower radius of gyration and shear 
viscosity, and higher density of functional groups than the linear PEGs,[25, 53] leading to 
the formation of gels with higher crosslink density and modulus.[54-57] Dissipative 
Particle Dynamics method[58, 59] was used to simulate aggregation and nanostructure 
formation and the distribution of reactive groups in SPELA and LPELA hydrogel 
precursor solutions. Bone marrow derived stromal cells (MSCs) were used to measure 
viability and differentiation of encapsulated cells to the osteogenic lineage. 
4.2. MATERIALS AND METHODS 
4.2.1.MATERIALS 
 Lactide monomer (LA; >99.5% purity) was purchased from Ortec (Easley, SC) 
and dried under vacuum at 40°C for at least 12 h prior to use. Calcium hydride, 
tetrahydrofuran (THF), deuterated chloroform (99.8% deuterated), trimethylsilane 
(TMS), triethylamine (TEA), tin (II) 2-ethylhexanoate (TOC), acryloyl chloride, 
dimethylsulfoxide (DMSO), Linear polyethylene glycol (LPEG, nominal Mw=4700), 4-
arm PEG ( SPEG, Mw=5000) Ethylenediaminetetraacetic acid disodium salt (EDTA), 
penicillin, streptomycin, and paraformaldehyde were purchased from Sigma-Aldrich (St. 
Louis, MO). The protected amino acids and Rink Amide NovaGel resin for the synthesis 
of acrylamide-terminated GRGD peptide were purchased from EMD Biosciences (San 
Diego, CA). Dichloromethane (DCM, Acros Organics, Pittsburgh, PA) was dried by 
distillation over calcium hydride. Diethyl ether and hexane were obtained from VWR 
(Bristol, CT). DCM Spectro/Por dialysis tube (molecular weight cutoff 3.5 kDa) was 
purchased from Spectrum Laboratories (Rancho Dominquez, CA). Dulbecco's phosphate-
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buffered saline (PBS) and Dulbecco's Modified Eagle's Medium (DMEM; 4.5 g/L 
glucose with L-glutamine and without sodium pyruvate) were obtained from GIBCO 
BRL (Grand Island, NY). Fetal bovine serum (FBS, screened for compatibility with rat 
BMS cells) was obtained from Atlas Biologicals (Fort Collins, CO). Trypsin and Quant-it 
PicoGreen dsDNA reagent kit were obtained from Invitrogen (Carlsbad, CA). 
QuantiChrom calcium and alkaline phosphatase (ALPase) assay kits were purchased 
from Bioassay Systems (Hayward, CA). BMP2 solution (100 μL, 1.5 mg/mL in BMP2 
buffer) was generously donated by Medtronic (Minneapolis, MN). The Live/Dead calcein 
AM (cAM) and Ethidium homodimer-1 (EthD) cell viability/cytotoxicity kit was 
purchased from Molecular Probes (Life Technologies, Grand Island, NY). 
4.2.2. SYNTHESIS OF LPELA AND SPELA MACROMONOMERS 
A two-step procedure was used to synthesize linear (LPELA) and star (SPELA) 
poly(ethylene glycol-co-lactide) acrylate macromonomers. In the first step, linear (LPEL) 
and star (SPEL) poly(ethylene glycol-co-lactide) macromers were synthesized by melt 
ring-opening polymerization with LPEG and SPEG, respectively, as polymerization 
initiators and TOC as the reaction catalyst, using a procedure similar to our previous 
work.[56] The PEG polymers were dried by azeotropic distillation from toluene.The LA 
and PEG were added to a three-neck reaction flask equipped with an overhead stirrer. 
The LA:PEG molar ratio was varied from 0 to 20 to synthesize macromonomers with 
different lactide segment lengths. The reaction flask was heated to 120ºC with an oil bath 
under steady flow of dry nitrogen to melt the reactants. Next, 1 ml of TOC was added and 
the reaction was allowed to continue for 8 h at 135ºC. After the reaction, the product was 
dissolved in DCM and precipitated in ice cold methanol followed by ether and hexane to 
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fractionate and remove the unreacted monomer and initiator. The synthesized LPEL and 
SPEL macromers were vacuum dried to remove any residual solvent and stored at -20ºC. 
In the next step, the terminal hydroxyl groups of LPEL and SPEL macromers 
were reacted with acryloyl chloride to produce LPELA and SPELA macromonomers, 
respectively. Prior to the reaction, macromers were dissolved in DCM and dried by 
azeotropic distillation from toluene to remove residual moisture. After cooling under 
steady flow of nitrogen, the macromer was dissolved in DCM and the reaction flask was 
immersed in an ice bath. Equimolar amounts of acryloyl chloride and TEA were added 
drop-wise to the solution to limit the temperature rise of the exothermic reaction. The 
reaction was allowed to proceed for 12 h. After the reaction, solvent was removed by 
rotary evaporation, the residue was dissolved in ethyl acetate to precipitate the by-product 
triethylamine hydrochloride salt. Next, ethyl acetate was removed by vacuum distillation, 
the macromer was re-dissolved in DCM and precipitated twice in ice cold ethyl ether. 
The synthesized macromonomer was dissolved in DMSO and purified by dialysis to 
remove any unreacted acrylic acid. The LPELA and SPELA products were dried in 
vacuum to remove residual solvent and stored at –40°C.  
4.2.3. MACROMONOMER CHARACTERIZATION 
The chemical structure of the macromonomers was characterized by a Varian 
Mercury-300  H-NMR (Varian, Palo Alto, CA) at ambient conditions with a resolution of 
0.17 Hz.[41] The sample was dissolved in deuterated chloroform at a concentration of 50 
mg/ml and 1% v/v TMS as the internal standard.  
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4.2.4. MACROMONOMER GELATION AND RHEOLOGICAL MEASUREMENTS 
The macromonomers were crosslinked in aqueous solution by UV free-radical 
polymerization with 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl) ketone (Irgacure 
2959; CIBA, Tarrytown, NY) photoinitiator as described.[56, 150] The initiator was 
dissolved in distilled deionized (DI) water at 50ºC. The macromonomer was dissolved in 
DI water by vortexing and heating to 50ºC. The macromonomer solution was added to 
the initiator solution, vortexed for 5 minutes, and loaded on the Peltier plate of the 
rheometer (TA Instruments, New Castle, DE) to monitor the crosslinking reaction. A 20 
mm plate acrylic geometry was used at a gap distance of 500 µm. A sinusoidal shear 
strain with frequency of 1 Hz and 1% strain was applied to the sample while sample was 
irradiated with a BLAK-RAY 100-W mercury long wavelength (365 nm) UV lamp 
(Model B100-AP; UVP, Upland, CA).[24, 45, 150] The UV exposure time for all 
samples was 1000s. The storage and loss moduli (
'',GG ) of the samples were recorded 
with irradiation time. The reported shear modulus is the measured G  after 1000 s of UV 
exposure. The notations LPELA-nLa-Mb and SPELA-nLa-Mb are used to identify the 
architecture (linear versus star) as well as composition of the samples, where a and b 
represent number of lactide monomers (nL) per macromonomer and macromonomer 
concentration (wt %), respectively. 
4.2.5. MEASUREMENT OF SWELLING RATIO AND SOL FRACTION  
After crosslinking, samples with dimensions 20 mm diameter × 300 µm thickness 
were removed from the Peltier plate to measure their swelling ratio and sol fraction. 
Samples were dried at ambient conditions for 12 h followed by drying in vacuum for 1 h 
at 40°C and the dry weight ( iw ) was recorded. Next, dry samples were swollen in DI 
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water for 24 h at 37°C and swelling medium changed every 6 h. After swelling, the 
surface water was removed and the swollen weight ( sw ) was recorded. Then, the swollen 
samples were dried as described above and the dry weight ( dw ) was recorded. The 

















                                                                     (equation 4.2) 
4.2.6. MEASUREMENT OF MASS LOSS 
The macromonomer precursor solutions were degassed, transferred to a PTFE 
mold (5 cm × 3 cm × 750 µm ), covered with a transparent glass plate, fastened with 
clips, and UV crosslinked as described.[41] Disc shape samples were cut from the gel 
using an 8 mm cork borer. The mass loss was measured in primary culture media (5 ml 
per sample) without fetal bovine serum at 37ºC and under mild agitation. The primary 
media was prepared by dissolving 13.4 g of Dulbecco‟s Modified Eagle Medium 
(DMEM) in 900 ml of DI water containing 3.7 g sodium bicarbonate and 10 ml antibiotic 
and antimycotic agents (1% v/v). At each time point, samples were removed from the 
media, washed with DI water several times to eliminate the excess salts and dried under 
vacuum. The dried sample weight was measured and compared with the initial dry weight 
to determine the fractional mass loss.  
4.2.7. BONE MARROW STROMAL CELL ISOLATION 
MSCs were isolated from the bone marrow of young adult male Wistar rats 
according to established protocols.[113, 238] Cell isolation was performed under a 
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protocol approved by the Institutional Animal Care and Use Committee of the University 
of South Carolina. The bone marrow cell suspensions were centrifuged at 200×g for 5 
min, cell pellets were re-suspended in 12 mL basal medium (DMEM supplemented with 
10% FBS, 100 units/mL penicillin (PEN), 100 µg/mL streptomycin (SP), 50 µg/mL 
gentamicin sulfate (GS) and 250 ng/mL fungizone (FZ)) and aliquoted into T-75 flasks. 
The flasks were subsequently maintained in a humidified 5% CO2 incubator at 37°C. 
Cultures were replaced with fresh medium at 3 and 7 days to remove haematopoietic and 
other unattached cells. After 10 days, cells were detached from the flasks with 0.05% 
trypsin-0.53 mM EDTA and used for in vitro experiments. 
4.2.8. ENCAPSULATION OF MSCS IN SPELA HYDROGEL 
SPELA-nL14.8 macromonomer was dissolved in PBS at 15 %wt and sterilized by 
filtration with a 0.2 µm filter. Acrylamide-terminated GRGD peptide (Ac-GRGD) was 
synthesized on Rink Amide NovaGel resin in the solid phase, purified by HPLC, and 
characterized by electrospray ionization (ESI) mass spectrometry as described 
previously.[113] To the macromonomer solution, 1 wt% Ac-GRGD (based on SPELA) 
was added to improve cell viability and cell-matrix interaction after MSC 
encapsulation.[113] For experiments with BMP2, 200 ng/mL of the protein was added to 
the precursor hydrogel solution.[239] Next, 1x10
6
 MSCs, suspended in 100 µL of PBS, 
was added to the SPELA macromonomer precursor solution and mixed gently with a pre-
sterilized glass rod. The density of MSCs in the gel was 2x10
6
 cells/mL. The mixture was 
injected between two sterile microscope glass slides and crosslinked by UV irradiation. 
After removing the gel from the glass slide under sterile condition, disks were cut with a 
sterile cork-borer and incubated in 2 ml PBS for 1 h with two PBS changes. Next, the 
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medium was replaced with osteogenic medium for two groups; with and without the 
addition of 200 ng/mL BMP2, and the encapsulated MSCs were incubated for 21 days. 
At each time point, some of the disks were stained with cAM/EthD live/dead assay (1 
µg/ml) to image live and dead cells, respectively. Stained samples were imaged with an 
inverted fluorescent microscope (Nikon Eclipse Ti-ε, Nikon, Melville, NY). 
At each time point, DNA content (cell number), ALPase activity, calcium content, 
and mRNA expression of osteogenic markers Dlx-5, Runx2, OP, and OC were measured. 
4.2.9. MEASUREMENT OF DNA CONTENT, ALPASE ACTIVITY, AND CALCIUM 
CONCENTRATION 
At each time point, some of the disks were homogenized and sonicated to rupture 
the membrane of the encapsulated cells and expose the DNA. Double stranded DNA 
(dsDNA) content of the homogenized samples were analyzed using a PicoGreen assay as 
described.[113] Analysis of dsDNA was performed using a Synergy HT plate reader 
(Bio-Tek, Winooski, VT) with emission and excitation wavelength of 485 and 528 nm, 
respectively. Alkaline phosphatase (ALPase) activity of the samples were measured with 
p-nitrophenyl phosphatase (Sigma-Aldrich) on a Synergy HT plate reader at 405 nm as 
described.[113] The measured p-nitrophenol concentration was correlated to ALPase 
activity in IU/L and normalized to cell numbers. Calcium content of the samples, as a 
measure of the total mineralized deposit in the sample, was measured using QuantiChrom 
Calcium Assay kit as described.[113] The absorbance was measured on a Synergy HT 
plate reader at 575 nm. Measured intensities were correlated to the amount of equivalent 
Ca
2+




4.2.10. mRNA ANALYSIS 
At each time point, total cellular RNA was isolated using TRIzol (Invitrogen, 
Carlsbad, CA) or RNeasy Mini-Kit (Qiagen, Valencia, CA) and analyzed with NanoDrop 
2000 (Thermo Scientific, Waltham, MA) as described.[113] 1µg of the extracted total 
RNA was subjected to cDNA conversion using the Reverse Transcription System 
(Promega, Madison, WI). The obtained cDNA was subjected to real time polymerase 
chain reaction (PCR) amplification with appropriate gene specific primers. The 
expression level of ribosomal protein S16 was used as the endogenous control. Primers 
for real-time PCR analysis were designed and selected using the Primer3 web-based 
software as described.[188] The PCR products were analyzed by agarose gel 
electrophoresis. The annealing temperatures and other parameters for amplification were 
optimized by classical PCR and agarose gel electrophoresis as described.[188] Real-time 
PCR (RT-qPCR) was performed to analyze the differential expression of Dlx5 and 
Runx2, markers for osteogenic differentiation, osteopontin (OP, early marker), and 
osteocalcin (OC, late marker) with SYBR green RealMasterMix (Eppendorf, Hamburg, 
Germany) using Bio-Rad CXF96 PCR system (Bio-Rad, Hercules, CA). The following 
forward and reverse primers were synthesized by Integrated DNA technologies 
(Coralville, IA): OP: forward 5′-GAC GGC CGA GGT GAT AGC TT-3′  and reverse 5′-
CAT GGC TGG TCT TCC CGT TGC-3′; OC: forward 5‟-AAA GCC CAG CGA CTC 
T-3′ and reverse 5‟-CTA AAC GGT GGT GCC ATA GAT-3′; Dlx5: forward 5′- CCT 
CAT GGC TAC TGC TCT CC-3′ and reverse 5′-CTC GGC CAC TTC TTT CTC TG-3′; 
Runx2: forward 5′-GCC GGG AAT GAT GAG AAC TA-3′ and reverse 5′-GGA CCG 
TCC ACT GTC ACT TT-3′; S16: forward 5′-AGT CTT CGG ACG CAA GAA AA-3′ 
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and reverse 5′-AGC CAC CAG AGC TTT TGA GA-3′.[240] Quantification of gene 
expression was based on the crossing-point threshold value (CT) for each sample, which 
was evaluated by the Relative Expression Software Tool (RESTTM) as the average of 
three replicate measurements.[241] The model of Pfaffl was used to determine the 
expression ratio of the gene.[241] The expression of S16 housekeeping gene was used as 
the reference and the fold difference in gene expression was normalized to the first time 
point. 
4.2.10. STATISTICAL ANALYSIS 
 Data are expressed as means±standard deviation. All experiments were done in 
triplicate. Significant differences between groups were evaluated using a two-tailed 
Student's t-test. A value of p<0.05 was considered statistically significant. 
4.3. SIMULATION METHOD 
The aqueous solutions of SPELA and LPELA macromonomers were simulated 
via Dissipative Particle Dynamics (DPD) approach, as described previously.[59] Figure 
4.1 shows the molecular structure and different bead types on SPELA and LPELA 
macromonomers. The bead types with equal mass and volume in the simulation volume 
were L (one lactide monomer), EO (four ethylene oxide repeat units), Ac (the acrylate 
group), SPEGc (the star PEG center) and W (eight water molecules). In DPD, each bead 
represents a soft particle interacting with the other beads via a soft pair-wise force 
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Figure 4.1. Coarse-grained representations of LPELA and SPELA macromonomers, 
respectively. Colors yellow, green, brown, and red represent SPEGc center, EO and L 
repeat units, and Ac terminal group. In a given arm, the length of lactide segment was 
significantly less than that of EO, leading to micellization and structure formation on the 
nanoscale. 
 
random and spring components of the force, respectively. Different components of the 
















                                                        (equation 4.4)
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(equation 4.7)
  
     
where ijr  is the vector joining bead i to j, ije  and ijr  are the unit vector in the direction 
of ijr and the magnitude of ijr respectively. ijv  is the velocity vector given by jiij vvv  . 
Dw and Rw are weight functions for dissipative and random forces, respectively, and  , 
  are the magnitude of the dissipative and random forces. The DijF and 
R
ijF act together 
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D rwrw   and
 TkB2
2  )[242] to preserve the dissipation as well as conservation of total 
momentum of the system. The spring force term acts to impose geometrical constraints 
on the covalently bonded beads[244]. The values of   and C constants were 4.5 and 4 
respectively[59, 244]. The repulsion between beads i and j is mainly dictated by the 
constant ijα  
in the conservative force function.  By choosing the system density 3  
3
cr , the DPD length scale, cr , was 8.18 Ǻ and the pair-wise interaction parameter 
between beads i and j, ijα , were determined using[58]: 






is the Flory-Huggins parameter between beads i and j. The values of 
ij  
in turn 







                                      (equation 4.9)  
where i and j are the solubility parameters of beads i and j, respectively, V is the bead 
molar volume, T is absolute temperature, and R is the gas constant. The solubility 
parameters were calculated via atomistic molecular dynamics simulation (Forcite and 
Amorphous Cell  modules, Materials Studio v5.5, Accelrys)[152] using the COMPASS 
force field, which is an ab initio force field optimized for condensed-phase systems[245]. 
The position and velocity of the beads at each time point were determined by 






   





m                                   (equation 4.10)  
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All DPD simulations were performed in a 303030 rc simulation box with 3D periodic 
boundary conditions with over 200000 time steps and dimensionless time step of 0.05. 
The Mesocite module of the Materials Studio (v5.5) was used to perform the DPD 
calculations.[152]  
4.4. RESULTS AND DISCUSSION 
4.4.1. MACROMONOMERS CHARACTERIZATION 
NMRH1   spectrum of SPELA-nL14.8 macromonomer is shown in Figure 4.2. 
NMR spectra of other SPELA macromonomers and LPELA are provided in Figures 4.3. 
The chemical shifts with peak positions at 3.6 and 4.3 ppm were attributed to the 
methylene hydrogens ( 2CH ) of PEG attached to ether (  22 CHOCH ) and ester 
(  OOCCH2 ) groups of lactide respectively.[246] The shifts with peak positions at 
1.6 and 5.2 ppm were attributed to the methyl ( 3CH ) and methine ( CH ) groups of  
lactide respectively.[246] The shifts with peak positions from 5.85 to 6.55 ppm (see the 
insets in Figure 4.2 and Figure 4.3) were attributed to the vinyl hydrogens ( 2CHCH  ) 
of the acrylate group at the end of each macromonomer arm as follows: Peak positions in 
the 5.82-5.87 ppm range were associated with the trans proton of unsubstituted carbon of 
the Ac; those in the 6.10-6.20 ppm range corresponded to the protons bonded to 
monosubstituted carbon of the Ac; and those in the 6.40-6.46 ppm range were associated 
with the proton of unsubstituted carbon of the acrylate group. The nM of SPELA was 
determined from the ratio of shifts centered at 1.6 and 5.2 ppm (lactide hydrogens) to 
those at 3.6 and 4.3 ppm (PEG hydrogens).  The number of acrylate groups per 







H-NMR spectrum of SPELA-nL14.8 macromonomer. The inset shows the 
chemical shifts with peak positions between 5.8 and 6.5 at higher intensity. 
 
(acrylate hydrogens) to those at 3.6 and 4.2 ppm (PEG hydrogens). The number of lactide 
monomers (nL) and functional acrylate groups per macromonomer, and nM  for LPELA 
and SPELA macromonomers as a function of lactide to PEG (LEGF) molar feed ratio are 
summarized in Table 4.1. LEGF ratio was varied from zero to 20 with intervals of 5. The 
nL values, shown in the first column, changed from 0 to 3.4, 6.4, 11.6 and 14.8 for 
SPELA and from 0 to 3.6, 7.4, 9.6 and 14.8 for LPELA as LEGF values were increased 
from zero to 5, 10, 15, and 20, respectively. As LEGF ratio was increased from zero to 
20, nM of SPELA (column 2) increased from 5.2 to 7.4 kDa and nM of LPELA 
increased from 4.7 to 6.8 kDa. As LEGF ratio was increased from zero to 20, number of 
lactides per arm of the macromonomer (column 4) increased from zero to 3.7 for SPELA 
and from zero to 7.4 for LPELA. The range for acrylate fraction per arm of SPELA and 






H-NMR spectrum of (a) SPELA-nL0 , (b) SPELA-nL3.4 , (c) SPELA-nL6.4 
and (d) SPELA-nL11.6,  (e) LPELA-nL0 , (f) LPELA-nL3.6 , (g) LPELA-nL7.4 , (h) 
LPELA-nL9.6 and (i) LPELA-nL14.8 macromonomers. The inset shows the chemical 
shifts with peak positions between 5.8 and 6.5 at higher intensity. EO, L, and Ac 




Table 4.1. Number of lactide monomers (nL), number-average molecular weight ( nM ), 
average number of lactide units per end group, and average number of acrylate groups 
per end group for SPELA and LPELA macromonomers as a function of lactide to PEG 
molar feed ratio in the polymerization reaction. 
 
Macromonomer nM  
Lactide units per end 
group in the feed  
Lactide units  
per end group 
Acrylate groups  
per end group 
SPELA-nL0 5300 0 0 0.85 
SPELA-nL3.4 5800 1.25 0.8 0.86 
SPELA-nL6.4 6200 2.5 1.6 0.82 
SPELA-nL11.6 6900 3.75 2.9 0.74 











LPELA-nL3.6 5200 2.5 1.8 0.85 
LPELA-nL7.4 5800 5 3.7 0.87 
LPELA-nL9.6 6100 7.5 4.8 0.77 
LPELA-nL14.8 6800 10 7.4 0.71 
 
that the standard deviation from the mean (s.d.) for, nM , average number of lactide units 
per end group, and average number of acrylates per end group were 100 Da, 0.1, and 
0.05, respectively. Therefore, the differences in acrylate groups per end group for 
SPELA-nL0, SPELA-nL3.4, and SPELA-nL6.4 (0.85, 0.86, and 0.82, respectively) and 
those between LPELA-nL0, LPELA-3.6 nL, and LPELA-7.4 nL (0.89, 0.85, and 0.87, 
respectively) were not statistically significant. In general, there was a decrease in the 
average number of acrylates per arm with increasing nL. This decrease was related to 
higher steric hindrance of hydroxyl endgroups in LPELA and SPELA macromonomers 
with longer length of lactide segments, leading to a lower effective reactivity with 




4.4.2. GENERAL OBSERVATIONS IN RHEOLOGICAL EXPERIMENTS 
Time evolution of the shear storage modulus ( G ) for gelation of SPELA 
macromonomer as a function of number of lactide monomers (nL) is shown in Figure 4.4. 
The intersection of storage and loss moduli ( G  , not shown in the figure), where G= 
G  , was used to determine the gelation time. All time sweep tests exhibited a lag or 
induction time, a developing portion, and a plateau region.[24] However the length of 
each region as well as the final value of Gwere affected by the macromonomer 
structure, i.e., linear versus star and the number of lactides. In general, the time for 
induction/lag time decreased with increasing nL, because the average distance between 
the reactive acrylate groups of the macromonomers decreased with increasing nL (see 
Figure 4.3). The slope and duration of the developing portion of the gelation curve 
decreased with increasing nL, mainly due to micelle/cluster formation by the 
hydrophobic lactide segments (See Figure 4.3). There was also a decrease in plateau 
shear modulus with increasing nL due to micelle/cluster formation (see Figure 4.3).  
4.4.3. EFFECT OF INITIATOR ON GELATION KINETICS 
The effect of initiator concentration on the storage modulus and gelation time of 
LPELA-nL7.4 and SPELA-nL14.8 macromonomers (both having 3.7 lactide monomers 
per end group) is shown in Figure 4.5.a and 4.5.b, respectively. SPELA-nL14.8 had the 
longest hydrophobic lactide segment length, compared with other SPELA 
macromonomers, potentially leading to highest steric hindrance of the acrylate groups in 
each arm in aqueous solution and lowest effective reactivity during cross-linking. 
Therefore, the effect of initiator concentration on gelation was investigated with SPELA-




Figure 4.4. Effect of number of lactide monomers per macromonomer on time evolution 
of the storage modulus of SPELA-M20 hydrogels. 
 
 
Figure 4.5. Effect of UV initiator concentration on (a) storage modulus and (b) gelation 
time of LPELA-nL7.4-M20 and SPELA-nL14.8-M20 hydrogels. Error bars correspond to 




length was used for comparison. It is well established that the viability of cells 
encapsulated in synthetic gels is adversely affected by low molecular weight species such 
as initiator, crosslinker, and small-molecule monomers that cross the cell membrane.[42] 
On the basis of previous studies, photoinitiator concentrations >2 wt% (based on the 
weight of macromonomer) significantly decreased viability of the seeded cells.[43] 
Therefore, the effect of initiator on gelation of SPELA and LPELA was tested with 
concentrations <1.4 wt%. In the absence of photoinitiator (0.00 wt%) the modulus of 
LPELA-nL7.4 and SPELA-nL14.8 systems was 0.13 and 0.08 Pa respectively and 
 'G/''G  was 5.3 and 1.8. Therefore, the precursor solutions without initiator did not 
form a hydrogel network with UV irradiation (no gelation time in Figure 4.5.b). For each 
initiator concentration, the modulus of SPELA gel was significantly higher than that of 
LPELA. The modulus of the hydrogels showed a maximum at 0.38 wt % initiator 
concentration for both LPELA-nL7.4 and SPELA-nL14.8 macromonomers. As the 
initiator concentration was increased from 0.08 to 0.38 wt%, the modulus of LPELA and 
SPELA gels initially increased from 13.1  3.0 to 20.2 4.1 kPa and from 17.5 2.0 to 
37.5 2.5 kPa, respectively. After that, the modulus decreased to 17.2  2.1 and 32.9
2.5 kPa for LPELA and SPELA hydrogels, respectively, when the initiator concentration 
was increased to 1.31 wt%. The modulus of the gels did not change for initiator 
concentrations >0.8 wt%. The initial increase in the gel modulus with initiator 
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where PK and tK are the rate constants for chain propagation and termination 
respectively, iR is the radical initiation rate, ]AC[  is the concentration of unreacted 
acrylates,   is initiation efficiency,   is molar extinction coefficient, 0I is the intensity 
of incident radiation,   is sample thickness, and ]I[ is photoinitiator concentration. 
According to equation 4.12, the rate of radical production increased with increasing 
initiator concentration to 0.38 wt% leading to a higher propagation rate of acrylates and 
higher extent of crosslinking. For initiator concentrations exceeding 0.38 wt%, the 
probability of formation of more than one radical on the same macromonomer increased, 
which led to the formation intra-molecular crosslinks, as opposed to inter-molecular 
crosslinks, and cluster formation and a decrease in storage modulus.[56] For initiator 
concentrations >0.8 wt%, the increase in propagation rate was offset by the increase in 
the rate of intra-molecular crosslinking, resulting in no change in modulus with increase 
in initiator concentration.  
As the initiator concentration was increased from 0.08 to 0.78 wt%, gelation time 
of LPELA and SPELA macromonomers decreased from 140  5 to 45 1 s and from 200
 9 to 42 2 s, respectively. At low initiator concentrations (0.08 to 0.23 wt%), SPELA 
had higher gelation times than LPELA but the two macromonomers reached similar 
gelation times for concentrations >0.5 wt%. The total volume of the hydrophobic 
domains in SPELA-nL14.8 was higher than LPELA-nL7.4. As a result, at low initiator 
concentrations, it was more likely for the SPELA polymerization reaction to become 
diffusion controlled than LPELA, leading to a higher gelation time for SPELA. As the 
initiator concentration was increased above 0.23 wt%, the reaction became less controlled 
by diffusion, leading to comparable gelation times for LPELA and SPELA at higher 
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concentrations. In addition, the higher concentration of reactive acrylates in SPELA was 
offset by the higher probability of intra-molecular crosslinking, leading to comparable 
gelation times for SPELA and LPELA at initiator concentrations >0.23 wt%. In the 
experiments that follow, the initiator concentration of 0.75 wt% was used, unless 
otherwise specified, to have low gelation times as well as high shear storage moduli. 
4.4.4. EFFECT OF MACROMONOMER CONCENTRATION ON GELATION 
KINETICS  
The effect of macromonomer concentration in the hydrogel precursor solution on 
gelation time and modulus of LPELA-nL7.4 and SPELA-nL14.8 hydrogels is shown in 
Figures 4.6.a and 4.6.b, respectively. The gelation time of SPELA gels decreased from 45
 8 to 30 1 s whereas LPELA gels decreased from 65  8 to 32 6 s as the 
macromonomer concentration increased from 10 to 25 wt%. The storage modulus of 
LPELA and SPELA gels increased from 1.2  0.5 to 28.3 3.5 kPa and from 1.5 0.6 to 
61.0 6.2 kPa, respectively, with increasing macromonomer concentration from 10 to 25 
wt%. In the absence of a crosslinker, the dependence of propagation rate of the 
crosslinking reaction on the concentration of reactive acrylate groups is given by Eq. 
4.11. According to that equation, higher acrylate concentrations increase propagation rate 
and density of crosslinks for both LPELA and SPELA macromonomers. Therefore, the 
decreasing trend of gelation time with increasing SPELA and LPELA macromonomer 
concentrations as well as the lower gelation time of SPELA at constant concentration (see 
Figure 4.6.a) can be attributed to the higher concentration of acrylates.[56]  
The shear modulus of an ideal network is proportional to the density of elastically 




Figure 4.6. Effect of macromonomer concentration on (a) storage modulus and (b) 
gelation time of LPELA-nL7.4 and SPELA-nL14.8 hydrogels. Error bars correspond to 
means ± 1 SD for n = 3. 
 
RTG E                                                                                                        (euation 4.13) 
where E  is the concentration of elastically active chains, R is the gas constant and T is 
absolute temperature. The higher acrylate densities for SPELA compared to LPELA and 
higher macromonomer concentrations led to higher propagation rates, higher density of 
elastically active chains, and higher modulus. Furthermore, due to a larger average 
distance between the macromonomers at low concentrations, the probability of intra-
molecular crosslinks that lead to loop formation and cyclization was higher.[24] Since 
intra-molecular crosslinks are not elastically active and do not contribute to the network 
modulus, the higher density of acrylates in SPELA was offset by higher intra-molecular 
crosslinks, leading to a smaller difference between the moduli of SPELA and LPELA 
gels at low concentrations (see Figure 4.5.b). As macromonomer concentration was 
increased, the probability of intra-molecular links decreased,[162] leading to higher 
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fraction of elastically active crosslinks in SPELA and larger difference between the 
moduli of SPELA and LPELA. 
As shown in Figure 4.6.b, the shear modulus of SPELA gels was significantly 
higher than those of LPELA for all macromonomer concentrations. For example, the ratio 
of LPELASPELA 'G/'G  increased from 1.2 at 10 wt% macromonomer concentration to 2.2 at 
25 wt%. As mentioned in the last paragraph, the lower values of LPELASPELA 'G/'G  
 at low 
concentrations can be attributed to the macromonomer architecture and its effect on nano-
scale structure formation. DPD simulations of the macromonomers in aqueous solution 
showed a uniform distribution of Ac beads over the simulation box in the absence of L 
beads [60]. With the addition of lactide segments to the macromonomer, the hydrophobic 
L and Ac beads aggregated and formed core of the micelles, as shown in Figure 4.7.a for 
SPELA-nL14.8-M20 . (W, EO and SPEGc beads are not shown for clarity.) The cross-
section of one of the micelles corresponding to the DPD simulations in Figure 4.7.a  is 
shown in the Figure 4.6.b. According to simulation results, hydrophilic ethylene oxide 
segments (EO beads) of the macromonomers surrounded the core and formed the 
micelle‟s corona. Localization of Ac beads in the micelles‟ cores led to the formation of  
elastically active inter-molecular and elastically inactive intra-molecular crosslinks. To 
quantify the proximity of Ac beads to other beads on the same macromonomer, the 
average number of intra-molecular acrylate beads [( )R(IN Acraint  ] in a sphere of radius R 








Figure 4.7. (a) DPD simulation of micellar cores for SPELA-nL14.8- M20; L and Ac 
beads  are shown in brown and red, respectively, whereas other beads are not shown for 
clarity. (b)  simulated crosssection of one of the micelles in panel a; L, Ac, EO, and 
SPEGc beads are shown in brown, red, green, and yellow, respectively, whereas water 
beads are not shown for clarity. (c) Intramolecular running integration number (IN) for 
Ac−Ac beads as a function of radius around an Ac bead for LPELA-nL7.4 and SPELA-
nL14.8 macromonomers in aqueous solution. SPELA macromonomers have significantly 
higher Ac−Ac integration number than LPELA, leading to shorter gelation times and 
higher modulus. 
 
where 0Ac  is the overall number density of Ac beads and Acraintg  (r) is the radial 
distribution function of intra-molecular acrylates in a shell of infinitesimal thickness at 
distance r from each Ac bead, located at the origin. The AcraintIN   profile for LPELA and 
SPELA hydrogels at 10% and 25% macromonomer concentrations is shown in Figure 
4.7.c. The AcraintIN   for LPELA and SPELA at R=15 Å decreased from 0.22 to 0.16 and 
from 0.93 to 0.60, respectively, with increasing macromonomer concentration from 10% 
to 25%. Therefore, the probability of intra-molecular reaction for SPELA was more 
 
79 
sensitive to macromonomer concentration than that of LPELA. This effect is reflected in 
the higher  LPELASPELA 'G/'G  
ratios at higher macromonomer concentrations. Hiemstra et 
al. synthesized star eight-arm methacrylate-functionalized PEG-PLLA (L-lactide) and 
PEG-PDLA (D-lactide) with molecular weight of 28 kDa and 12 lactides per 
macromonomer. The modulus of those gels was generally <10 kPa, which is significantly 
lower than the four-arm SPELA gel synthesized in this work [57]. The effect of 
macromonomer concentration on swelling ratio and sol fraction of LPELA-nL7.4 and 
SPELA-nL14.8  hydrogels is shown in Figures 4.8.a and 4.8.b, respectively. The LPELA-
nL7.4-M10 samples disintegrated upon removal from peltier plate of the rheometer, so 
the swelling and sol fraction of that sample was not measured. The swelling ratio of 
SPELA and LPELA gels decreased from 430 to 300% and from 810 to 580%, 
respectively, as the macromonomer concentration increased from 10/15% to 25%. The 
higher swelling ratio of LPELA gels compared to SPELA was related to the lower 
fraction of hydrophobic segments per macromonomer in LPELA along with lower 
crosslink density of LPELA gels. Sol fraction of LPELA gels decreased from 32.1  2.0% 
to 26.8 1.5% as concentration increased from 15 to 25%. The sol fraction of SPELA 
decreased from 13.2  1.1 to 11.6 1.1, 6.4 1.0 and 4.9 0.9 as macromonomer 
concentration increased from 10 to 15, 20 and 25%, respectively. Sol fraction of the 
hydrogels decreased by 2.7, 4.8 and 5.4 folds by changing macromonomer architecture 
from linear to star at 15, 20 and 25% concentration, respectively. The significantly lower 
sol fraction of SPELA hydrogel compared to LPELA was due to the higher concentration 
of reactive acrylate groups in SPELA at the same macromonomer concentration. The 




Figure 4.8. Effect of macromonomer concentration on (a) swelling ratio and (b) sol 
fraction of LPELA-nL7.4 and SPELA-nL14.8 hydrogels. Error bars correspond to means 
± 1 SD for n = 3. 
decrease in inter-molecular distance between the acrylate groups with concentration, 
which enhanced the probability of formation of elastically active crosslinks. 
4.4.5. EFFECT OF NUMBER OF LACTIDES PER MACROMONOMER ON 
GELATION KINETICS  
Figure 4.9 (a,b) shows the effect of number of lactide monomers per 
macromonomer on shear modulus and gelation time, respectively, for LPELA-M20 and 
SPELA-M20 hydrogels. G  of the hydrogels initially decreased from 116  10 kPa to 58
 2 kPa and from 69 8 kPa to 26 4 kPa with the addition of 3.6 and 3.4 lactide 
monomers per macromonomer (nL) for SPELA and LPELA hydrogels, respectively, 
corresponding to 1.8 and 0.85 monomers per arm of LPELA and SPELA hydrogels. 
Afterward, G  decreased at a slower rate to 6.5 2.5 kPa and 37.0 2.0 kPa for LPELA 
and SPELA gels, respectively, when nL increased to 14.8. The gelation time of SPELA 




Figure 4.9. Effect of number of lactide monomers per macromonomer (nL) on (a) storage 
modulus and (b) gelation time of LPELA-M20 and SPELA-M20 hydrogels. Error bars 
correspond to means ± 1 SD for n = 3. 
 
 10 s to 39  2 s with increasing nL from 0 to 14.8. The decrease in G and gelation time 
of the hydrogels with increasing lactide segment length is related to aggregation and 
micelle formation of the macromonomers in aqueous solution. The size of the micelles‟ 
core increased with increasing lactide segment length[60]. At any given time, 
macromonomer arms can have one of three conformations, namely bridge, which 
connects two different micelle cores, loop with at least two arms of a macromonomer in 
the same micelle, and free arm which is in solution (not part of the micelles).[59] The 
dynamic nature of these conformations leads to the formation of a transient physical 
network in the precursor solution. In SPELA-nL0 system, the gelation time was high due 
to a relatively large average distance between the uniformly distributed acrylate groups. 
The localization of reactive acrylate groups in the micelles core with increasing lactide 
content decreased the average distance between the acrylate groups.[59] As a result, the 
reaction rate between acrylates increased with increasing lactide segment length. In 
addition, the lifetime of the bridging arms in the core increased with increasing lactide 
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segment length.[59, 249] Those factors worked together to decrease gelation time with 
increasing lactide content of the macromonomer. At the same time, due to very low water 
content of the micelles, mobility of the acrylate groups and diffusion of initiator in the 
micelles significantly decreased with increasing micelles‟ core size. As a result, a fraction 
of the acrylates, trapped in the micelles‟ core, did not react to form elastically active 
crosslinks, which led to a decrease in the hydrogel  modulus with increasing 
macromonomer lactide content.      
The effect of number of lactides per macromonomer on sol fraction and swelling 
ratio of LPELA and SPELA hydrogels is shown in Figure 4.10.a and 4.10.b, respectively. 
The swelling ratio of LPELA gels decreased dramatically from 700% to 110% when nL 
increased from 0 to 14.8 while that of SPELA decreased slightly from 430% to 350%. 
The decrease in network density with increasing nL had a positive effect on swelling ratio 
whereas the increase in hydrophobicity with increasing nL had a negative effect on 
swelling ratio. . The molecular weight between crosslinks, cM , for an ideal network in 






























                (equation 4.15) 
where F is functionality of crosslinks (three for crosslinks at chain ends), nM is 
macromonomer molecular weight, G is the network modulus,   is specific volume of the 
macromonomer, and r,2 and s,2 are the macromonomer volume fraction in the 
crosslinked gel before and after swelling equilibrium, respectively. According to the 




Figure 4.10. Effect of number of lactide monomers per macromonomer (nL) on (a) 
swelling ratio and (b) sol fraction of LPELA-M20 and SPELA-M20 hydrogels. Error bars 
correspond to means ± 1 SD for n = 3. 
 
lactide segments), cM increases and G decreases with nM . Therefore, the higher 
swelling of LPELA-nL0 compared with SPELA-nL0 is attributed to the lower crosslink 
density of the linear LPELA compared with star SPELA. In the presence of lactide, 
aggregation of hydrophobic segments produced micellar inhomogeneity in the network 
and increased hydrophobicity. On the basis of simulation results, water content of the 
hydrophobic domains was <1%. So the SPELA and LPELA gels may be better described 
as nanophase separated networks.[250] The interfacial free energy of the micelles with 
the aqueous phase increased with increasing nL for both SPELA and LPELA 
macromonomers. However, the micelles in SPELA had a lower interfacial energy than 
LPELA. The ethylene oxide chains in star SPELA macromonomer provided greater 
surface coverage for micelles‟ core, as predicted by DPD simulation (data not shown), 
thus lowering the interfacial energy of SPELA compared with LPELA. In addition, the 
lower radius of gyration of star SPELA led to higher steric repulsion between the EO 
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units in the macromonomer, which reduced the equilibrium core size and the average 
distance between the micelles in SPELA compared with LPELA. Therefore, as nL 
increased, SPELA macromonomers formed smaller micelles closer to each other while 
LPELA formed larger micelles farther away from each other. The higher inter-micellar 
distance in LPELA and extension of the bridging arms of the cores sharply reduced 
swelling ratio of LPELA as nL was increased (see Figure 4.10.a) while the swelling ratio 
of SPELA was unaffected by nL. SPELA hydrogel had a significantly lower sol fraction 
than LPELA, as shown in Figure 4.11.b. For example, sol fraction of LPELA and SPELA 
hydrogels increased from 24 2% to 32 3% and from 2.5 0.5% to 6.4 1.0% as nL 
increased from 0 to 14.8. This was attributed to the higher density of reactive acrylate 
groups in SPELA compared to LPELA, which increased the probability of incorporating 
macromonomers in the gel network. 
The effect of lactide content per macromonomer on mass loss of the SPELA and 
LPELA hydrogels is shown in Figure 4.11(a,b) respectively. There was no significant 
difference between the mass loss curves of SPELA-nL6.4 and SPELA-nL14.8 (p = 0.34), 
but there was a significant difference between the mass loss of all other SPELA pairs (p < 
0.05). There was a significant difference between the mass loss of all LPELA pairs (p < 
0.05). Mass loss of SPELA-nL0 and LPELA-nL0 was <10% after 42 days. For a given 
time, mass loss of SPELA increased with increasing nL up to nL = 11.6, followed by a 
decrease in mass loss for higher nL values, but it was higher than LPELA at any 
incubation time. Mass loss of LPELA increased with nL. For  example, mass loss of 
SPELA hydrogels after 28 days changed from 7 to 37, 80, 100, and 87% as the number of 
lactide monomers in SPELA increased from zero to 3.4, 6.4, 11.6, and 14.8, respectively, 
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whereas those of LPELA increased from 7 to 15, 26, 38, and 46% as the number of 
lactide monomers in LPELA increased from zero to 3.6, 7.4, 9.6, and 14.8. Sawhney et 
al. reported degradation time of 50 days for LPELA with PEG molecular weight of 6 kDa 
and 5 lactide units per macromonomer, but the swelling ratio of those gels were 
significantly higher than our gels.[251] The addition of only 3.4 lactides per 
macromonomer (<9 wt % of dry macromonomer and <2 wt % of swollen hydrogel) 
increased mass loss to 50% after 42 days.    
 
Figure 4.11. Effect of number of lactide monomers per macromonomer (nL) on mass loss 
of (a) SPELA-M20 and (b) LPELA-M20 hydrogels with incubation time. Error bars 
correspond to means ±1 SD for n = 3. 
The SPELA hydrogel with 11.6 lactides per macromonomer completely degraded after 
28 days. Assuming the formation of carboxylic acid groups by degradation of lactides 
does not significantly affect mass loss, degradation rate of SPELA is given by: 
  OHCOOkR SPELA 2deg,                                                                       (equation 4.16) 
where k is the degradation rate constant, and [-COO-] and [H2O] are the concentrations 
of ester groups and water in the hydrogel, respectively. Degradation of PLA matrices is 
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controlled by the low concentration of water in the matrix while degradation of SPELA 
hydrogel is controlled by relatively low concentration of degradable ester units. The 
decline in the concentration of ester groups in the hydrogel with degradation was offset 
by the increase in water content (increased swelling ratio), leading to nearly constant 
degradation rate, as shown in Figure 4.12. The increase in mass loss with nL (up to 11.6) 
was attributed to the higher concentration of ester groups in SPELA hydrogel. The 
decrease in mass loss for nL>11.6 was attributed to micelle formation with significantly 
reduced local concentration of water, leading to reduced rate of degradation. 
Images a−d in Figure 4.12 show live (green) and dead (red) cells 1 h after 
encapsulation in SPELA-nL3.4, SPELA-nL6.4, SPELA-nL11.6, and SPELA-nL14.8 
hydrogels, respectively. On the basis of the images, the number of lactides per 
macromonomer did not have a significant effect on cell viability. Cell viability was 
quantified by dividing the image into smaller squares and counting the number of live 
and dead cells. The fraction of viable cells for SPELA-nL0, SPELA-nL3.4, SPELA-
nL6.4, SPELA-nL11.6, and SPELA-nL14.8 gels was 92 ± 3, 90 ± 4, 92 ± 4, 94 ± 4, and 
91 ± 3, respectively. 
DNA content, ALPase activity, and extent of mineralization of MSCs 
encapsulated in SPELA are shown in Figure 4.13(a−c), respectively. The cell free gels 
did not have DNA count, ALPase activity, and mRNA expression (Figure 4.13) but 
showed slight calcium content. For all time points, MSCs in BM had higher cell count 
than those cultured in OM, and the addition of BMP2 did not affect DNA count. At day 
21, DNA count of MSCs in BM decreased slightly (statistically significant) compared 




Figure 4.12. Live (green) and dead (red) image of MSCs 1 h after encapsulation in (a) 
SPELA-nL3.4, (b) SPELA-nL6.4, (c) SPELA-nL11.6, and (d) SPELA-nL14.8 hydrogels 
(without BMP2). The scale bar is 100 μm. 
groups was statistically lower than days 4 and 7 (indicated by a star in Figure 4.13.a) and 
statistically lower than BM group. This trend is consistent with previous reports that cell 
number decreases with differentiation of MSCs in osteogenic medium. Wang et al. 
reported a decrease of 24 and 51% in DNA content after 3 and 6 weeks, respectively, 
with osteogenic differentiation of human umbilical cord MSCs seeded in PLGA 
scaffolds.[252] Oliveira et al. reported a decrease of 20% in DNA content after 7−14 days 
with osteogenic differentiation of rat MSCs.[253]  Burdick et al. observed a decreasing 
trend in cell viability in 2 weeks for rat calvarial osteoblasts encapsulated in PEGDA 




Figure 4.13. (a) DNA content, (b) ALPase activity, and (c) calcium content of MSCs 
encapsulated in SPELA-14.8 hydrogel. Experimental groupsinclude gels without MSCs 
incubated in osteogenic media (OM+no MSCs, red, control), gels with MSCs incubated 
in basal media (BM, green,control), gels with MSCs incubated in osteogenic media (OM, 
blue), and gels with MSCs and BMP2 incubated in osteogenic media 
(OM+BMP2,orange). One star indicates statistically significant difference (s.d.; p < 0.05) 
between the test time point and first time point (day 4) in the samegroup, and two stars 
indicate significant difference between the test group and all other groups at the same 
time point. Error bars correspond tomeans ±1 SD for n = 3. 
lower ALPase activity, calcium content, and expression of osteogenic marker than OM 
and OM+BMP2.  ALPase activity of both groups (with and without BMP2) significantly 
increased (indicated by one star) from day 4 to 7 and 14 and returned to the baseline level 
after 21 days. This was consistent with our previous results that the peak ALPase activity 
is the start of mineralization.[113] ALPase activity of BMP2 group at days 7 and 14 was 
significantly higher than that of OM (without BMP2, indicated by two stars). Calcium 
content of both groups increased significantly on days 7−21 compared with day 4 
(indicated by one star). However, calcium content of the BMP2 group was significantly 
higher that the OM group for days 7−21 (indicated by two stars). For example, calcium 
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contents of the BMP2 group after 7, 14, and 21 days were 8.7 ± 1.0, 27.1 ± 2.7, and 45.1 
± 1.4 mg/dL, respectively, whereas those of OM were 3.1 ± 1.3, 11.6 ± 1.6, and 34.4 ± 
2.6 mg/dL. Results in Figure 4.13.c demonstrate that the calcium content of MSCs in OM 
and OM+BMP2 groups was due to osteogenic differentiation and mineralization of 
MSCs and not due to the calcium in osteogenic media. mRNA expression levels of Dlx5, 
Runx2, OP, and OC of the MSCs for both groups (with and without BMP2) are shown in 
Figure 4.14(a−d) with incubation time. The fold differences in mRNA expression of the 
markers are normalized to those at time zero. BMP2 protein forms complexes with type I 
and type II BMP2 receptors (BRI and BRII) on the surface of MSCs, which activates the 
Smad-dependent and Smad-independent p38 pathways as well as internalization of the 
receptors.[254] The expression of Dlx5 and Runx2 is the early event in the BMP2 
signaling cascade. Dlx5 regulates the activity of osteogenic master transcription factor 
Runx2 by Smad-dependent pathways, which in turn drives the expression of osteogenic 
genes. The expressions of Dlx5 and Runx2 were up-regulated for all time points (Figure 
4.14.a,b) for both OM and BMP2 groups. However, for BMP2 group, there was a sharp 
increase in the expression of Dlx5 on days 7 and 14 and the expression of Runx2 on day 
7. mRNA expression of OP and OC increased gradually for both OM and BMP2 groups 
with incubation time, but the fold difference was significantly higher for BMP2 group at 
each time point. For example, the fold differences in OC mRNA expression for OM 
group increased from 0.4 ± 0.2 to 1.1 ± 0.4, 3.5 ± 0.5, and 6.0 ± 0.4 after 4, 7, 14, and 21 
days of incubation, respectively, whereas those for BMP2 group increased from 0.6 ± 0.2, 
2.2 ± 0.2, 7.4 ± 1.1, and 11.5 ± 1.3. Results in Figures 4.13 and 4.14 taken together 




Figure 4.14. mRNA Expression levels, as fold difference, of (a) Dlx5, (b) Runx2, (c) OP, 
and (d) OC of MSCs encapsulated in SPELA-14.8 hydrogels. Experimental groups 
include gels with MSCs incubated in basal media (BM, green, control), gels with MSCs 
incubated in osteogenic media (OM, blue), and gels with MSCs and BMP2 incubated in 
osteogenic media (OM+BMP2, orange). One star indicates statistically significant 
difference (s.d.; p < 0.05) between the test time point and the first time point (day 4) in 
the same group, and two stars indicate significant difference between the test group and 
all other groups at the same time point. Error bars correspond to means ±1 SD for n = 3. 
 
osteogenic media, whereas those incubated in BM did not undergo osteogenic 
differentiation. Yang et al. investigated osteogenic differentiation of MSCs encapsulated 
in RGD-conjugated PEG hydrogels.[114] The calcium content of MSCs with optimum 
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RGD density after 21 days was 0.00008 mg/mg DNA, compared with 0.057 mg/mg DNA 
in this work. The higher calcium content in this work may be related to the degradable 
nature of SPELA matrix, leading to increase in water content, free volume, and greater 
cell-matrix interaction with incubation time. The addition of inductive factors like BMP2 
significantly enhanced differentiation and mineralization of MSCs. Kim et al. reported 
that the addition of BMP2 to MSCs encapsulated in hyaluronic acid gels increased OC 
expression by 80%.[255] Na et al. reported that the addition of BMP2 to MSCs 
encapsulated in poly(N-isopropylacrylamide-co-acrylic acid) gels increased the 
expression of OC after 8 weeks of incubation.[256] 
4.5. CONCLUSION  
A novel approach to tissues regeneration is to encapsulate progenitor cells in inert 
and biodegradable hydrogels loaded with soluble growth factors to guide their 
differentiation and maturation. To this end, linear (LPELA) and star (SPELA) 
poly(ethylene glycol-co-lactide) acrylate macromonomers with short lactide segments 
were synthesized. SPELA hydrogels had significantly higher modulus, lower gelation 
time, and lower sol fraction compared with LPELA. Mass loss of the SPELA hydrogel 
depended strongly on the number of lactides per SPELA macromonomer (nL) and 
showed a biphasic behavior. Molecular dynamic simulations demonstrated that the 
biphasic behavior mass loss was related to aggregation and micelle formation of the 
lactide monomers of SPELA in aqueous solution. MSCs encapsulated in SPELA-nL14.8 
and incubated in osteogenic media had significantly higher ALPase activity, extent of 
mineralization, and expression of osteogenic markers compared with those incubated in 
basal media. The expression of osteogenic markers and extent of mineralization increased 
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with coencapsulation of BMP2 with MSCs in the SPELA hydrogel and incubation in 
osteogenic media when compared to without BMP2. Results demonstrate that the PEG-
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Hydrogels are used extensively in medicine for soft tissue repair.[176, 257-259] 
Due to their high diffusivity of nutrients and biomolecules,[24-26] hydrogels are very 
useful as a matrix in tissue engineering for in situ delivery of cells to the site of 
regeneration and regulation of cell fate.[21, 29, 30, 41] Only those hydrogels that degrade 
and provide free volume for the newly formed tissue can be utilized as a matrix in 
regenerative medicine.[101, 102] However, viability and fate of the encapsulated cells are 
limited by toxic side effects of gelation and degradation reactions in the hydrogel matrix. 
Consequently, natural hydrogels derived from the components of extracellular matrix 
(ECM) of biological tissues that physically crosslink and degrade enzymatically are 
frequently used as the delivery matrix in clinical applications.  
Minor variation in the sequence distribution of natural gels can dramatically affect 
the fate of encapsulated cells. With many cell-interactive ligands and regulatory factors, it 
is difficult to tailor the properties of natural matrices to a particular application in 
regenerative medicine.[31] For example, differentiation of mesenchymal stem cells 
(MSCs) shifted from osteogenic to chondrogenic lineage by changing the matrix from 
collagen type I to type II.[32, 33] Moreover, due to their low stiffness, natural gels are 
limited in practical applications by soft tissue compression.[34-36] Therefore, there is a 
need to synthesize novel hydrogels with tunable physical, mechanical, and biological 
properties for a wide range of applications in regenerative medicine such as chondrocyte 
implantation in cartilage regeneration or as cardiac patches to treat heart infarction.  
Polyethylene glycol (PEG) hydrogels are inert, non-immunogenic, and compatible 
with stem cells and can be conjugated with multiple bioactive peptides to modify the cell 
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microenvironment and regulate cell fate.[112-114] However, PEG hydrogels are non-
degradable which limits their use as a supporting matrix in regenerative medicine. PEG 
macromonomers copolymerized with hydroxy acid (HA) monomers produce block 
copolymers that have limited solubility in aqueous solution[35] and self-assemble to form 
nanoparticles for drug delivery.[260-266]  We previously demonstrated that star PEG 
macromonomers chain-extended with very short hydrolysable lactide segments (SPELA) 
dissolved in aqueous solution and formed a micellar gel.[35]  Remarkably, the results 
showed a biphasic relationship between the lactide segment length and gelation or 
degradation rate. We hypothesized that the observed biphasic dependence was related to 
the transition from surface to bulk hydrolysis in the micelle phase with increasing lactide 
segment length. To test the hypothesis, we investigate in this work gelation and 
degradation of star PEG macromonomers chain-extended with short hydroxy acid (HA) 
segments (SPEXA where “X” is HA monomer type) with a wide range of 
hydrophobicity. HA monomers included least hydrophobic glycolide (G), lactide (L), p-
dioxanone (D), and most hydrophobic ε-caprolactone (C). All HA chain-extended PEG 
hydrogels showed the transition from surface to bulk degradation with increasing HA 
segment length. Chain extension of PEG macromonomers with short HA segments 
localized the reactive moieties within micelles and reduced their average distance, 
thereby increasing gelation and degradation rates with increasing segment length. As the 
micelle size was increased above a certain value, the average distance between the 
reactive moieties within the micelles began to increase and degradation rates decreased.  
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5.2. SIMULATION METHOD  
Solution of SPEXA macromonomers in water was simulated via Dissipative 
Particle Dynamics (DPD) using an approach described previously.[35, 60] The molecular 
structure of the macromonomer was divided into different beads with equal mass, as 
shown in Figure 5.1. The beads included L (lactide repeat unit), G (glycolide), D (p-
dioxanone), C (ε-caprolactone), EO (ethylene oxide repeat unit), Ac (acrylate functional 
group), SPEGc (star PEG core), and W (three water molecules). The meso-structure of 
the macromonomer is also shown in Figure 5.1. The notations SPEXA-nA or SPEXA-
mB are used to identify length of the degradable segment, where A is the number of 
repeat units or ester groups per arm, B is the number of monomers per arm, and X is HA 
monomer type (G, L, D, and C). When X is C or D, A equals B but A=2B when X is G or 
L. In DPD, each bead represents a soft particle interacting with the other beads via a soft 
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ijF are the conservative, dissipative, 
random and spring components of the force, respectively. Different components of the 
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Figure 5.1.  Bead reperesentation of SPEXA (X= L, G, C or D) macromonomer in DPD. 
Beads SPEGc (yellow), EO (green), G (blue), D(pink), L (orange), C (purple) and Ac 
(red) represent star PEG core, ethylene oxide repeat unit, glycolide, p-dioxanone, lactide, 







                                                                         
(equation 5.5) 
where ijr  is the vector joining bead i to j, ije  and ijr  are the unit vector in the direction 
of ijr and the magnitude of ijr , respectively. ijv  is the velocity vector given by jiij vvv 
. Dw and Rw are weight functions for dissipative and random forces, respectively, and  , 
  are the magnitude of dissipative and random forces. DijF and 
R
ijF  act simultaneously to 
preserve dissipation and to conserve the total momentum in the system. The dissipative 




D rwrw   
and  TkB2
2   in order to satisfy the dissipation-fluctuation condition.[244] The 
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spring force term imposes geometrical constraints on the covalently bonded beads. 
Values of   and C constants were 4.5 and 4, respectively.[60] The repulsion between 
beads i and j is mainly dictated by the constant ijα  
in the conservative force function.  
By choosing the system density 3  
3
cr , the DPD length scale, rc, was 6.74 Ǻ and the 
values of ijα  were determined using[58] 
ijij  27.378                                                                           
(equation 5.6) 
where
ij is the Flory-Huggins parameter between beads i and j. Values of ij  








                                                                            (equation 5.7) 
where i and j are solubility parameters of beads i and j, respectively, V is bead molar 
volume, T is absolute temperature, and R is gas constant. Solubility parameters were 
calculated via atomistic molecular dynamics simulation performed via Forcite and 
Amorphous Cell  modules, Materials Studio (v5.5, Accelrys)[267] using the COMPASS 
force field, which is an ab initio force field optimized for condensed-phase systems.[245] 
Position and velocity of the beads at each time point were obtained by solving the 






   





m                                                               (equation 5.8) 
All DPD simulations were performed in 303030 rc boxes with 3D periodic 
boundary conditions over 2x10
5
 time steps and dimensionless time step of 0.05. The 
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Mesocite module of Materials Studio (v5.5, Accelrys)[267] was used for DPD 
calculations.  
5.3. EXPERIMENTAL METHODS 
5.3.1. MATERIALS 
 Lactide (L), glycolide (G) and p-dioxanone (D) monomers with >99.5% purity 
were purchased from Ortec (Easley, SC). ε-Caprolactone (C) monomer with >99% purity 
was purchased from Alfa Aesa (Ward Hill, MA). All monomers were dried under 
vacuum at 40°C for at least 12 h prior to use. 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-
propyl) ketone (Irgacure-2959) photoinitiator was obtained from CIBA (Tarrytown, NY). 
Calcium hydride, tetrahydrofuran (THF), deuterated chloroform (99.8% deuterated), 
trimethylsilane (TMS), triethylamine (TEA), tin (II) 2-ethylhexanoate (TOC), acryloyl 
chloride (Ac) , dimethylsulfoxide (DMSO), 4-arm PEG (SPEG, 4 arm, nominal Mw=5 
kDa), ethylenediaminetetraacetic acid disodium salt (EDTA), and paraformaldehyde were 
purchased from Sigma-Aldrich (St. Louis, MO). The protected amino acids and Rink 
Amide NovaGel resin for the synthesis of acrylamide-terminated GRGD peptide were 
purchased from EMD Biosciences (San Diego, CA). Dichloromethane (DCM, Acros 
Organics, Pittsburgh, PA) was dried by distillation over calcium hydride. Other solvents 
were obtained from VWR (Bristol, CT) and used as received. Dulbecco's phosphate-
buffer saline (PBS) and Dulbecco's Modified Eagle's Medium (DMEM; 4.5 g/L glucose 
with L-glutamine and without sodium pyruvate) were obtained from GIBCO BRL (Grand 
Island, NY). Fetal bovine serum (FBS), screened for compatibility with rat MSCs, was 
purchased from Atlas Biologicals (Fort Collins, CO). TRIzol for isolation of cellular 
RNA and trypsin were purchased from Invitrogen (Carlsbad, CA). Penicillin (PN), 
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streptomycin (SP), fungizone (FG), gentamicin sulfate (GS), dexamethasone (DEX), 
ascorbic acid (AA), and ß-sodium glycerophosphate (GP) were purchased from Sigma-
Aldrich. Quant-it PicoGreen dsDNA reagent kit was obtained from Invitrogen (Carlsbad, 
CA). QuantiChrom calcium and alkaline phosphatase (ALP) assay kits were purchased 
from Bioassay Systems (Hayward, CA). Sircol total collagen assay kit was obtained from 
Biocolor (Carrickfergus, UK).  
5.3.2. CHARACTERIZATION 
The chemical structure of SPEXA macromonomers was characterized by a Varian 
Mercury-300 
1
H-NMR (Varian, Palo Alto, CA) at ambient conditions with a resolution of 
0.17 Hz as described previously.[35] The sample was dissolved in deuterated chloroform 
at a concentration of 50 mg/ml, and 1% v/v TMS was used as the internal standard. 
Number- (Mn) and weight-average molecular weight (Mw) and polydispersity index (PI) 
of the macromonomers were measured by Gel Permeation Chromatography (GPC, 
Waters 717 System, Milford, MA) in THF with 1 mL/min flow rate as previously 
described.[52]  
5.3.3. MACROMONOMER SYNTHESIS 
SPEG macromer chain-extended with short HA segments was synthesized by ring 
opening polymerization (ROP) as described.[35] SPEG and TOC were the 
polymerization initiator and catalyst, respectively. Briefly, dry HA monomer and SPEG 
were added to a three-neck reaction flask with an overhead stirrer and immersed in an oil 
bath (only SPEG was added to the flask for D monomer). Molar ratio of SPEG to 
monomer was selected based on the desired theoretical length of the HA segment. Next, 
the reaction flask was heated to 120°C under nitrogen to melt the mixture, maintained at 
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that temperature for 1 h to remove moisture, and TOC was added to the mixture. The 
reaction was run at 140°C for 12 h for C and L monomers and 160°C for 10 h for G 
monomer. Since equilibrium was shifted toward monomer in polycondensation of p-
dioxanone for temperatures >100°C, SPEG and catalyst mixture was heated to 130°C for 
10 min to remove moisture, the mixture was cooled to 85°C, D monomer was added, and 
reaction was run at that temperature for 48 h. After the reaction, the product was purified 
by precipitation in ice-cold hexane to remove any unreacted monomer, initiator and 
catalyst.  
In the next step, chain ends of the macromer were acrylated to produce SPEXA 
macromonomer. SPEX macromer (product of the first reaction) was dried by azeotropic 
distillation from toluene. The macromer was dissolved in DCM, the flask was immersed 
in an ice bath, and the reaction was carried out by the addition of equimolar amounts of 
AC and TEA drop-wise to the macromer solution under dry nitrogen. After 12 h, solvent 
was removed by rotary evaporation and the residue was dissolved in ethyl acetate to 
precipitate the byproduct triethylamine hydrochloride salt. After vacuum distilling ethyl 
acetate, the product was re-dissolved in DCM and precipitated in ice-cold ethyl ether 
twice. The product was dissolved in DMSO and dialyzed against water in a 3.5 kDa MW 
cutoff Spectro/Por dialysis tube (Spectrum Laboratories, Rancho Dominquez, CA) to 
remove any remaining impurities. SPEXA macromonomer was dried in vacuum to 
remove residual solvent and stored at –20°C.            
5.3.4. MACROMONOMER GELATION AND RHEOLOGICAL MEASUREMENTS 
The aqueous SPEXA hydrogel precursor solution was crosslinked by UV free-
radical polymerization with Irgacure-2959 photoinitiator as previously described.[150] 
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To monitor gelation kinetics, the hydrogel precursor solution of the photoinitiator and 
macromonomer on the peltier plate of an AR-2000 rheometer (TA Instruments, New 
Castle, DE) was irradiated with a long wavelength (365 nm) mercury UV lamp (Model 
B100-AP; UVP, Upland, CA) at a distance of 10 cm from the sample. The gap distance 
between the peltier plate and the upper 20 mm transparent acrylic geometry was 500 µm. 
A sinusoidal shear strain with frequency of 1 Hz and amplitude of 1% was exerted on the 
sample via the upper geometry and the storage ( G ) and loss moduli ( ''G ) was recorded 
with time. The time at which ''' GG   was recorded as the gelation time. The notation X-
mN is used for the hydrogels with X representing the HA monomer, m for monomer, and 
N for the number of HA monomers per macromonomer arm. For example, m0 denotes 
PEG hydrogel without chain extension with HA monomer and C-m1.8 denotes SPECA 
hydrogel with average of 1.8 ε-caprolactone monomers per macromonomer arm. 
5.3.5. MEASUREMENT OF EQUILIBRIUM WATER CONTENT AND MASS LOSS 
Hydrogels  20 mm diameter and 300 µm thickness were removed from the 
rheometer and dried in ambient conditions for 12 h followed by drying in vacuum for 1 h 
at 40°C. Dry samples were swollen in DI water for 24 h at 37°C with a change of 
swelling medium every 6 h. After swelling, surface water was removed and the swollen 
weights (ws) were measured. The swollen samples were dried as described above and dry 
weights (wd) were recorded. The equilibrium water content was calculated by dividing 
the weight of water (the difference between swollen and dry weights) by the swollen 
weight as described.[35] To measure mass loss, the hydrogel precursor solution was 
crosslinked in a polytetrafluoroethylene (PTFE) mold (5 cm × 3 cm × 750 µm) covered 
with a transparent glass plate. Disk-shape samples were cut from the gel and their mass 
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loss was measured in 5 mL PBS at 37ºC under mild agitation. At each time point, 
samples were washed with DI water several times and dried under vacuum. The dried 
sample weight was measured and compared with the initial dry weight to determine mass 
loss as described.[35] 
5.3.6.MARROW STROMAL CELL ISOLATION AND ENCAPSULATION IN 
HYDROGELS  
MSCs were isolated from the bone marrow of young adult male Wistar rats as 
described.[35, 268]  Cell isolations were performed under a protocol approved by the 
Institutional Animal Care and Use Committee of the University of South Carolina. The 
suspension of bone marrow cells was centrifuged at 200g for 5 min and the cell pellets 
were resuspended in 12 mL basal medium consisting of DMEM supplemented with 10% 
FBS, 100 units/mL PEN, 100 μg/mL SP, 50 μg/µL GS and 250 ng/mL FZ, and  cultured 
in a humidified 5% CO2 incubator at 37°C. Cultures were replaced with fresh medium at 
3 and 7 days to remove hematopoietic and other unattached cells. After 10 days, cells 
were detached from the flasks with 0.05% trypsin-0.53 mM EDTA and used for in vitro 
experiments. The experimental groups for encapsulation of MSCs in SPEXA hydrogels 
included m0, L-m1.7, D-m1.7 and C-m1.8. SPEGA hydrogel was not used for cell 
encapsulation because it completely degraded in a few days (see Figure 6d). Cell 
encapsulation and osteogenic differentiation experiments were carried out in SPEXA 
hydrogels while maintaining a constant compressive modulus of 50 kPa by varying the 
concentration of SPEXA macromonomer in the hydrogel precursor solution. Acrylamide-
terminated GRGD peptide (Ac-GRGD) was synthesized on Rink Amide NovaGel resin 
in the solid phase, purified by high-performance liquid chromatography (HPLC), and 
 
104 
characterized by electrospray ionization (ESI) mass spectrometry as previously 
described.[113] Ac-GRGD peptide in the amount of 2 wt%, based on the macromonomer 
weight, was added to the hydrogel precursor solution to facilitate cell adhesion to SPEXA 
matrix, and the mixture was sterilized by filtration. Next, 1×10
6
 MSCs suspended in 100 
μL PBS was gently mixed with the hydrogel precursor solution to reach the final density 
of 5×10
6
 cells/mL. The mixture was injected between two sterile glass slides and 
crosslinked as described above. UV exposure time for all cell-seeded precursor solutions 
was 200 s, which was the minimum required time for the gel to reach its plateau modulus. 
After gelation, samples were incubated in 2 mL PBS for 1 h with two PBS changes. Next, 
the medium was replaced with complete osteogenic medium (basal medium 
supplemented with 100 nM DEX, 50µg/mL AA, 10mM GP) and cultured for 28 days. To 
measure the effect of photoinitiator on cell viability, 10 mg/mL initiator was added to the 
suspension of MSCs in SPEXA precursor solution. After 10 min, the suspension was 
centrifuged and cells were re-suspended and cultured in basal medium (without initiator). 
After incubation for 2 days, MSCs were counted with a hemocytometer and cell  numbers 
were normalized to those cells cultured in PBS (no exposure to initiator).  
5.3.7. BIOCHEMICAL ANALYSIS AND MRNA ANALYSIS 
At each time point (7, 14, 28 days), gel samples were washed with serum-free 
DMEM for 8 h to remove serum components, washed with PBS, lysed with lysis buffer 
(10 mM tris and 2% triton), and sonicated. After centrifugation, the supernatant was used 
for measurement of total collagen content, alkaline phosphatase (ALP) activity and 
calcium content. Total collagen content was measured with a Sircol collagen assay based 
on selective binding of G-X-Y amino acid sequence of collagen to Sircol dye, according 
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to manufacturer‟s instructions.[269] Briefly, 1 mL Sircol dye was added to the sonicated 
cell lysate, incubated for 30 min and centrifuged at 10,000 rpm for 5 min to separate the 
collagen–dye complex. After removing the supernatant, the collagen-dye complex was 
mixed with 1 mL Sircol alkali reagent and absorbance was measured on a plate reader at 
555 nm. ALP activity and calcium content as a measure of the total mineralized deposit 
were measured using QuantiChrom ALP and calcium assays as previously 
described.[199] For mRNA analysis, at each time point, total cellular RNA of the sample 
was extracted and converted to cDNA as described.[199] The cDNA was  amplified with  
gene specific primers designed using the Primer3 software as previously described.[188] 
Expression of collagen type I (Col-I), ALP and osteocalcin (OC) was measured by 
performing real-time quantitative polymerase chain reaction (RT-qPCR) using a CXF96 
PCR system (Bio-Rad, Hercules, CA) with the following primers (synthesized by 
Integrated DNA technologies, Coralville, IA): Col-1: forward 5‟-GCA TGT CTG GTT 
AGG AGA AAC C-3‟  and reverse 5‟-ATG TAT GCA ATG CTG TTC TTG C-3‟; ALP: 
forward 5`CCT TGA AAA ATG CCC TGA AA-3` and reverse 5`-CTT GGA GAG AGC 
CAC AAA GG-3; OC: forward 5`-AAA GCC CAG CGA CTC T-3` and reverse 5`-CTA 
AAC GGT GGT GCC ATA GAT-3`; S16: forward 5′-AGT CTT CGG ACG CAA GAA 
AA-3′ and reverse 5′-AGC CAC CAG AGC TTT TGA GA-3′.[269] The expression ratio 
of the gene of interest to that of S16 housekeeping gene was determined using Pfaffl 
model[241] and normalized to the first time point. 
5.3.8. STATISTICAL ANALYSIS 
 Data are expressed as means ±standard deviation. All experiments were done in 
triplicate. Significant differences between groups were evaluated using a two-way 
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ANOVA with replication test followed by a two-tailed Student's t-test. A value of p<0.05 
was considered statistically significant. 
5.4. RESULTS AND DISCUSSION 
5.4.1. CHARACTERIZATION OF MACROMONOMERS 
1
H-NMR spectra of star-PEG (m0), SPEGA (G-m2.8), SPEDA (D-m2.9), SPELA 
(L-m2.9) and SPECA (C-m2.8) are provided in Figures 5.2.a to 5.2.e, respectively. The 
assignment of chemical shifts for PEG macromer in the NMR spectra of lactide chain-
extended SPEXA was previously described by us.[35] The shifts with peak position at 
3.6 and 4.3 ppm in Figure 5.2(a-e) corresponded to methylene protons of PEG attached to 
ether and ester groups of HA repeat units, respectively. The shifts with peak position at 
4.8-4.9 ppm in Figure 5.2.b corresponded to methylene protons of glycolide; those at 3.7, 
4.2 and 4.4 ppm in Figure 5.2.c corresponded to β, α, γ methylene protons of p-
dioxanone, respectively; those at 1.6 and 5.2 ppm in Figure 5.2.d corresponded to methyl
and methine protons of lactide; and those at 1.4, 1.7, 2.3 and 4.1 ppm in Figure 5.2.e 
corresponded to γ, β, α, ε ethylene protons of ε-caprolactone. The shifts with peak 
position from 5.85 to 6.55 ppm were attributed to vinyl hydrogens of the Ac as follows: 
peak positions in the 5.82-5.87 ppm range corresponded to the trans protons of 
unsubstituted carbon in Ac; those in the 6.10-6.20 ppm range corresponded to the protons 
bonded to monosubstituted carbon; and those in the 6.40-6.46 ppm range corresponded to 
the proton of unsubstituted carbon. The number of HA repeat units per macromonomer 
(m) was determined from the ratio of the shifts centered at 4.8-4.9 ppm (glycolide 
hydrogens), 3.7, 4.2 and 4.4 ppm (p-dioxanone), 1.6 and 5.2 ppm (lactide) and 1.4, 1.7, 




Figure 5.2. H-NMR spectra of (a) star PEG, (b) SPEGA (G-m2.8), (c) SPEDA (D-m2.9), 
(d) SPELA (L-m2.9) and (e)  SPECA (C-m2.8). 
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acrylate groups per macromonomer was determined from the ratio of the shifts between 
5.85 and 6.55 ppm (acrylate hydrogens) to those at 3.6 and 4.2 ppm (PEG). nM  of 
SPEGA, SPELA, SPEDA, and SPECA macromonomers depending on HA segment 
length was in the range of 5.6-6.5 kDa, 5.8-7.4 kDa, 5.4-6.3 kDa and 5.5-6.4 kDa, 
respectively, and the corresponding fraction of acrylated chain-ends was in the range of 
0.78-0.87, 0.75-0.86, 0.73-0.82 and 0.75-0.85. Polydispersity of SPEGA, SPELA, 
SPEDA, and SPECA macromonomers was in the range of 1.24-1.44, 1.17-1.34, 1.20-
1.35 and 1.22-1.38 respectively.  
5.4.2. STRUCTURE FORMATION IN SPEXA PRECURSOR SOLUTIONS  
Formation of nanoscale structure by SPEXA macromonomers in aqueous medium 
is shown in Figure 5.3. In the absence of HA monomer, the distribution of acrylate 
groups attached to SPEXA chain ends was uniform in aqueous medium[60] but the 
extension of SPEXA arms with hydrophobic X segments induced aggregation as shown 
in Figure 5.3. For SPEGA and SPEDA with n=2, hydrophobic segments were not 
sufficiently long to form stable micellar structures. However, SPELA and SPECA 
macromonomers (see first column of Figure 5.3), due to higher hydrophobicity of lactide 
and ε-caprolactone monomers, formed stable micelles with n=2. All four SPEXA 
macromonomers formed stable micelles for n=4 (second column of Figure 5.3). The 
aggregate size increased and number density decreased with increasing n from 4 to 8. 
According to the theory of micellization in block copolymers in solution, degree of 
aggregation increases with increasing block size, driven by the decrease in overall surface 
free energy of solvophobic blocks.[270] Cross-sectional view of one of the aggregates 




Figure 5.3. Evolution of core of the micelles in 20% aqueous solutions of SPEXA. Only 
X and Ac (red) beads are shown for clarity. “n” is the number of HA repeat units. G, D, L 
and C beads are shown by blue, pink, orange and purple, respectively. The scale bars are 
5 nm. 
 
In the images of Figure 5.3, hydrophobic HA segments and hydrophilic EO beads formed 




Figure 5.4. Cross section of the micelles formed in 20% aqueous solutions of SPEXA. 
“n” is the number of HA repeat units. SPEGc, EO and Ac beads are shown by yellow, 
green and red, respectively. G, D, L and C beads are shown by blue, pink, orange and 
purple, respectively. Water beads are not shown for clarity. The scale bars are 2 nm. 
 
change in core size and aggregation number for SPELA micelles is dominated by 
interfacial free energy (the product of interfacial tension   and interface area a ).[60] 
Due to the presence of hydrophilic EO segments at the interface, the effective interfacial 
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tension in SPEXA micelles is different from the interfacial tension between the micelle 
core and water, WC .[249]   can be calculated by minimizing the chemical potential of 


































                
(equation 5.9) 
where WC  
is interfacial tension between the micelles‟ core and water, k , T , s  and N  
are Boltzmann constant, absolute temperature, statistical EO segment length, and number 
of statistical EO segments on each SPEXA arm. iC  and bC are concentrations of EO 
segments at the interface and in bulk, respectively. Equation 5.9 implies that an increase 
in iC  has a negative contribution to interfacial tension. In other words, dense EO 
coverage of the interface decreases effective interfacial tension between the hydrophobic 
domains and water. According to Figure 5.4, the micelle core size of SPECA 
macromonomers with n=8 was similar to that of other monomers even though ε-
caprolactone was significantly more hydrophobic than the other monomers. This 
discrepancy can be explained by higher packing of EO segments in the corona, thus 
decreasing the effective interfacial tension of SPECA micelles.  
Effect of number of hydrophobic X beads on core diameter of micelles, number of 
macromonomers per micelle (aggregation number), number density of micelles, and 
fraction of macromonomer free arms is shown in Figures 5.5.a to 5.5.d, respectively. 
Assuming there were only X and Ac beads in the core, total number of beads taking part 












Figure 5.5. Effect of number of degradable HA repeat units on each arm on (a) core 
radius (a), aggregation number (b), number density of micelles (c) and free arm fraction 
of the micelles (d) in 20% aqueous solutions of SPEXA. Error bars correspond to means 
± SD for 5 simulation runs.  
 
where  and cV  are bead number density and micelle core volume, respectively. Core 
radius of SPEGA and SPEDA micelles increased from 0 to 22 Ǻ when n increased from 2 
to 8. Core radius of SPELA and SPECA micelles increased from 9 and 11 Ǻ to 23 and 24 
Ǻ, respectively, with increasing n from 2 to 8. Aggregation number showed an increasing 
trend with n after micelle formation (n=2 for L and C and n=4 for G and D). Average 
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aggregation number of SPECA increased from 4 to 19 when n increased from 2 to 8 
which was the highest aggregation number among the four macromonomers. SPEGA had 
the lowest aggregation number, which ranged from 0 to 14 when n increased from 2 to 8. 
The increase in SPEXA aggregation number with increasing n is attributed to the increase 
in the volume of hydrophobic segments and the decrease in corona thickness of micelles, 
leading to an increase in effective interfacial tension between the core and water with 
increasing n.[60]  
Number density of micelles initially increased with n due to a transition from 
uniform distribution of macromonomers in the system to the formation of micelles. The 
number density then decreased with n due to the increase in size and aggregation number 
of micelles. Figure 5.5.d shows the effect of number of HA monomers on each arm (n) on 
the fraction of free arms. For n=0, acrylate groups were uniformly distributed in solution 
and fraction of free arms was unity. Fraction of free arms for SPELA decreased from 1 to 
0.70, 0.14, 0.05 and zero as n increased from zero to 2, 4, 6 and 8, respectively, whereas 
for SPEDA it decreased from 1 to 0.93, 0.23, 0.09 and zero. Fraction of free arms 
decreased at a faster rate for SPECA and reached zero for n=6. SPEGA macromonomers 
with n≤ 2 did not form micelles and had a free arm fraction of unity, and fraction of 
SPEGA free arms decreased to 0.57, 0.18 and 0.04 as n increased from 2 to 4, 6 and 8, 
respectively. The slower rate of decrease in fraction of free arms in SPEGA was 
consistent with lower hydrophobicity of glycolide compared to the other monomers.  
5.4.3. GELATION KINETICS OF SPEXA PRECURSOR SOLUTION  
Rate of crosslinking of SPEXA macromonomers in aqueous solution depended on 
the proximity of acrylate groups to photo-activated acrylates while the rate of photo-
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activation of acrylates depended on the proximity of initiator molecules to acrylate 
groups. Therefore, rate of crosslinking depended on average distance between the 
acrylates and initiator molecules. Distribution of photoinitiator beads (pink color) in 
SPELA-m3 solution and cross-section of one of the micelle cores are shown in Figures 
5.6.a and 5.6.b, respectively. Simulation images indicate that 98% of the photoinitiator 
beads partitioned to the hydrophobic core of the micelles in the proximity of acrylates 
(see pink beads in Figures 5.6.a and 5.6.b). The simulated fraction of initiators in the 
aqueous phase (those not partitioned to the micelles‟ core) in SPELA solutions is shown 
in Figure 5.6.c. Fraction of initiators in the aqueous phase decreased from 100% to 7.4, 
3.3 and 2% when m increased from 0 to 1, 2 and 3, respectively. Partition of a large 
fraction of initiators to the micelles‟ core confined the gelation reaction to the micelle 
phase, thus potentially reducing the exposure of encapsulated cells to toxic initiator 
molecules. MSCs in 20 wt% SPEXA solutions were exposed to 10 mg/mL photoinitiator 
for 10 min, the cells were re-suspended in basal medium (without initiator) and cultured 
for 2 days. Figure 5.6.d compares the normalized cell numbers for SPEXA solutions after 
exposure to photoinitiator to that in SPEXA-m0 (acrylated star PEG without HA chain-
extension). Groups included SPEGA (G-m1.6), SPELA (L-m1.7), SPEDA (D-m1.7), 
SPECA (C-m1.8) and PEG (m0). The cell number was significantly higher for SPELA 
(0.87±0.04) and SPECA (0.84±0.05) solutions compared to SPEXA-m0 (0.77±0.05) 
which can be explained by partitioning of initiator molecules to the hydrophobic micelle 
phase (see Figure 5.6.c), whereby the exposure of encapsulated cells to initiator 





Figure 5.6. (a) Distribution of photoinitiator molecules in the simulation box in SPELA-
m3 precursor solution and (b) in the corresponding cross-section of one of the micelles. L 
and Ac beads in (a-b) are shown in orange and red, respecctively, while the initiator bead 
is in purple. EO and water beads are not shown for clarity. (c) DPD simulation of the 
effect of number of degradable lactide monomers per SPELA arm on fraction of initiators 
in aqueous solution. (d) Effect of exposure of MSCs to photoinitiator (10 mg/mL)  in  20 
wt% SPEXA precursor solution on the fraction of viable cells as a function of HA type. 
P, G, L, C and D in (d) represent PEG (no HA, control group), SPEXA with glycolide, 
lactide, ε-caprolactone and p-dioxanone HA monomer, respectively. “star” indicates a 
statistically significant difference between the test group and P. (e) Effect of number of 
degradable HA monomers per arm on simulated Ac-Ac running integration number and 
(f) experimental gelation time of 20% SPEXA precursor solutions. 
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Micelle formation sharply reduced the average inter-acrylate and acrylate-initiator 
distance, leading to a significant increase in the rate of initiation and propagation of the 
acrylates. To quantify the average inter-acrylate distance (related to crosslinking rate) or 
proximity of water beads to ester groups on SPEXA macromonomers (related to 
hydrolytic degradation rate), the average number of Ac (or W) beads in a sphere of radius 
R around an Ac (or ester) bead or the running integration number of beads “a” around 
beads “b”, )(RINab  






0 )(4)(                                                              (equation 5.11) 
where 0b  is overall number density of type “b” beads and )(rgab  is radial distribution 
function of bead “b” around bead “a”, located at the origin. The running integration 
number of Ac-Ac beads in SPELA solutions ( AcAcIN  ) at crR   (the DPD length scale 
6.74 Å, see Methods section) initially increased with increasing m from 0 to 2, as shown 
in Figure 5.6.e, and then decreased as m increased from 2 to 3. Conversely, a unimodal 
increase in AcAcIN  was observed for SPEGA, SPECA and SPEDA solutions with 
increasing m from 0 to 3. The increase in AcAcIN   with m was attributed to a decrease in 
average Ac-Ac distance in the micelles‟ core. As the core of the micelles continued to 
increase in size and their separation distance continued to increase for m>2, average 
distance between the Ac beads began to increase, leading to a decrease in AcAcIN  , as 
predicted for SPELA in Figure 5.6.c. Furthermore, SPELA and SPECA macromonomers 
had higher AcAcIN   than SPEGA and SPEDA for 3m .  The predicted AcAcIN   
values 
are related to gelation time of the macromonomers in aqueous solution. Gelation time of 
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20 wt% SPEXA solutions was measured with a rheometer as a function of number of HA 
monomers per arm and the results are shown in Figure 5.6.f. Gelation times of SPELA 
and SPECA precursor solutions were shorter than those of SPEGA and SPEDA, as 
predicted by simulation (see Figure 5.6.e). Gelation time of 20 wt% SPEGA, SPEDA, 
SPELA and SPECA solutions decreased from 150 s to 61, 64, 28 and 34 s, respectively, 
with increasing m from 0 to 3 (see Figure 5.6.f). The initial sharp decrease in gelation 
time was attributed to aggregate formation and an increase in AcAcIN  . Simulation results 
in Figure 5.6.e predict that the AcAcIN   
value for SPELA should decrease for m>2. 
However, a decrease in AcAcIN   
for SPELA at higher m values was offset by an increase 
in residence time of the arms in the micelle core, leading to no change in gelation time. 
Residence time of a hydrophobic segment in the micelle core is proportional to[249, 272] 
3/2.~ n                                                                      (equation 5.12) 
where   is effective interfacial tension between the hydrophobic domains and water. As a 
result, residence time of the unreacted Ac groups in the micelles‟ core increased with n, 
which increased the rate of crosslinking, thereby gelation time was reduced. Furthermore, 
fraction of bridging arms between micelles increased with increasing residence time, 
which in turn increased the extent of physical gelation. Therefore, gelation time of the 
macromonomer solutions continued to decrease with increasing n.  
5.4.4. DEGRADATION OF SPEXA HYDROGELS 
Degradation of SPEXA hydrogels depended on the proximity of water beads to 
ester links on HA segments. Local distribution of water beads around hydrophobic cores 
of SPEXA-n4 micelles is shown in Figure 5.7.g. Water beads were in close proximity to 
G beads in SPEGA solution. The relatively small size of G cores along with lower 
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hydrophobicity of G beads compared to other HA monomers led to a short average 
distance between G and W beads. when SPEGA was replaced with SPELA, size of the 
micelles‟ core increased and local concentration of W beads around the core decreased 
(Figure 5.7.g, see image “L”), thereby increasing the average L-W bead distance. A dip 
in the concentration of W beads observed proximal to the micelle core in SPELA was 
attributed to the higher hydrophobicity of L beads, compared to G, leading to a higher 
packing of EO beads at the core-water interface. Concentration of W beads proximal to 
the micelles‟ core increased by exchanging SPELA with SPEDA but core size in SPEDA 
was significantly larger than SPEGA. The lowest concentration of W beads at the core 
margins was observed for SPECA micelles where the higher hydrophobicity of C cores 
compared to other HA monomers overcame the energy of chain extension and forced EO 
beads to undergo high-entropy packing at the core-water interface by repelling water 
beads from the interfacial layer.  
The running integration number of water beads around ester links, WesterIN  , for 
SPEXA macromononers (data not shown) initially increased with the addition of one 
monomer to SPEXA-m0. Then, WesterIN  decreased for all SPEXA solutions with m>1 
due to increase in micelle size and decrease in total micelle surface area. SPEGA and 
SPECA solutions had the highest and lowest WesterIN  for all m values, respectively. 
However, degradation rate of SPEXA hydrogels depended on the density of ester groups 
as well as proximity of ester groups to water beads. Assuming that the formation of 
carboxylic acid groups by ester dissociation did not affect hydrolysis rate (this is a good 





Figure 5.7. (a) Effect of number of HA monomers per arm (m) on predicted hydrolysis 
rate of 20 wt% SPEXA precursor solutions. (b) Effect of HA monomer type on 
experimental mass loss of SPEXA hydrogels with incubation time. (c-f) Effect of number 
of HA monomers per macromonomner on experimental mass loss of SPELA, SPEGA, 
SPEDA and SPECA  hydrogels, respectively, with incubation time. (g) Effect of 
degradable HA monomer type on distribution of water beads around core of the micelles. 
(h) Effect of number of HA monomers per arm on experimentally-measured equilibrium 
water content of SPEXA hydrogels. In (g), G, D, L, C, Ac and water beads are shown by 
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blue, pink, orange, purple, red and light blue, respectively, and EO beads are not shown 
for clarity.  
hydrolysis rate (P) at the mesoscale scale, which is proportional to the rate of degradation 
at the macroscale, is defined by 
esteresterWester ININP                  (equation 5.13) 
In the above equation, WesterIN   and esteresterIN   are proportional to the 
concentration of water and ester groups in the micelles, respectively. The simulated 
relative hydrolysis rate in the reaction volume for 20 wt% SPEXA macromonomers in 
aqueous solution is shown in Figure 5.7.a as a function of m. For all m values, SPEGA 
had the highest relative hydrolysis rate followed by SPELA, SPEDA and SPECA. 
Relative hydrolysis rate for SPECA and SPEDA solutions increased from zero to 5.2 and 
12.5, respectively, with increasing m from zero to 4. Likewise, relative hydrolysis rate of 
SPELA and SPEGA solutions increased from zero to 13.4 and 22.5, respectively, with 
increasing m from zero to 3 and then decreased to 12.3 and 21.0 with increasing m from 
3 to 4. The relatively large difference in predicted relative hydrolysis rates between 
SPEXA macromonomers for a given m indicated that hydrolysis was related to 
equilibrium water content and concentration of ester groups in the micelles, not to the 
bulk water concentrations (the solutions had similar bulk water contents, see Figure 
5.7.h). The predicted biphasic hydrolysis rate for SPELA and SPEGA in Figure 5.7.a was 
attributed to the low proximity of water to ester beads in larger micelle cores at higher m 
values. SPECA with the most hydrophobic micelles had the lowest predicted hydrolysis 
rate while SPEGA with the least hydrophobic micelles had the highest hydrolysis rate. 
Mass loss of 20 wt% SPELA, SPEGA, SPEDA and SPECA hydrogels with incubation 
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time for different m values are shown in Figures 5.7(c-f). SPELA-0L without lactide 
chain extension had <5% mass loss after 6 weeks of incubation.  
Mass loss of SPELA gels was linear with incubation time for all m values. 
SPELA hydrogels lost 6%, 37%, 80% and 100% mass after 4 weeks as m increased from 
zero to 0.8, 1.6 and 2.9, respectively. However, SPELA mass loss decreased from 100% 
to 87% as m increased from 2.9 to 3.7, which was consistent with the predicted decrease 
in SPELA hydrolysis rate for 3 ≤ m ≤ 4 in Figure 5.7.a (brown curve). SPEGA gels had 
the fastest degradation rate among HA monomers. The time for complete degradation of 
SPEGA gels initially decreased from 8 to 2 days with increasing m from 0.8 to 1.6. 
However, SPEGA degradation time increased from 2 to 3 days when m increased from 
1.6 to 2.8 mainly due to a transition from surface (controlled by the number of ester 
groups) to bulk degradation (domination by water content of the micelles). The difference 
in experimental (1.6 < m < 2.8) and simulated (3 < m < 4) transition range for SPEGA 
was attributed to the polydispersity of G segments, leading to a wider distribution of 
micelle core sizes. Mass loss of SPEDA and SPECA gels after 42 days ranged between 
30-39% and 80%-89% respectively. The non-linear degradation trend for SPEDA was 
attributed to a wider micelle size distribution, which was not taken into account in the 
simulations. The experimentally measured mass losses for SPEXA hydrogels at similar m 
values (1.6 ≤ m ≤ 1.8) are compared in Figure 5.6.b. SPEGA and SPELA hydrogels 
completely degraded in 3 days and 5 weeks, respectively, whereas SPEDA and SPECA 
hydrogels lost 40% and 20% their mass in 6 weeks. Equilibrium water content of SPEXA 
hydrogels as a function of m is shown in Figure 5.7.h. The difference in water content of 
SPEXA gels was not statistically significant (p values for the difference between water 
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contents were >0.17). Therefore, the wide range of degradation rates from a few days to 
many months observed for SPEXA gels, as shown in Figure 5.7.b, can only be explained 
by differences in equilibrium water content of the micelles with HA type and number of 
HA monomers per segment.  
5.4.5. OSTEOGENIC DIFFERENTIATION OF MARROW STROMAL CELLS IN 
SPEXA HYDROGELS  
MSCs were encapsulated in SPEXA gels and the effect of HA monomer type on 
osteogenic differentiation of MSCs was evaluated. SPEGA gel due to its relatively fast 
degradation (see Figure 5.7.d) was not used for MSC encapsulation. Groups included 20 
wt% SPELA (L-m1.7), SPEDA (D-m1.7), SPECA (C-m.18) and PEG (m0). The effect of 
HA type on total collagen content with incubation in osteogenic medium is shown in 
Figure 5.8.a. Total collagen content of L-m1.7 gel increased from 54 μg/μg DNA at day 7 
to 83 and 122 μg/μg DNA at days 14 and 21, respectively. Total collagen content of L-
m1.7 gel was significantly higher than those of C-m1.8, D-m1.7 and m0 gels for all 
incubation times. The higher secretion of collagen by MSCs seeded in L-m1.7 gels is 
attributed to hydrolytic degradation of the matrix concurrent with ECM production. Rate 
of ECM production is related to the rate of matrix degradation.[102, 169] ECM 
production is limited by free volume when rate of matrix degradation is slower than that 
of ECM production. Conversely, ECM production is limited by cell adhesion when rate 
of matrix degradation is faster than that of ECM production. ALP activity and extent of 
mineralization of MSCs in SPEXA gels are shown in Figures 5.8.b and 5.8.c, 
respectively. Consistent with previous results, ALP activity of all groups increased from 




Figure 5.8. (a) Total collagen, (b) ALP activity and (c) alcium content of MSCs 
encapsulated in SPEXA hydrogels with incubation time in osteogenicc medium. mRNA 
expression of (d) Col-1, (e) ALP and (f) OC of MSCs encapsulated in SPEXA hydrogels 
with incubation time in osteogenicc medium. “star” indicates statistically significant 
difference (p<0.05) between the test group and all other groups at the same time point. 
Error bars correspond to mean ± SD for 3 experiments. 
 
ALP activity of L-m1.7 was significantly higher than the other groups. Calcium content 
of all groups had an increasing trend with time. Calcium content of L-m1.7 increased 
from 10.3±1.2 to 40.8±8.5 and 224.7±18.5 mg/mg DNA with incubation time from day 7 
to 14 and 28. After 28 days, calcium content of L-m1.7 was significantly higher than the 
other groups. Furthermore, at day 28, calcium content of D-m1.7 and C-m1.8 was 
significantly higher than that of m0 group. It can be inferred from the results that 
degradation of SPEXA gels contributed significantly to mineralization with L-m1.7 gel 
having 2.3-fold higher mineral deposition compared to non-degradable m0 (PEG gel). 
 
124 
Higher extent of mineralization of MSCs in degradable gels is consistent with previous 
reports. In one study, Human MSCs encapsulated in a hydrolytically degradable PEG 
matrix and incubated in osteogenic medium displayed higher cell-cell contact and cell 
spreading compared to non-degradable PEG.[30, 273] In another study, mineralization of 
osteoblasts increased by three folds with conjugation of lactide segments in PEG 
dimethacrylate hydrogels.[101]   
mRNA expression levels of Col-1, ALP and OC are shown in Figures 5.8(d-f), 
respectively. Col-1 expression for all groups was significantly higher at day 28 compared 
to day 7. For example, Col-1 mRNA expression of L-m1.7 increased from 2.9±0.7 to 
16.6±1.7 and 45.2±5.0 when incubation time increased from day 7 to 14 and 28. At day 
28, Col-1 mRNA expression of L-m1.7 was 2.5 fold higher than PEG gel. ALP mRNA 
expression (Figure 5.8.e) showed a trend similar to its bioactivity in Figure 7b. At day 14, 
ALP mRNA expression of L-m1.7 was significantly higher than the other gels and 2.2 
times higher than PEG gel. OC expression of all groups increased from day 7 to 28 with 
L-m1.7 and C-m1.8 gels showing significantly higher OC expression at day 28 compared 
to D-m1.7 and PEG gels. Taken together, the findings of this work demonstrate that chain 
extension of PEG hydrogels with short HA segments resulted in the formation of micellar 
hydrogels that support differentiation and mineralization of MSCs with a wide range of 
degradation rates from a few days to many months.  
5.5. CONCLUSIONS 
Structure formation and gelation kinetics of SPEXA macromonomers in aqueous 
solution and degradation of SPEXA gels were investigated by simulation and 
experimental measurement. In the absence of HA monomer, distribution of acrylate 
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groups was uniform in aqueous solution but the extension of the macromonomer arms 
with hydrophobic X segments induced aggregation and micelle formation. Core radius of 
SPEGA and SPEDA micelles increased from 0 to 22 Ǻ when number of HA repeating 
units per arm (n) increased from 2 to 8 while that of SPELA and SPECA micelles 
increased from 9 and 11 Ǻ to 23 and 24 Ǻ, respectively. Aggregation resulted in 
partitioning of the polymerization photoinitiator to the micelle phase, which confined the 
gelation reaction to the micelle phase, thereby improving viability of encapsulated MSCs. 
Micelle formation sharply reduced the average inter-acrylate and acrylate-initiator 
separation distance, leading to a significant increase in gelation rates of SPEXA gels. For 
example, gelation time of 20 wt% SPEGA, SPEDA, SPELA and SPECA solutions 
decreased from 150 s to 61, 64, 28 and 34 s, respectively, with increasing number of HA 
monomers per arm (m) from 0 to 3. The simulated hydrolysis rates of SPEXA gels were 
strongly dependent on HA type and number of HA repeat units, consistent with 
experimentally measured degradation rates. For all HA types, hydrolysis rate of SPEXA 
gels was biphasic. For example, as m increased from 0.7 to 1.2, 1.8 and 2.8, mass loss of 
SPEGA gels after 2 days increased from 20% to 46% and 80% and then decreased to 
66%, respectively. Similarly, as m increased from 0.8 to 1.7, 2.9 and 3.7, mass loss of 
SPELA gels after 3 weeks increased from 32% to 50% and 62% and then decreased to 
46%. All SPEXA gels had similar initial water contents irrespective of HA type and n. A 
biphasic relationship between HA segment length and gel degradation rate indicated a 
transition from surface to bulk hydrolysis in the micelle phase. The micellar SPEXA 
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Hydrogels, due to their high water content and high diffusivity of nutrients and 
biomolecules, are very attractive as a carrier for delivery of stem cells to the site of defect 
in regenerative medicine.[21, 24, 28, 87, 88] After injection and in situ hardening, the 
hydrogel matrix guides the development of seeded cell into the desired tissue.[24] In 
most in situ applications, the hydrogel should have robust mechanical stability to prevent 
deformation and rupture by soft tissue compression or other mechanical loads.[44] In 
addition, the hydrogel should be degradable to provide volume for tissue 
regeneration.[48] Hydrogels based on small-molecule monomers, due to their potentially 
high network density, have excellent structural stability, but viability of the seeded cells 
is severely reduced by the diffusion of toxic monomers across the cell membrane.[42] 
Naturally based injectable gels have excellent biocompatibility and support cell-matrix 
interaction, but they have very low cross-link density and mechanical strength.[31, 274] 
Physically cross-linked hydrogels, due to the transient nature of the cross-links, also 
suffer from low mechanical strength.[36, 235] There is a need to develop synthetic 
biodegradable macromonomers for applications in regenerative medicine with robust 
mechanical properties. In that regard, hydrogels based on functionalized poly(ethylene 
glycol) (PEG) macromers are inert and nonimmunogenic and have a compressive 
modulus exceeding 1 MPa.[169, 275] PEG hydrogels have been used extensively to 
investigate the effect of matrix physiochemical, mechanical, and biological factors on cell 
function in vitro.[26, 44] To impart degradability to the hydrogels, short degradable 
lactide segments can be attached to the PEG macromer by ring opening polymerization 
prior to acrylate functionalization to produce a degradable PEG based hydrogel.[136, 
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218, 276] However, the hydrophobic lactide segments in the hydrophilic PEG, in addition 
to reducing the solubility of the macromonomer in aqueous solution and the water 
content of the resulting PEG hydrogel, cause micelle formation.[134, 135] Experimental 
results with four-arm star poly(ethylene glycol-co-lactide)-acrylate (SPELA) 
macromonomer demonstrate that the hydrogel modulus increases slightly with the 
addition of 1−2 lactides per arm followed by a sharp decrease in modulus for higher 
lactide segment lengths.[52] The formation of nanostructure by macromonomers in the 
hydrogel precursor solution alters the spatial distribution and accessibility of the reactive 
functional groups, which in turn affects the rate and extent of cross-linking.[277] 
Therefore, a molecular-scale understanding of the factors that affect nanostructure 
formation in these mixtures will aid us in designing hydrogels from macromonomers with 
improved physical and mechanical properties. Atomistic molecular simulations are 
limited to the atomic time and length scales.[278] Mesoscale methods in which the 
dynamics of the system is based on course-grained beads made up of a group of atoms 
have been developed to simulate the nanostructure of copolymers.[244, 279, 280] 
Hoogerbugge and Koelman[243] introduced the dissipative particle dynamics (DPD) 
approach, later revised by Espanol and Warren,[242] to simulate the dynamics of soft 
spherical beads interacting through pairwise additive force fields. The DPD approach has 
been used to simulate the mesoscale dynamics of polymer systems [281-285] after Groot 
and Warren related the conservative force terms to the Flory− Huggins interaction 
parameter.[58, 80] DPD has been used to simulate the microstructure and microphase 
separation for linear and multiarm block copolymer mixtures and solutions.[184, 244, 
286-290] The objective of this work was to simulate the nanostructure and micelle 
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formation of SPELA macromonomer, a four-arm PEG with short lactide chains 
terminated with acrylates. In this work, the effect of the four-arm SPELA lactide segment 
length and macromonomer concentration in aqueous solution on micelle formation and 
distribution of the acrylate groups will be simulated with DPD. The distribution of the 
acrylates, namely free from the micelles, tethered, and trapped in the micelles, provide 
information on the crosslinking efficiency of the SPELA macromonomer and then 
ultimate modulus of the hydrogel. 
6.2. METHODS 
6.2.1. THEORY 
In DPD simulation, the polymer solution is divided into different beads (set of 
atoms) with equal mass and volume. The SPELA macromonomer is synthesized by 
ringopening polymerization of lactide monomers initiated by a four-arm star PEG (MW 
of 5 kDa), followed by acrylation of the chain ends with acryloyl chloride. Figure 6.1 
shows the molecular structure and different bead types on SPELA macromonomer. The 
bead types included lactide (L, dark brown), ethylene oxide (EO, green), acrylate (Ac, 
red), and star PEG center (SPEGc, light brown). Three water molecules were used for the 
solvent bead. The evolution of the position and velocity of all beads is governed by 












m                                                                           (equation 6.1) 
where ir  , im  , iv and if are the position vector, mass, velocity vector, and total force 
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ijF are the conservative, dissipative and  random 
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(equation 6.5) 
where ijr and ije are the magnitude and unit of the vector joining bead i to j ( jiij rrr  ),
ijv  is given by jiij vvv   , and ijα  
is a constant that describes the maximum repulsion 
between the interacting beads i and j.
 ij
α , which is dependent on the characteristics of 
the mixture plays a significant role in determining the nanostructure of the equilibrated 
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macromonomer solution. The system contains dissipation as well as total momentum 






Dw and Rw are r-dependant 
weight functions for dissipative and random forces respectively,  and  ,   are the 
magnitude of dissipative and random forces. ij is a random variable with a Gaussian 
probability distribution. Espanol and Warren showed that the parameters of the 
dissipation and random forces have to satisfy fluctuation-dissipation conditions
2
ijRijD )]r(w[)r(w   and  Tk2 B
2  .[242]. The optimized weight function 
2
ijijD )r1()r(w  within the cutoff distance for soft chains in aqueous solution was used 
in the simulation. [58] 
According to the force balance (equation 6.2), the beads on the macromonomer 
that are not directly connected move like soft spheres in the solution. However, the 
motion of the adjacent beads that are directly connected is constrained by covalent bonds. 
Thus, an additional spring force has to be included to simulate the motion of adjacent 
beads on the macromonomer chains. The spring force acting on the bonded consecutive 





i C rF                                                                            (equation 6.6) 
where beads j are those that are connected to bead i. A value of 4 was used in the 
simulation for spring constant C to properly account for the distance between connected 
beads.[244] Due to the domination of repulsive forces between soft spheres in the mean 
segment length,[244] the end point distribution of the macromonomer is not very 
sensitive to the value of constant C. 
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6.2.2. SIMULATION PARAMETERS 
The parameters of the conservative force were set by choosing the mapping of 
three water molecules per DPD bead in order to simulate the diffusivity and 
compressibility of water.[291-293] This mapping made it possible to simulate the 
structure of SPELA macromer with small L:EO ratio and one acrylate per arm. All beads 
in the simulation system had the same volume of 90 Å
3
 and the same mass 54 amu. By 
choosing the system density ρ = 3rc
−3
, the DPD fundamental length scale, rc, was 6.46 Å 
and the bead−bead interaction parameters were determined by[58]  
 ijiiij
27.3                                                                        (equation 6.7) 
where
ij is the Flory-Huggins parameter between beads i and j and ii is the repulsion 
parameter between beads of the same type. To satisfy the compressibility of water, the 
mapping of three water molecules per bead led to 78ii .[291]. Flory-Huggins 
parameters were calculated using: 





                                                                             (equation 6.8) 
where i and j are the solubility parameters of beads i and j respectively, V is the bead 
molar volume, T is the absolute temperature, and R is the gas constant.  The solubility 
parameters were calculated via atomistic Molecular Dynamics simulation (Forcite 
module in Materials Studio V. 5.5 (Accelrys)) using the COMPASS forcefield which is 
an ab initio forcefield optimized for condensed-phase systems[245].  To arrive at the 
initial packing for each bead type, 64 beads were simulated in a cubic unit cell with 3D 
periodic boundary conditions using the rotational isomeric state (RIS) method,[294] 
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subject to equilibration at 298 K. After geometric optimization, the unit cell was 
equilibrated by the annealing dynamics simulation method, which included five cycles of 
NVT ensemble dynamics between 300 and 800 K to prevent the system from being 
trapped in a local minimum. After reaching the lowest energy configuration, 1500 ps of 
thermalizing NPT dynamics (1 fs time step) was performed to reach the actual system 
temperature and pressure. Next, the cohesive energy density (CED) was determined by 
sampling the system and collecting data for 500 ps. The CED was related to the solubility 


















                                                              (equation 6.9) 
where ivH , and im,V  are the molar enthalpy of vaporization and molar volume of bead i 
respectively. The bead−bead repulsion parameters, ij , calculated from the solubility 
parameters using eqs 6.7 and 6.8, are given in Table 6.1. 
The initial condition of each simulation was the random distribution of coarse-
grained SPELA-nL macromonomers and water beads inside the simulation box with 3D 
periodic boundary conditions. The parameter “n” in SPELA-nL is equal to the number of 
L beads on each arm of the macromonomer. The total numbers of L and EO beads were 
held constant at 32 while n was varied, and the macromer concentration was 30% v/v 
unless otherwise specified. The macromonomer was simulated in cubic boxes with 
lengths of 30rc, 40rc, and 50rc. The relative distribution and structure of the 
macromonomer after equilibration was independent of size of the simulation box. The 
simulated root-mean-square radius of gyration (Rg) of the four-arm PEG (MW of 5.9 kDa 
with 33 beads on each arm) was 25.4 Å, which was in the theoretical range 21.2−27.8 
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Table 6.1. DPD Interaction Parameters ( ij ) Used in the Simulation. 
  Ac L EO SPEGc W 
Ac 78.0 83.2 91.9 118.7 98.9 
L 83.2 78.0 86.8 86.3 92.3 
EO 91.9 86.8 78.0 93.3 80.5 
SPEGc 118.7 86.3 93.3 78.0 115.6 
W 98.9 92.3 80.5 115.6 78.0 
 
Å.[53, 295] Furthermore, the length of the simulation box (197 Å for 30rc) was an order 
of magnitude larger than Rg, indicating that the finite size effects may have no effect on 
our results.[289] Bead diffusivities reached steady-state values after 150000 time steps. 
All simulations ran 200000 times with a dimensionless time step of 0.05. For each 
sample, the DPD simulation was repeated five times (with randomly seeded 
macromonomers in the simulation box) and the results were reported as the mean ± 
standard deviation. All atomistic and mesoscale calculations were performed via the 
Amorphous Cell, Forcite, and Mesocite modules of Materials Studio v5.5 (Accelrys, San 
Diego, CA).[267] 
6.3. RESULTS AND DISCUSSION 
6.3.1. EFFECT OF LACTIDE FRACTION  
Figure 6.2 shows the effect of the number of lactides on structure formation of 
SPELA-nL macromers in water (30% v/v). It should be noted that the W, EO, and SPEGc 
beads are not shown in Figure 6.2 for clarity. In the absence of lactide (n = 0), the 
acrylates were uniformly distributed over the volume of the simulation box. Addition of 
lactide segments (n ≥ 2) to the macromonomer led to the formation of micellar structures. 




Figure 6.2. Evolution of micellar cores for SPELA-nL macromonomers in 30% aqueous 
solution. “L” and “Ac” represent lactide and acrylate beads respectively. The other beads 
in the image are not shown for clarity.  
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macromonomers aggregated and formed the core of the micelles while the hydrophilic 
EO segments, facing the aqueous phase, formed the micelle‟s corona. Those arms that are 
not part of the hydrophobic core of the micelles are referred to as “free arms”. With 
increasing number of lactides per arm, the core size of the micelles increased while the 
number of free arms decreased. A cross section of the structures, corresponding to those 
in Figure 6.2, is shown in Figure 6.3. With increasing n, more arms of each 
macromonomer participated in the formation of the micellar core. Consequently, the core 
size increased with n while the corona thickness decreased, as shown in Figure 6.3. At 
low n with small hydrophobic domains, the EO segments had an extended conformation 
in the aqueous phase at the water−micelle interface. However, as n and the volume of the 
hydrophobic domain increased, the EO segments adopted a 2D stretched conformation on 
the surface of the micelles. This change in conformation is caused by repulsive 
interactions between water and lactide segments at the interface dominating over the 
reduction in entropy as the EO segments adopt a 2D conformation on the micelle surface.  
The effect of number of lactides on each arm on the core radius and number 
density of micelles is shown in Figure 6.4.a. The core size increased with the volume 
fraction of lactide segments, while the number density decreased. Although the 
aggregation of lactide segments and formation of micelles reduces the total free energy of 
the solution, two positive contributions to the free energy controlled the core size and 
number density.[296] One factor is the free energy of the water−micelle interface, which 
is proportional to the core surface area per macromonomer. The other factor is the steric 
repulsive energy between the hydrophilic EO segments positioned at the corona−core 




Figure 6.3. Cross section of the micelles for SPELA-nL macromonomers in 30% aqueous 
solution. “L”, “Ac”, “EO”, and “SPEGc” represent lactide, acrylate, ethylene oxide, and 
the star PEG core, respectively. The water beads are not shown for clarity. 
 
macromer. The number of EO beads per unit core surface area deceases with increasing 




Figure 6.4. The effect of the number of lactide beads on each arm on (a) the micelle core 
size and number density and (b) the aggregation number of micelles in 30% aqueous 
solution of SPELA-nL macromonomers. n represents the number of lactide beads on each 
macromonomer arm, which has a total of 32 L and EO beads. Error bars correspond to 
means ± 1 SD for n = 5 simulations. 
 
the EO layer thickness on the core surface decreases with increasing n, thus leading to an 
increase in interfacial free energy. Since the core size increased with n (see Figures 6.2 
and 6.3), the net effect is the domination of interfacial over repulsive free energy, which 
led to the formation of micelles with smaller core surface areas per molecule, larger 
cores, and lower number density of micelles. The average number of SPELA 
macromonomers in a micelle or aggregation number, aggn , can be calculated by the 
following equation, assuming there are only L and Ac beads in the micelle‟s core:  






                                                                                    (equation 6.10) 
where  and cV  are the bead number density and micelle core volume, respectively. 
Figure 4b shows that the aggregation number increased with n. According to Figure 
6.4.b, there was a sharp increase in aggn  from 3 to 9 when n was raised from 2 to 4. That 
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increase can be related to the transition from macromonomer density fluctuation (size < 
Rg) to micelle formation (see Figure 6.2). aggn  also increased sharply when n was raised 
from 12 to 16, which can be related to the transition from micellar to microphase 
separated solution. For the case of SPELA-20L, the small interfacial surface area per 
macromonomer could not be achieved for minimization of free energy by spherical 
packing, which led to the formation of continuous phases in the simulation box (data not 
shown). 
6.3.2. EFFECT OF MACROMONOMER CONCENTRATION 
The effect of macromonomer concentration on core radius and number density of 
micelles for SPELA-4L is shown in Figure 6.5. The core radius slightly increased from 
14.9 to 16 Å as the SPELA concentration was increased from 5 to 30%. The ratio of 
water to lactide beads was higher for lower SPELA concentrations, resulting in a stronger 
repulsive interaction at the micelle−water interface and smaller core size. Since there was 
a slight change in core size with concentration, the number density of micelles increased 
with increasing macromonomer concentration. In addition, the distribution of acrylates in 
the core of the micelles did not change significantly with increasing SPELA 
concentration. 
6.3.3. INTER-MICELLAR BRIDGING 
The cross sections in Figure 6.3 show that the center of the macromonomers 
(SPEGc) is positioned in the corona of the micelles. Therefore, the arms can possess three 
different conformations, namely, the intermicellar bridges, loops in which at least two 
arms of a macromonomer are in the same micelle, and free arms. The three 




Figure 6.5. The effect of macromonomer concentration on the core size and number 
density of the micelles in aqueous solution of SPELA-4L macromonomers. Error bars 
correspond to means ± 1 SD for n = 5 simulations. 
 
 
Figure 6.6. Schematic representation of bridge, loop ,and free arm conformations of 
SPELA macromonomers in aqueous solution. “L”, “Ac”, and “EO” represent lactide, 
acrylate, and ethylene oxide beads, respectively. 
 
arms are in solution and considered free. For SPELA macromonomer with n > 0, 
aggregation of hydrophobic lactide groups and micelle formation results in the creation of 
loops and bridges. Assuming ideal solution and connectivity of the macromonomer arms 
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does not affect partitioning, the relation between the mole fraction of arms in the micelles 




















                                                   (equation 6.11) 
where ( 0f
0
mic  ) is the standard chemical potential of micellization per arm, aggn  is the 
aggregation number of macromonomers in a micelle, and R  and T  are the gas constant 
and absolute temperature, respectively. According to Figure 6.5, macromonomer 
concentration has a slight effect on micelle core size and thus the aggregation number. 
Therefore, on the basis of eq 6.11, the fraction of free arms, faX , does not change 
significantly with an increase in the total macromonomer concentration TX  = maX  + faX
. However, it significantly increases the fraction of arms with bridge and loop 
conformation. Therefore, there is a smaller fraction of free arms and larger fraction of 
loops and bridges at higher macromonomer concentrations. As the ratio of L to EO 
increases at constant TX , the fraction of free arms decreases. The number of bridges per 
micelle and the bridge fraction of the arms as a function of n are shown in Figure 6.7. The 
number of bridges per micelle continuously increased with n, while the bridge fraction 
showed a biphasic behavior. The bridge fraction initially increased when n increased 
from 2 to 4, which can be attributed to the decrease in the fraction of free arms from 70 to 
14% of total arms. With increasing n to values >4, the intermicellar distance increased 
while the length of hydrophilic EO segments connecting the micelles decreased, thus 




Figure 6.7. The effect of the number of lactide beads on each arm on the number of 
bridges per micelle and bridge fraction in 30% aqueous solution of SPELA-nL 
macromonomers. Error bars correspond to means ± 1 SD for n = 5 simulations. 
 
The contribution of each bridge to the elastic modulus of the physically formed 
network is related to the residence time of the arm in the micelle‟s core, which is 
proportional to[249] 
        
3/2n.~                                                                                        (equation 6.12) 
where   is the effective interfacial tension between the micelle‟s core and solution. With 
increasing n, the EO segments adopt a thinner interfacial layer on the core surface with 
lower entropy, thus increasing the interfacial tension of the micelle−water interface. 
Therefore, both n and   increased the residence time of the bridges with increasing 
number of lactides per arm. As a result, the contribution of each bridge to the elastic 
modulus of the network increased with n [298] even though the fraction and number 
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density of bridges decreased for n > 4. That effect, in turn, reduced the mobility and 
accessibility of the reactive acrylate groups with increasing n. 
6.3.4. DISTRIBUTION OF REACTIVE ACRYLATE BEADS 
The reactivity of an acrylate group in the macromonomer depends on its mobility 
and its proximity to other acrylates in the solution. The acrylate mobility, in turn, depends 
on the concentration of water in the microenvironment. To quantify the proximity of an 
acrylate bead to water beads or other acrylate beads, the average number of water ( wAcn  ) 
or acrylate ( AcAcn  ) beads in a sphere of radius R around an acrylate bead or the running 
integration number of beads “a” around beads “b”, ban , was calculated by[248] 




ab0bba                                                                    (equation 6.13) 
where 0b is the overall number density of beads of type „b‟  and   abg (r) is the radial 
distribution function of bead “b” around bead “a” located at the origin. [299] The effect 
of the number of lactides in the SPELA macromonomer on wAcn   and AcAcn   in a radius 
of 20 Å is shown in Figure 6.8.a and 6.8.b, respectively. wAcn   increased with radial 
distance, but the SPELA-0L macromonomer (n = 0) had the highest integration number 
with maximum coverage of acrylate groups by water beads. With increasing n and 
formation of larger lactide cores, the fraction of hydrophobic acrylates facing water 
decreased, leading to a decrease in wAcn  . The wAcn   value for SPELA-0L at radial 
distance rc was an order of magnitude higher than that of SPELA-16L. This large 
difference emphasizes the higher accumulation of water beads around acrylates, and 




Figure 6.8. The running integration numbers for (a) Ac−W beads and (b) Ac−Ac beads of 
SPELA-nL macromonomers in 30% aqueous solution. 
 
of lactides. According to Figure 6.8.b, SPELA- 0L with the most uniform distribution of 
acrylate beads had the lowest AcAcn  . The hydrophilic EO segments in SPELA-0L served 
as an energy barrier against the formation of acrylate aggregates; thus, the acrylate local 
density was the same as the overall density. Increasing n and the phase separation of 
lactide and acrylate beads led to an increase in AcAcn  , as shown in Figure 6.8.b. As n 
increased from 0 to 2 and 4, the fraction of macromonomer arms incorporated in the 
micelles increased from 0 to 30 and 86%, respectively, which led to a higher local density 
of acrylates and a decrease in the average Ac−Ac bead distance. With further increase in 
n, the local density of acrylates in the micelles‟ core decreased and the intermicellar 
distance increased which led to an overall decrease in AcAcn   for n > 4. Therefore, AcAcn   
reached a maximum value for n = 4.  
Figure 6.9 shows the effect of n on the radial distribution of acrylates in the core 




Figure 6.9. The distribution of Ac beads in the core of micelles for SPELA-nL 
macromonomers in 30% aqueous solution. 
 
the central part of the micelles‟ core. However, a significant fraction of acrylate beads in 
micelles with smaller cores, due to volume constraints, were positioned near the surface 
layers. For example, in SPELA-4L with relatively smaller core size, 66% of the acrylates 
were positioned near the surface layer, away from the core‟s center. The average size of 
the micelles‟ core increased with n, which relaxed the volume constraint, thus increasing 
the fraction of acrylates in the core‟s inner layers. Therefore, the maximum fraction of Ac 
beads for macromonomers with n = 8 and n = 16 were located below the surface layer to 
minimize the interfacial free energy, as shown in Figure 6.9. Figure 6.10 shows the 
variation of free and tethered fractions of acrylates with the number of lactides in each 
arm. All acrylates were distributed uniformly in SPELA-0L. Increasing n led to the 
formation of larger micelles and a decrease in the fraction of free arms. The fraction of 
free arms decreased dramatically from 0.70 to 0.14 when n was increased from 2 to 4, 




Figure 6.10. The effect of the number of lactide beads on each arm on the fraction of Ac 
beads on free arms and core surface of the micelles for SPELA-nL macromonomers in 
30% aqueous solution. Error bars correspond to means ± 1 SD for n = 5 simulations. 
 
micelles. A 66% increase in the size of the lactide segment of the arms (n changing from 
2 to 4) led to a 420% increase in the core volume of the micelles, while the number 
density of micelles decreased by only 10%. When n was increased to 8, almost all 
acrylates (>99%, see Figure 6.10) became part of the core volume of the micelles. The 
reactive acrylate groups on SPELGA macromonomers cross-link by photopolymerization 
in aqueous solution and form mechanically robust hydrogel networks.[52] The covalent 
cross-links are stronger than the transient physical bridges between micelles. The reaction 
between the free acrylates, which are in contact with the aqueous phase, forms 
intermolecular cross-links and increases the cross-link density. The reaction between the 
acrylates in the micelle‟s core that belong to the same macromonomer (loops) increases 
the residence time of the bridges, while the reaction between those acrylates on different 
macromonomers (bridges) changes a transient bridge to a permanent cross-link. Since 
there is a high fraction of loops in the micelles‟ core (see the bridge fraction in Figure 
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6.7), a large fraction of the core acrylates undergo cyclization, which do not contribute to 
the elastic modulus of the network. 
The effect of the number of lactide beads, n, on the reaction of acrylates and 
network formation can be divided into two regimes. SPELA-0L with 100% free acrylates 
produces networks with the highest and most uniform cross-link density. For low n 
values (n ≤ 4), most of the acrylates are free (see Figure 6.7.a) and the average distance 
between the acrylates in the micelles‟ core is relatively small (see Figure 6.3). Therefore, 
both free acrylates in the aqueous phase and core acrylates in the micelle phase contribute 
to network formation. With increasing n, the Ac−Ac integration number grows, which 
increases the rate of propagation reaction between the acrylates, leading to a reduction in 
gelation time (formation of infinite network). For n > 4, the fraction of free acrylates is 
negligible, so cross-linking is dominated by the reaction between the core acrylates. Since 
the solvent concentration in the micelle‟s core is very low, the core acrylates have 
significantly low diffusivity compared to free acrylates. Also, the average distance 
between the acrylates in the micelles‟ core increases with n. Thus, the rate of cross-
linking decreases with increasing n for n > 4, leading to decreasing density of permanent 
bridges and lower elastic modulus of the network. 
6.4. CONCLUSION 
The mesoscale structure of the four-arm star poly(ethylene glycol-co-lactide)-
acrylate (SPELA) macromonomer in aqueous solution was simulated by dissipative 
particle dynamics (DPD). The short lactide segments on each arm led to the formation of 
micelles. The micelle size, aggregation number (average number of macromonomers per 
micelle), and the number of intermicellar bridges increased with increasing number of 
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lactides per arm. Among three possible conformations of the arms (free, loop, and 
bridge), the fraction of free arms decreased with increasing n while the fraction of loops 
decreased. The fraction of bridges showed a maximum at n = 4. There was a transition 
from the uniform distribution of acrylates for n = 0 to nearly complete incorporation in 
the micelles for n > 4. For the acrylates incorporated in the micelles, the fraction tethered 
to the core surface (those within a volume element facing the aqueous phase) decreased 
with increasing n. The average integration number of water beads around the acrylates 
was highest for the SPELA-0L (n = 0) and decreased with increasing n. The average 
integration number of acrylates around an acrylate had a biphasic behavior with a 
maximum at n = 4. The macromer concentration did not have a significant effect on the 
distribution of acrylates and the size of the micelles. The results predict that the 
conversion of SPELAnL acrylates in the cross-linking reaction decreases with increasing 
n, thus reducing the modulus of the hydrogel. The results also predict that there is a trade-
off between the hydrogel modulus and degradation with higher n values favoring 
degradation. The predictions of the simulation can be used to design novel PEG-based 
hydrogels with robust mechanical properties and the desired degradation rate by changing 
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A feasible approach to the restoration of injured bone tissue is the use of tissue 
engineering strategies to transplant undifferentiated human mesenchymal stem cells 
(hMSCs) in a supportive carrier loaded with bone morphogenetic proteins. In particular, 
human recombinant bone morphogenetic protein (BMP-2) is used extensively in certain 
clinical applications such as spine fusion, sinus augmentation and alveolar ridge 
augmentation to accelerate bone regeneration and healing.[62] Due to its short-half-life 
and diffusion of the protein away from the site of regeneration, doses much higher than 
the endogenous amount are loaded in the implant to induce bone formation.[62, 64] High 
doses of BMP-2 protein in vivo cause undesired side effects such as bone overgrowth, 
immune response, and tumorigenesis.[65] For example, the probability of an adverse side 
effect with the use of BMP-2 in spine fusion may be as high as 40%.[65] Encapsulation 
or grafting in nano- and microspheres is used to localize the protein to the site of 
regeneration and reduce diffusion,[239, 300, 301] however tumor formation and 
inflammatory response persists in some patients.[302]  
The side effects of BMP-2 protein stems from its ability to promote cell migration 
and vascularization and its involvement in tumor angiogenesis.[303] Therefore, an 
attractive approach to reduce the protein‟s side effects in bone tissue engineering is to use 
peptides derived from the bioactive domains of BMP-2 and other morphogenetic 
proteins.[66] BMP-2 protein is a homodimer of two 114 amino acid residues with two 
distinct epitopes. The wrist epitope is assembled around the central α-helix while the 
knuckle epitope is located on the two aligned double-stranded β-sheets.[304, 305] It has 
been shown that the activity of BMP-2 protein is mainly due to the interaction of the 
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knuckle epitope with type II BMP receptor (BMP-II).[304] Multiple peptides derived 
from the knuckle epitope of BMP-2 protein have been shown to have osteoinductive 
potential.[18, 202] Among those, a peptide corresponding to residues 73-92 (hereinafter 
referred to as BMP-2 peptide) showed highest alkaline phosphatase (ALP) and 
osteogenic differentiation of MSCs, but the peptide activity was significantly lower than 
BMP-2 protein.[66] The higher activity of the protein compared to the BMP-2 peptide 
may be due to conformations differences between the native and free states of the peptide 
in aqueous medium. Peptides have recently been used to generate tubular, fibrillar, 
micellar, or vesicular nanostructures due their amphiphilic nature.[306-309] For example, 
peptides with a hydrophilic head and a hydrophobic tail spontaneously self-assemble to 
form vesicular structures in aqueous solution.[310] Peptide aggregation may alter the 
overall conformation and presentation of the amino acid sequence that interacts with cell 
surface receptors which adversely affects the osteoinductive potential of the peptide. 
Although the structure and activity of BMP-2 protein has been extensively investigated in 
vitro and in vivo, there is limited data on aggregation and nanostructure formation by 
osteogenic peptides in aqueous solution and its effect on osteogenesis.  
The objective of this work was to investigate the effect of concentration and 
hydrophobicity of the BMP-2 peptide on peptide aggregation and differentiation of 
hMSCs encapsulated in an inert polyethylene glycol (PEG) hydrogel. To test the effect of 
BMP-2 peptide on differentiation, the encapsulated hMSCs were cultured in osteogenic 
medium without dexamethasone (DEX). Molecular dynamic simulation was used to 
predict the effect of concentration and hydrophobicity on peptide aggregation and critical 
micelle concentration (CMC) using a MARTINI coarse-grained force field.[60, 311, 312] 
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The peptide concentration was varied by 1000-fold from 0.005 mM to 5 mM with BMP-2 
protein as the positive control. Hydrophobicity of the peptide was varied by capping PEG 
chain ends with 0-6 lactide monomers. PEG as an inert matrix with tunable properties[51, 
52, 113] was used for encapsulation of hMSCs to isolate and investigate the effect of 
BMP-2 peptide hydrophobicity on its osteoinductive potential. Experimental and 
simulation results revealed that osteoinductive potential of the BMP-2 peptide is 
correlated with its CMC and the concentration of free peptide in aqueous medium and not 
the total peptide concentration. 
7.2. MATERIALS AND METHODS 
7.2.1. REAGENTS 
Linear polyethylene glycol (PEG) with nominal molecular weight of 3.4 kDa was 
purchased from Acros (Pittsburg, PA). Lactide (L) monomer with >99.5% purity was 
purchased from Ortec (Easley, SC) and it was dried under vacuum at 40°C for at least 12 
h prior to use. 4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl) ketone (Irgacure-2959) 
photoinitiator was obtained from CIBA (Tarrytown, NY). The protected amino acids and 
Rink Amide NovaGel
TM
 resin were purchased from EMD Biosciences (San Diego, CA). 
Piperidine, calcium hydride, tetrahydrofuran (THF), trimethylsilane (TMS), triethylamine 
(TEA), tin (II) 2-ethylhexanoate (TOC), acryloyl chloride (Ac), acrylic acid, 
dimethylsulfoxide (DMSO), and ethylenediaminetetraacetic acid disodium salt (EDTA) 
were purchased from Sigma-Aldrich (St. Louis, MO). Dichloromethane (DCM, Acros) 
was dried by distillation over calcium hydride. Other solvents were obtained from VWR 
(Bristol, CT) and used as received. The protected amino acids and Rink Amide NovaGel 
resin for peptide synthesis were purchased from EMD Biosciences (San Diego, CA). 
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N,N-dimethylformamide (DMF), acetonitrile (MeCN), N,N-diisopropylethylamine 
(DIEA), N,N'-diisopropylcarbodiimide (DIC), triisopropylsilane (TIPS), N,N-
dimethylaminopyridine (DMAP), hydroxybenzotriazole (HOBt) and trifluoroacetic acid 
(TFA) were received from Acros. Dulbecco's phosphate-buffer saline (PBS) and 
Dulbecco's Modified Eagle's Medium (DMEM; 4.5 g/L glucose with L-glutamine and 
without sodium pyruvate) were received from GIBCO BRL (Grand Island, NY). Fetal 
bovine serum (FBS) was purchased from Atlas Biologicals (Fort Collins, CO). TRIzol for 
isolation of cellular RNA and trypsin were purchased from Invitrogen (Carlsbad, CA). 
Penicillin (PN), streptomycin (SP), fungizone (FG), gentamicin sulfate (GS), 
dexamethasone (DEX), ascorbic acid (AA), and ß-sodium glycerophosphate (βGP) were 
purchased from Sigma-Aldrich. Quant-it PicoGreen dsDNA reagent kit was obtained 
from Invitrogen (Carlsbad, CA). QuantiChrom calcium and alkaline phosphatase (ALP) 
assay kits were purchased from Bioassay Systems (Hayward, CA). Human mesenchymal 
stem cells (hMSCs), harvested and cultured from normal human bone marrow, were 
purchased from Lonza (Allendale, NJ). The cells were tested for purity by high 
expression of CD105, CD166, CD29, and CD44 and low expression of CD14, CD34 and 
CD45 markers as described by the supplier (Lonza).  
7.2.2. SYNTHESIS OF LACTIDE-CAPPED PEG MACROMER  
The PEG macromer was capped with short lactide segments (<6 monomers) by 
condensation polymerization as we previously described.[35, 52] Briefly, the residual 
moisture was removed from the PEG macromer by azeotropic distillation from toluene. 
The PEG macromer and lactide monomers were heated to 120°C under dry nitrogen 
atmosphere in a reaction flask equipped with an overhead stirrer. After melting, 1 mL of 
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TOC catalyst was added and the reaction was allowed to proceed for 8 h at 135°C. After 
the reaction, the product was dissolved in DCM and precipitated in ice cold methanol, 
followed by precipitation in ether and hexane to remove the unreacted monomer and 
PEG. Then, the product was dried in vacuum and stored at -20°C. In the next step, the 
lactide-capped PEG was functionalized by reaction with AC using the following 
procedure. Equimolar amounts of AC and TEA were added dropwise to a cooled solution 
of the capped macromer in DCM and the reaction was allowed to continue for 12 h. After 
the reaction, solvent was removed by rotary evaporation and the residue was re-dissolved 
in ethyl acetate to precipitate the byproduct triethylamine hydrochloride salt. Next, ethyl 
acetate was removed by vacuum distillation and the functionalized macromer was 
dissolved in DCM and precipitated twice in ice cold ethyl ether. The product was 
dissolved in DMSO, purified by dialysis, freeze dried and stored at -20°C. A similar 
procedure was used for functionalization of PEG to produce PEG diacrylate (PEGDA) 
macromer. The synthesized macromers were characterized by 
1
H-NMR (Varian, Palo 
Alto, CA) as we previously described.[35] The synthesized macromer is hereinafter 
referred to as Ln where “L” stands for lactide-capped PEG macromer and “n” is the 
number of lactide monomers per chain end. 
7.2.3. BMP-2 peptide synthesis and conjugation to the macromer 
The amino acid sequence KIPKA SSVPT ELSAI STLYL (BMP-2 peptide, Figure 
7.1.a) was synthesized manually on Rink Amide NovaGel
TM
 resin in the solid phase as 












Figure 7.1. Bead representation of the BMP-2 peptide (a) and the peptide/lactide-capped 
PEG conjugate (b). Lactide, ethylene oxide and acrylate units in (b) are shown in brown, 
green and blue beads respectively. (c) Schematic representation of hMSCs encapsulated 
in the PEGDA (blue network) hydrogel matrix for all groups. Experimental groups 
included the peptide (shown in red) dissolved in the hydrogel network (d), peptide 
covalently attached to the hydrogel network (e), and peptide/lactide-capped PEG 
conjugate attached to the hydrogel network (f). The red lines and circles in (d-f) represent 
the peptide chain and peptide aggregate, respectively. The lactide-capped PEG macromer 
in (f) is shown by brown-green colors. 
 
and product yield.[313] Briefly, the Fmoc-protected amino acid (1 equiv), HOBt (2 
equiv) and DIC (1.1 equiv) were added to 100 mg resin swelled in DMF. Next, 0.2 mL of 
0.05 M DMAP was added to the mixture and the coupling reaction was allowed to 
proceed for 4-6 h at 30°C with orbital shaking. After each coupling reaction, the resin 
was tested for the presence of unreacted amines using the Kaiser reagent.[314] The 
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coupling reaction was repeated if the test result was positive. Otherwise, the resin was 
treated with 20% piperidine in DMF and the next Fmoc-protected amino acid was 
coupled. For direct conjugation of BMP-2 peptide to the hydrogel matrix, acrylamide-
terminated BMP-2 peptide was synthesized by the reaction between N-terminal amine of 
the peptide with acrylic acid directly on the resin under reaction conditions used for 
amino acid coupling. Acrylamide-terminated cell-adhesive GRGD peptide (Ac-GRGD) 
was synthesized using a similar procedure. For conjugation of the peptide to lactide-
capped PEG macromer, the amino acid sequence cysteine-glycine-glycine (CGG) was 
coupled to the lysine end of the BMP-2 peptide directly on the resin. After coupling the 
last amino acid, the peptide was cleaved from the resin by treating with 95% TFA/2.5% 
TIPS/2.5% water for 2 h and precipitated in cold ether. The peptide was further purified 
by preparative HPLC and characterized by electrospray ionization (ESI) mass 
spectrometry as we previously described.[113]  
The Michael addition reaction between the cysteine‟s sulfhydryl group on the 
peptide and the acrylate on the macromer was used for conjugation, similar to a 
procedure we previously described.[315] Figures 7.1.a and 7.1.b show the bead structure 
of the BMP-2 peptide and peptide-macromer conjugate, respectively. Blue, brown, and 
green beads in Figure 7.1.b represent acrylate, lactide, and ethylene oxide units of the 
macromer, respectively. Briefly, a solution of the peptide in sodium borate buffer was 
added to the solution of macromer in DMF in a 1:1 molar ratio to terminate on average 
one end of the macromer with peptide and leaving the unreacted acrylate-terminated end 
for attachment to the hydrogel matrix. The conjugation reaction was allowed to proceed 
for 24 h at 30°C. After the reaction, the solution was dialyzed against distilled deionized 
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(DI) water to remove the unreacted monomer and peptide, and freeze dried to obtain the 
dry peptide-macromer conjugate. The number of peptides per lactide-capped PEG chain 
was determined by 
1
H-NMR as we described previously.[315] The conjugate is 
hereinafter referred to as PLn where “P”, “L” and “n” stand for BMP-2 peptide, lactide-
capped PEG macromer, and number of lactide monomers per chain end, respectively. 
7.2.4. DYNAMIC LIGHT SCATTERING 
Dynamic light scattering (DLS) was used to determine CMC of the peptide as 
described.[316] Solutions with different concentration of the peptide in PBS were 
prepared by sonication for 10 min. A 20 µL aliquot of the peptide solution was used for 
DLS measurements on a DynaPro MSX DLS instrument (Wyatt Technology, Santa 
Barbara, CA). The intensity of scattered light at 90° angle was collected and averaged 
over 50 data points using the DynaPro software (Wyatt Technology). Intersection of the 
two linear lines fitted to the data for scattered light intensity at low and high 
concentrations was used to define CMC for the peptide as previously described.[317] 
7.2.5. CELL ENCAPSULATION AND CULTURE 
Prior to cell encapsulation, hMSCs were cultivated at 5000 cells/cm
2
 in a high 
glucose DMEM medium supplemented with 10% FBS, 100 units/mL penicillin and 100 
µg/mL streptomycin. The medium was refreshed every 3 days. When the cultivated 
hMSC colonies reached approximately 70% confluency, the cells were detached with 
0.1% trypsin- 0.03% EDTA and sub-cultivated at 1:3 ratio. According to supplier‟s 
instructions (Lonza, Allendale, NJ), all hMSCs used in cell culture experiments were 
passaged <5 times. The following procedure was used for encapsulation of hMSCs in 
BMP-2 peptide incorporated PEGDA hydrogels by UV polymerization, as shown in 
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Figure 7.1.c.[35, 51] First, BMP-2 peptide, with or without conjugation to the lactide-
capped macromer, was dissolved in a solution of Irgacure-2959 photoinitiator (1 wt% of 
PEGDA) in PBS. Next, 1 wt% Ac-GRGD adhesive peptide was dissolved in a solution of 
PEGDA macromer (15 wt%) in PBS to improve cell viability and cell-matrix interaction 
after encapsulation. After sterilization by filtration, the initiator and macromer solutions 
were mixed by vortexing for 5 min to generate the hydrogel precursor solution. Then, 
1x10
6
 hMSCs, suspended in 100 µL PBS, was added to the precursor solution and mixed 
gently with a pre-sterilized glass rod. The suspension of cells in the precursor solution 
was injected between two sterile microscope glass slides and crosslinked by UV 
irradiation with a BLAK-RAY 100-W mercury long wavelength (365 nm) UV lamp 
(Model B100-AP; UVP, Upland, CA) as we described previously.[88] The final density 
of hMSCs in the gel was 2x10
6
 cells/mL. Experimental groups included peptide dissolved 
in PEGDA gel (Figure 7.1.d, peptide in red), peptide covalently attached to PEGDA gel 
(Figure 7.1.e), and peptide/lactide-capped PEG conjugate attached to PEGDA gel (Figure 
7.1.f). Abbreviations “P” and “cP” denote BMP-2 peptide dissolved in and conjugated to 
PEGDA hydrogel, respectively, “PLn” denotes BMP-2 attached to lactide-capped 
macromer and dissolved in PEGDA gel, and “cPLn” denotes BMP-2 peptide attached to 
lactide-capped macromer and conjugated to PEGDA gel. After removing from the glass 
slide and cutting the gel with a cork borer, the disk-shape samples were incubated in 
basal medium for 24 h with two medium changes. The medium was then replaced with 
osteogenic medium without DEX (50 µg/mL AA and 10 mM βGP) and incubated for 28 
days. The cell-encapsulated gels (without BMP-2 peptide) incubated in basal medium and 
osteogenic medium without DEX were used as negative controls while those with 0.0004 
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mM BMP-2 protein dissolved in the gel (and medium) were used as the positive 
control.[318, 319] For the groups with peptide dissolved in the gel, the peptide was also 
added to the culture medium for concentration uniformity.  
7.2.6. BIOCHEMICAL AND mRNA ANALYSIS 
At each time point, the samples were divided in two groups. One group was 
homogenized and sonicated to rupture the membrane of the encapsulated cells and expose 
the DNA. Double stranded DNA (dsDNA) content of the homogenized samples was 
analyzed using the PicoGreen assay as described.[35] Analysis of dsDNA was performed 
using a Synergy HT plate reader (Bio-Tek, Winooski, VT) with emission and excitation 
wavelength of 485 and 528 nm, respectively. Alkaline phosphatase (ALP) activity of the 
samples was measured using the QuantiChrom ALP assay kit on a Synergy HT plate 
reader at the wavelength 405 nm as described.[35] The measured intensity was correlated 
to ALP activity in IU/L and normalized to cell numbers. Calcium content of the samples, 
as a measure of the total mineralized deposit, was measured using the QuantiChrom 
Calcium Assay kit as described.[35] The absorbance was measured on a Synergy HT 
plate reader at the wavelength of 575 nm. Measured intensities were correlated to the 
amount of equivalent Ca
2+
 using a calibration curve made with calcium chloride solutions 
of known concentrations. For mRNA analysis, total cellular RNA was isolated using 
TRIzol as described.[113] 250 ng of the extracted total RNA was subjected to cDNA 
conversion using Promega reverse transcription system (Madison, WI). The obtained 
cDNA was subjected to real-time quantitative polymerase chain reaction (rt-qPCR) 
amplification with SYBR green RealMasterMix (Eppendorf, Hamburg, Germany) using 
Bio-Rad CXF96 PCR system (Bio-Rad, Hercules, CA) and the appropriate gene specific 
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primers. PCR experiments were performed to analyze the differential expression of 
osteogenic markers ALP and RunX-2 with time for hMSCs encapsulated in the gels. 
Primers for rt-qPCR were designed and selected using the Primer3 web-based software as 
described.[188] The following forward and reverse primers were synthesized by 
Integrated DNA technologies (Coralville, IA): ALP: forward 5‟-ATG GGA TGG GTG 
TCT CCA CA-3‟ and reverse 5‟- CCA CGA AGG GGA ACT TGT C-3‟; RunX-2: 
forward 5‟-ATG ACA CTG CCA CCT CTG A-3‟ and reverse 5‟-ATG AAA TGC TTG 
GGA ACT GC-3‟; GAPDH: forward 5‟-CAT GAC AAC TTT GGT ATC GTG G-3‟ and 
reverse 5‟-CCT GCT TCA CCA CCT TCT TG-3‟.[320] The model of Pfaffl was  used to 
determine the expression ratio of the gene.[241] The expression of GAPDH 
housekeeping gene was used as the reference, and the fold difference in gene expression 
was normalized to the first time point. 
7.2.7. Statistical analysis 
Data are expressed as means ± standard deviation. All experiments were done in 
triplicate. Significant differences between groups were evaluated using a two-way 
ANOVA with replication test, followed by a two-tailed Students t-test. A value of p < 
0.05 was considered statistically significant. 
7.2.8. Simulation Method 
The atomistic structure of the BMP-2 peptide and lactide-capped PEG macromer 
were coarse-grained into different beads (set of atoms) using the MARTINI coarse 
graining model.[311, 312] The MARTINI force field has been parameterized and applied 
previously to the simulation of proteins, peptides, polymers, and polymer-peptide 
conjugates.[321-326] This model is based on the four to one mapping with each bead in 
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the coarse-grained model representing four heavy atoms in the atomistic model. The 
coarse graining of the peptide and macromer is schematically illustrated in Figure 7.1.a.  
There were a total of 16 bead types for the peptide backbone, amino acid side chains, 
ethylene oxide repeat unit (EO), acrylate group (Ac) and lactide repeat unit (L). Each 
amino acid was coarse grained into a backbone bead and  between zero to three side 
chain beads, based on the original MARTINI model developed for simulation of 
proteins.[311, 312] After coarse graining, the beads were assigned pairwise interactions 
that included polar (P), nonpolar (N), apolar (C), and charge (Q) interactions. To 
accurately represent its real nature, the interactions were grouped into subtypes based on 
the extent of hydrogen bonding or the degree of polarity of the beads. The polar beads 
were divided into five subtypes based on the degree of polarity from low (P1) to high 
(P5). Apolar beads were divided into five subtypes from high (C1) to low apolar (C5). 
The nonpolar as well as charged beads were divided into four subtypes, namely hydrogen 
donor, hydrogen acceptor, hydrogen donor and acceptor and incapable of hydrogen 
bonding. For example, 4 water molecules were represented by a polar bead with degree 
of polarity of 4 or P4. For non-bonded interactions, the following Lennard-Jones potential 





























       (equation 7.1) 
where ij is the depth of the potential well which is related to the strength of interaction 
between beads i and j, and ij is the minimum distance of approach between beads i and 
j. To account for electrostatic interaction between charged beads, the following columbic 










                    (equation 7.2) 
where 
iq and jq are values of the point charges on beads i and j, 0 is the dielectric 
constant of free space and 
rel  is the relative dielectric constant of the medium. To 
account for interaction between bonded beads, the following potential functions were 
used: harmonic function (
bV ) for bond length, cosine harmonic function ( aV ) for bond 
angle, and dihedral function (








aijkaa KV         (equation 7.4) 
)]cos(1[ dijkldd nKV          (equation 7.5) 
where 
bK , aK and dK are force constants for bond stretching, bond angle bending and 
bond torsional rotation, respectively. ijr ,  ijk and ijkl represent the distance between 
bonded beads i and j, the angle between bonded beads i, j, and k, and the dihedral angle 
between beads i, j, k , and l respectively. 
bd , a , d  and n are the equilibrium bond 
length, bond angle, phase angle, and periodicity, respectively. Simulations were 
performed under NVT ensemble dynamics. A time step of 10 fs was employed and the 
total simulation time was 5 µs. The temperature was held at 37°C using the Nose 
thermostat.[327] The simulations were performed in a 200×200×200 Å box with 3D 
periodic boundary conditions. To cover a broader range of concentrations, a bigger 
400×400×400 Å box was used to simulate the effect of peptide concentration. The 
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Mesocite module of Materials Studio (v5.5, Accelrys) was used for the mesoscale 
simulations.[267] 
For simulations to investigate the interaction of BMP-2 peptide with the cell 
membrane, a template membrane with a width of 40 Å was generated using 
Dipalmitoylphosphatidylcholine (DPPC) lipid as one face of the simulation box with the 
box filled with water. The coarse graining of DPPC has been described elsewhere.[328] 
The cell membrane was simulated under NVT ensemble for 100 ns to form the bilayer 
structure. After forming the lipid bilayer, the other components of system (peptide or 
peptide-macromer conjugate) were added to the simulation box. Next, the interaction 
type of all lipid bilayer beads was constrained to P4 type in order to account for the 
interaction with water beads. Then, dynamic simulations were run for 5 µs to allow the 
formation of peptide or peptide-macromer aggregates in aqueous solution similar to the 
simulations without the lipid bilayer membrane. Next, the constraint was removed from 
the membrane beads and the pairwise bead interaction potential was changed 
accordingly. Finally, the system was simulated for 5 µs similar to that without the lipid 
bilayer membrane.  
7.3. RESULTS 
The average number of lactides per chain end of lactide-capped PEG, average 
number of acrylates per chain end, and average number of BMP-2 peptides per conjugate 
was determined from the NMR spectra of macromers as we previously described.[35, 
315] The number of lactide repeat units per chain end of the lactide-capped PEG 
macromer was determined from the ratio of the peaks at 1.6 and 5.2 ppm (lactide 
hydrogens) to those at 3.6 and 4.3 ppm (PEG hydrogens).[35] The average number of 
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lactide repeat units per chain end for L2, L4 and L6 macromers was 1.9, 3.6 and 5.6 
respectively. The number of reactive acrylate groups per chain end was determined from 
the ratio of the peaks between 5.85 to 6.55 ppm (acrylate hydrogens) to those at 3.6 and 
4.2 ppm (PEG hydrogens).[35] The average number of acrylates per chain end before 
peptide conjugation for L0, L2, L4 and L6 macromers was 0.85, 0.85, 0.83 and 0.82, 
respectively. The number of peptides in a peptide/lactide-capped PEG conjugate was 
determined using the acrylate/PEG molar ratios before and after conjugation as 
previously described.[315] The average number of peptides per conjugate for L0, L2, L4 
and L6 macromers was 0.57, 0.49, 0.52 and 0.45, respectively. Several studies have 
demonstrated that >95% of acrylated PEG/peptide conjugates are integrated in PEGDA 
hydrogel network during photo-crosslinking.[113, 329, 330] 
Figure 7.2 (a-e) shows the effect of dissolved (not attached to the gel network) 
BMP-2 peptide concentration on osteogenic differentiation of hMSCs encapsulated in the  
PEGDA hydrogel incubated in osteogenic medium without DEX. Peptide concentration 
ranged from 0.00025 mM to 5 mM. Negative and positive control groups were gels 
without peptide and with 0.0004 mM  BMP-2 protein, respectively. The clinically used 
concentration of BMP-2 protein is 1 mg/mL    (~ 0.04 mM) [331] but the typical 
concentration used for in vitro 3D experiments is in the 1-10 µg/mL (~0.00004-0.0004 
mM) range.[318, 319] In this work, the upper concentration of 0.0004 mM was used to 
elucidate the effect of peptide on differentiation of hMSCs. DNA content, ALP activity 
and calcium content of the groups are shown at a single time point (7, 14 and 21 days, 
respectively) in Figure 7.2(a-c). DNA content of the groups at day 7 did not change 




Figure 7.2. DNA content (a, day 7), ALP activity (b, day 14), and calcium content (c, day 
21) of hMSCs encapsulated in PEGDA hydrogel (15 wt%) and incubated in osteogenic 
medium without DEX as a function of dissolved BMP-2 peptide concentration in the 
hydrogel matrix. Control groups included hMSCs encapsulated in PEGDA hydrogel (15 
wt%) and cultured in osteogenic medium without  DEX (OM) and without the BMP-2 
peptide (0 mM, negative control) and those cultured in OM with 0.0004 mM BMP-2 
protein (0.01 Pr, positive control). Effect of the BMP-2 peptide concentration on ALP (d) 
and RunX-2 (e) mRNA marker expression of hMSCs encapsulated in PEGDA hydrogel. 
 
a maximum on day 14 consistent with the biphasic activity of ALP in osteogenic 
differentiation of MSCs.[332] ALP activity of the groups at day 14 did not significantly 
change when the peptide concentration increased from 0 to 0.00025 and 0.0005 mM 
(Figure 7.2.b).  The ALP activity of the groups at peptide concentrations above 0.0005 
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mM was significantly higher than the ALP activity of the group without peptide (Figure 
7.2.b). The ALP activity of groups increased by 1.7 and 2.2 fold when the peptide 
concentration increased from 0.0005 mM to 0.0025 and 0.005 mM respectively. The 
growth rate of ALP activity of groups decreased with increasing the peptide 
concentration above 0.005 mM. A 1000-fold increase in the concentration of peptide in 
the gel from 0.005 mM to 5 mM increased ALP activity only by 1.4-fold at day 14 
(Figure 7.2.b). ALP activity of hMSCs encapsulated in PEGDA gel with 0.005 mM 
BMP-2 peptide was 2.4-fold higher than the gel without peptide (ctrl group in Figure 
7.2.b) after 14 days while that with 0.0004 mM BMP-2 protein (same weight 
concentration as peptide, 10 µg/mL)  was 7.2-fold higher.  The effect of peptide 
concentration on the extent of mineralization of encapsulated hMSCs (Figure 7.2.c), as 
measured by calcium content, was consistent with ALP activity. Calcium content of the 
gels did not significantly change with the addition of 0.00025 and 0.0005 mM peptide to 
the gels. The calcium content increased from 245 50 to 340 40 and 420 50 mg/mg 
DNA with increasing the peptide concentration by 5 and 10 folds from 0.0005 to 0.0025 
and 0.005 mM respectively, but the calcium content increased at a slower rate from 420
 50 to 700 100 mg/mg DNA with 500-fold increase in peptide concentration from 
0.005 mM to 2.5 mM. Further increase in peptide concentration from 2.5 to 5 mM did not 
significantly change calcium content. The ALP and RunX-2 mRNA expression as a 
function of peptide concentration in Figures 7.2.d and 7.2.e, respectively, were consistent 
with ALP activities and calcium contents (Figures 7.2.b and 7.2.c). Notably, 
osteoinductive potential of BMP-2 peptide was significantly less than that of BMP-2 
protein as the calcium content and ALP mRNA expression of hMSCs cultured with 10 µg 
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protein/mL (0.0004 mM) BMP-2 protein were 4-fold and 12-fold higher than those 
cultured with the same 10 µg peptide/mL mass concentration of the peptide (0.005 mM) , 
respectively. Furthermore, RunX-2 expression of hMSCs cultured with BMP-2 protein 
(0.0004 mM, pink bar in Figure 7.2.e) and those cultured with BMP-2 peptide at highest 
concentrations (2.5 and 5 mM, light green and light blue) peaked on day 7 while those 
cultured with 0.005-0.5 mM peptide peaked on day 14. To summarize, the results in 
Figure 7.2 indicated that the osteoinductive potential of BMP-2 peptide was significantly 
less than that of the protein and even 12000-fold higher peptide molar concentrations 
could not achieve the osteoinductive potential of BMP-2 protein.  
The results in Figure 7.2 prompted us to investigate stability of the peptide in 
aqueous solution. The hydrophobicity index for each amino acid, from N-terminus (left 
side) to C-terminus (right side) of the BMP-2 peptide, based on the difference in free 
energy of the aqueous and condensed phases,[333] is shown in Figure 7.3.a. The positive 
and negative indices indicate hydrophobic and hydrophilic residues, respectively. The 
distribution of hydrophobicity was not uniform along the peptide chain as the average 
hydrophobicity indices on N- (left) and C-terminus (right) sides of the peptide were -0.28 
and 0.84, respectively (see the dash lines in Figure 7.3.a). Overall the peptide was 
hydrophobic with an average hydrophobicity index of 0.28. The overall hydrophobicity 
suggested that the peptides form aggregates in aqueous solution to reduce the overall free 
energy. Indeed, molecular dynamic simulations in Figure 7.3.c show that the aggregation 
number (number of peptides per aggregate) increased with concentration of the peptide in 
aqueous solution. By extrapolating to aggregation number of one in Figure 7.3.c, the 




Figure 7.3. (a) Hydrophobicity index for each amino acid from N-terminus (left side) to 
C-terminus (right side) of the BMP-2 peptide. (b) intensity of scattered light as a function 
of peptide concentration in aqueous solution. (c) Simulated aggregation number of the 
BMP-2 peptide (number of peptides per aggregate) as a function of the peptide 
concentration in aqueous solution. (d) density of free BMP-2 peptide and total peptide 
density as a function of peptide concentration in aqueous solution. 
 
to surfactants, the peptide is soluble in aqueous solution below CMC but it forms 
aggregates in equilibrium with the free peptide in solution above CMC with the 
propensity for aggregation increasing with peptide concentration.[334] CMC of the 
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peptide was measured by dynamic light scattering from the intersection of the two lines 
fitted to the scattered light intensity at high and low concentrations, as shown in Figure 
7.3.b. The intensity of scattered light did not change significantly at low concentrations in 
the absence of aggregation but it increased exponentially above CMC with aggregation.  
The experimentally measured CMC was 0.019 mM which was lower than the predicted 
value of 0.04 mM from simulations (Figure 7.3.c).  The predicted higher CMC was most 
likely due to the error in extrapolating the aggregation number from higher 
concentrations to the aggregation of unity at CMC. However, the experimental and 
simulated CMCs were within the range of 0.005-0.05 mM which was observed in the cell  
studies (Figure 7.2). A lower growth rate of ALP activity and mineralization of hMSCs in 
PEGDA gels with peptide concentration when the peptide concentration was in the 
0.005-0.05 mM range compared to the 0.0005-0.005 range can be related to the initiation 
of aggregation within the former range (see Figure 7.2.b and 7.2.c).  The predicted total 
and free peptide densities as a function of peptide concentration in solution are compared 
in Figure 7.3.d. According to simulation results, the fraction of free peptide above CMC 
concentration decreased sharply from 0.54 to 0.16, 0.09 and 0.06 as the peptide 
concentration was increased from 0.5 mM to 2.5, 5 and 10 mM, respectively. However, 
the decrease in fraction of free peptide was offset by an increase in peptide number 







 while the total peptide density increased by 20-folds from 0.28 
x10
18




 (Figure 7.3.d). The effect of peptide concentration, added to the 
gel and culture medium, on ALP activity (day 14) and calcium content (day 21) of 
hMSCs encapsulated in 15% PEGDA gel is shown in Figure 7.2.b and 7.2.c, respectively. 
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Note that concentration scale in the figures is logarithmic. As the total peptide 
concentration was increased by 10-folds from 0.5 to 5 mM in a range well above CMC, 
ALP activity and calcium content increased by 1.1 and 1.2 folds, respectively, while the 
free  peptide concentration increased by 1.6-fold from 0.26 to 0.42 mM (see Figure 7.4). 
Therefore, the data suggests a better correlation between osteogenic activity and the free 
peptide concentration. Further, the significantly lower osteogenic activity of the peptide 
compared to BMP-2 protein even at 12000-fold higher concentration, can be partially 
(see other effects due to peptide interaction with the cell membrane) explained by 
aggregation in aqueous solution.  
The effect of peptide hydrophobicity and its conjugation to the PEGDA network 
on DNA content, ALP activity and calcium content of the encapsulated hMSCs is shown 
in Figures 7.5.a to 7.5.c, respectively. Groups included gels incubated in basal medium 
(BM), osteogenic medium without DEX (OM), OM with peptide conjugated to the gel 
(cP), OM with peptide dissolved in the gel (P), OM with peptide/lactide-capped PEG 
macromer with zero (cPL0), 2 (cPL2), 4 (cPL4), and 6 (cPL6) lactides conjugated to the 
gel. DNA content of hMSCs cultured in BM increased with incubation time while those 
incubated in OM decreased, with or without peptide (Figure 7.5.a). The increase in DNA 
content in BM indicated that hMSCs were able to grow in the encapsulating PEG matrix 
but DNA content decreased with incubation time as the encapsulated cells underwent 
differentiation in osteogenic medium consistent with previous reports.[252, 253]  
Addition of BMP-2 peptide, peptide hydrophobicity, or peptide conjugation to the PEG 





Figure 7.4. ALP activity (b, day 14), and calcium content (c, day 21) of hMSCs 
encapsulated in PEGDA hydrogel (15 wt%) and incubated in osteogenic medium without 
DEX as a function of dissolved BMP-2 peptide concentration in the hydrogel matrix. 
Control groups included hMSCs encapsulated in PEGDA hydrogel (15 wt%) and 
cultured in osteogenic medium without  DEX (OM) and without the BMP-2 peptide (0 
mM, negative control) and those cultured in OM with 0.0004 mM BMP-2 protein (0.01 
Pr, positive control). 
 
ALP activity of the encapsulated hMSCs cultured in BM did not change with 
incubation time while those cultured in OM, with or without peptide, peaked on day 14. 
The addition of BMP-2 peptide to the culture medium significantly increased the peak 
ALP activity on day 14, as shown by one star in Figure 7.5.b. Further, the group with 
BMP-2 peptide dissolved in the medium (P) had significantly higher ALP activity on day 
14 compared to those groups in which the peptide was conjugated to the PEG gel (cP, 
cPL0, cPL2, cPL4, cPL6), as shown by two stars in Figure 7.5.b. This is consistent with 
the fact that BMP-2 protein is associated with the soluble, not the insoluble fraction of the 
bone matrix.[335] Further, ALP activity for cPL0 group (peptide-PEG conjugate attached 
to the gel) was 3000 450 IU/mg DNA which was higher than that for cP group (peptide 
attached to the gel) with 2200 260 IU/mg DNA. Notably, ALP activity of the 




Figure 7.5. DNA content (a), ALP activity (b), and calcium content (c) of hMSCs 
encapsulated in PEGDA hydrogel and incubated in basal medium (BM, control group), 
osteogenic medium without DEX (OM, control group), OM with the BMP-2 peptide 
covalently attached to the hydrogel network (cP), OM with BMP-2 peptide dissolved in 
the hydrogel (P), OM with peptide/lactide-capped PEG conjugate with zero (cPL0), 2 
(cPL2), 4(cPL4) and 6 (cPL6) lactide units, attached to the hydrogel network. One star 
indicates a statistically significant difference (p<0.05) between the test and OM groups at 
each time point. Two stars indicates a statically significant difference between the test 
and all other groups at each time point. Error bars correspond to means±1 SD for n=3. 
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capped with a hydrophobic lactide segment (cPL2, cPL4 and CPL6 groups). However, 
the lactide segment length did not significantly change the peak ALP activity of hMSCs.  
The extent of mineralization of hMSCs, as measured by calcium content, did not 
change with incubation time in BM but it increased in all OM groups (with or without 
peptide), as shown in Figure 7.5.c. The addition of BMP-2 peptide to the gel (P group, 
Figure 7.5.c) significantly increased calcium content compared to that without peptide 
(OM medium, Figure 7.5.c). Consistent with ALP results, the calcium content of hMSCs 
cultured in the gel with dissolved peptide (P group) was 680  40 mg/mg DNA which 
was significantly higher than that conjugated to the gel (cP group, 370  50 mg/mg 
DNA), as shown by two stars in Figure 7.5.c. Extension of the peptide with a PEG chain 
increased the calcium content of hMSCs from 370  50 to 500 40 mg/mg DNA at day 
28. However, extension of the peptide with a lactide-capped PEG chain (lactide segment 
length of two, cPL2) significantly reduced calcium content at day 28 compared to PEG-
extended peptide. The length of the lactide segment in lactide-capped PEG conjugated 
peptide did not affect calcium content of hMSCs.  
We hypothesized that the lower osteoinductive potential of the peptide groups 
conjugated to PEG or lactide-capped PEG was due to increased aggregation. The images 
in Figure 7.6 show the simulated equilibrium structure of BMP-2 peptide or 
peptide/lactide-capped PEG conjugates in aqueous solution (15 wt%). The blue and 
brown beads are for acrylate and lactide units, respectively, and ethylene oxide beads are 
not shown for clarity. Images 7.6.a to 7.6.g correspond to acrylate-terminated (blue 
beads) PEG, lactide-capped PEG (2 lactides, L2), PL0, PL2, PL4 and PL6, respectively. 




Figure 7.6. Evolution of the BMP-2 peptide aggregates in PEGDA hydrogel (15 wt%) 
without the peptide or lactide-capped PEG macromer (a, control), with lactide-capped 
PEG macromer (b, control, L0 group), the peptide (c, P group), the peptide-PEG 
conjugate (d, PL0 group), the peptide/lactide-capped  PEG conjugate with 2 (e, PL2 
group), 4 (f, PL4 group), and 6 (g, PL6 group) lactides. The blue and brown beads 
correspond to acrylate and lactide beads, respectively. Ethylene oxide and water beads 
are not shown for clarity. 
 
simulated aqueous solution, as shown by the acrylate beads in Figure 7.6.a. PEG chains 
capped with lactide and terminated with an acrylate group formed micellar structures 1-3 
nm in size as shown in Figure 7.6.b,[35, 51] with lactide and ethylene oxide beads 
forming the core and corona of the micelles, respectively. The acrylate-terminated 
peptide without (Figure 7.6.c) or with conjugation to PEG (Figure 7.6.d) formed 
irregularly-shaped aggregates (Figures 7.6.c,d) due to its amphiphilic nature. In the 
peptide case, hydrophobic side chains of the amino acids formed the core of the 
aggregates while ethylene oxide beads covered surface of the aggregates with hydrophilic 
amino acids (polar and charged) positioned at the core-corona interface (Figure 7.6.d). 
The size of the aggregates increased when the peptide-PEG macromer was capped with 2, 
4 and 6 lactide units as shown in Figures 7.6.e, 7.6.f and 7.6.g, respectively, and the 
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number density of the aggregates decreased with increasing lactide segment length. The 
cross sections of one of the aggregates in the simulations of Figure 7.6 are shown in 
Figure 7.7 with green beads representing ethylene oxide (EO) units. The cross sections in 
Figure 7.7 show that the aggregates in aqueous solution are covered with ethylene oxide 
units of PEG to reduce the interfacial free energy between the aqueous phase and 
hydrophobic structures, thus stabilizing the aggregates. Notably, thickness of the EO 
layer increased with aggregate size. 
The average aggregation number (nagg) and fraction of the free peptide (P) and 
peptide conjugated to lactide-capped PEG (cPL0, cPL2, cPL4 and cPL6) are shown in 
Figure 7.7.h. Due to PEG hydrophilicity, nagg decreased from 3.4 to 3.0 and aggregate 
distribution narrowed with conjugation of the peptide to PEG (cP). The nagg increased 
from 3 to 3.9, 5.8 and 7.7 as the PEG macromer in peptide-PEG conjugate was capped 
with 2 (cPL2), 4 (cPL4) and 6 (cPL6) lactides, respectively. The nagg increased from 3.4 
to 4.3, 6.6 and 11.1 when the peptide was directly conjugated to lactide without PEG with 
segment length of 2, 4, and 6, respectively. On the other hand, the fraction of free peptide 
in solution increased from 0.06 to 0.1 with conjugation of the peptide to PEG (cP). 
Further, the fraction of free peptide decreased from 0.1 to 0.04, 0.03 and 0.02 for cPL2, 
cPL4 and cPL6, respectively. 
To quantify the proximity of different beads, the average number of “b” beads in 
a sphere of radius R around bead “a” or the running integration number of beads “b” 










Figure 7.7. Cross-section of one of the BMP-2 peptide aggregates in Figure 5 with green 
beads representing ethylene oxide units. Images (a-g) correspond to aggregates without 
the peptide or lactide-capped PEG macromer (a), with lactide-capped PEG macromer (b), 
the peptide (c), peptide-PEG conjugate (d), peptide/lactide-capped PEG conjugate with 2 
(e), 4 (f), and 6 (g) lactides. Water beads are not shown for clarity.  (h) Simulated average 
aggregation number and the fraction of free peptide (h) and the water-amino acid 
integration number for lysine (charged), serine (uncharged but polar), and isoleucine 
(nonpolar) (i) for the peptide only (P), peptide-PEG conjugate attached to the hydrogel 
network (cPL0), peptide/lactide-capped PEG conjugate attached to the gel network with 2 





0b  is the overall number density of “b” beads and )(rgab  is the radial distribution 
function of bead “b” around bead “a”, located at the origin. The integration numbers 
between water and amino acids lysine (K), serine (S) and isoleucine (I) representing 
charged, polar and hydrophobic amino acids, respectively, are shown in Figure 7.7.i. 
Isoleucine with lowest INAA-w (green curve in Figure 7.7.i) was confined to the center of 
the aggregates while lysine with highest INAA-W was situated on the aggregate surface in 
proximity to the PEG layer (see Figures 7.7.b-g). The simulation results in Figure 7.7 
indicated that, due to peptide aggregation, the encapsulated hMSCs may interact with the 
PEG layer on the surface of peptide-PEG aggregates or amino acids different from the 
BMP-2 peptide sequence, leading to a lower osteoinductive potential of the lactide-
capped PEG conjugated peptide. 
The effect of peptide aggregation on interaction of the peptide with the cell 
membrane was simulated by molecular dynamics and the results are shown in Figure 7.8. 
When a single peptide (not an aggregate) or a single peptide-PEG conjugate was in 
contact with the cell membrane, the distance between the center of masses of the peptide 
and cell membrane did not change significantly. However, when an aggregate of the 
BMP-2 peptides (P, upper left and right images) or an aggregate of the peptide-PEG 
conjugates (PL0, lower left and right images) were in contact with the cell membrane, 
higher energetic interaction, penetration of the peptide and pore formation in the 
membrane was observed. However, conjugation of the peptide to PEG (PL0) reduced the 
attractive interaction between the conjugate and cell membrane and the extent of pore 
formation. Notably, covalent attachment of the peptide-PEG conjugate to the hydrogel 




Figure 7.8. Effect of an aggregate of the BMP-2 peptide (top images) and an aggregate of 
the peptide-PEG conjugate (bottom images) on energetic interaction, penetration of the 
peptide and pore formation in the cell membrane. The water beads are not shown for 
clarity. The images on the left and right show the side and top views of the membrane, 
respectively. In the top view, all membrane beads are shown in gray for clarity. 
 
7.4. DISCUSSION 
Aside from cost efficiency, osteogenic peptides are less likely to lose their activity 
by denaturation than their corresponding protein. Therefore, a wider range of methods 
can be used for incorporation of osteogenic peptides in engineered scaffolds. Li and 
collaborators measured osteoinductivity of the BMP-2 peptide loaded in nano-hydroxy 
apatite/collagen/poly(L-lactic acid) scaffolds by implantation in a rat calvarial 
defect.[336] They reported that 3 mg of the BMP-2 peptide loaded in the scaffold had 
osteoinductive potential similar to 1 µg of BMP-2 protein, indicating that 3000-fold 
higher BMP-2 peptide concentrations are required to achieve the same activity as the 
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protein. Our results demonstrate that although the addition of the BMP-2 peptide 
significantly increased osteoinductive potential, but the level of activity was much less 
than that of BMP-2 protein even at 12000-fold higher molar concentrations (1000-fold 
higher mass concentrations). Further, the expression of RunX-2, a marker for the onset of 
osteogenic differentiation, was delayed with the BMP-2 peptide compared to BMP-2 
protein (Figure 7.2.e). One factor that can lower osteoinductive potential of the peptide is 
aggregation in aqueous solution. The peptide is derived from BMP-2 protein based on its 
ability to differentiate MSCs to the osteogenic lineage without consideration for its 
stability in aqueous solution. Hydrophobicity index analysis of each amino acid indicated 
that the peptide is amphiphilic with an overall positive index of hydrophobicity. 
Therefore, the peptide tends to form aggregates above its CMC in aqueous solution to 
reduce the interfacial free energy. The BMP-2 peptide concentration range of 0.00025-
0.005 mM was below the peptide‟s CMC concentration of 0.019 mM (or 0.040 mM 
based on the simulation results). Therefore, based on the experimental and simulated 
values for CMC, the peptides in cell encapsulation experiments with 0.00025-0.005 mM 
concentrations were most likely not aggregated. Above CMC concentration, the fraction 
of free peptide decreased with increasing peptide concentration but the free peptide 
density in the hydrogel slightly increased which could explain the slight increase in 
osteoinductive potential with increasing peptide concentration in Figure 7.2. Therefore, 
the experimental and computational results indicate that osteoinductive potential of the 
BMP-2 peptide is related to the density of free non-aggregated peptide in aqueous 
solution, not the overall concentration. Further, simulation results show that the amino 
acids in the peptide aggregates facing the aqueous phase may be different from those of 
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the free peptide (Figure 7.7.i) which may lead to non-specific interaction of the 
aggregates with cell surface receptors. In addition, simulation results in Figure 7.8 show 
that the peptide aggregates (P) had a higher energy of interaction with the cell membrane 
than the free peptide, leading to undesired pore formation on the membrane and reduced 
peptide activity. When the peptide was conjugated to PEG (PL0), the peptide aggregates 
were shielded from the cell membrane by surface-bound PEG chains, which slightly 
increased peptide activity. This is consistent with previous results that palmitoylation of 
pro-apoptotic peptides can affect micelle stability and cell uptake.[337]  
The results show that there was higher osteogenic differentiation of encapsulated 
hMSCs when the BMP-2 peptide was dissolved in the hydrogel matrix as compared to 
conjugated peptide (Figure 7.5) which was similar to the previously reported lower 
activity of BMP-2 protein attached to immobilized heparin.[338] Conjugation of the 
peptide to the hydrophilic PEGDA matrix decreased the degree of freedom of the peptide 
beads, which decreased aggregation and increased the free peptide density. Further 
capping the PEG chain with hydrophobic lactide units increased aggregation number of 
the conjugated peptide which can be explained by a decrease in CMC. The free energy of 
micelle formation is related to CMC by [334, 339] 
)ln(0 CMCRTGmic                     (equation 7.7) 
where R and T are the gas constant and absolute temperature respectively and 0micG is 
the difference in free energy of the peptide between the dissolved and aggregated states. 
CMC and 0micG  increased with conjugation of the peptide to hydrophilic PEG, leading to 
an increase in free peptide concentration and higher osteoinductive potential of the PEG-
conjugated peptide (cPL0) compared to cP. However, the addition of hydrophobic lactide 
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units to the PEG-peptide conjugate offset the positive effect of PEG conjugation to the 
peptide, leading to an insignificant change in osteoinductive potential of cPL2, cPL4 and 
cPL6 groups compared to cPL0.  
7.5. CONCLUSION 
In this work, the effect of concentration and hydrophobicity of the BMP-2 
peptide, from residues 73-92 of the knuckle epitope of BMP-2 protein, on differentiation 
of hMSCs encapsulated in PEGDA hydrogel was investigated experimentally and by 
molecular dynamic simulation. The encapsulated cells were cultured in osteogenic 
medium without DEX supplemented with the BMP-2 peptide. The index of 
hydrophobicity of the peptide was varied by conjugation to a lactide-capped PEG chain 
with 0-6 lactide units. The BMP-2 peptide dissolved in the hydrogel had significantly 
higher osteoinductive potential than the attached peptide consistent with the fact that 
BMP-2 protein is associated with the soluble not the insoluble fraction of the bone 
matrix. The osteoinductive potential of the BMP-2 peptide was significantly less than the 
protein even at 12000-fold higher molar concentrations which was explained by peptide 
aggregation in aqueous solution. Based on simulation results, the fraction of free peptide 
in solution decreased while the concentration of free peptide increased slightly with 
1000-fold increase in peptide concentration in aqueous solution, which reduced 
osteoinductive potential of the peptide. A decrease in the index of hydrophobicity of the 
peptide by conjugation to PEG increased CMC which increased osteoinductive potential 
of the peptide. Conversely, an increase in the index of hydrophobicity of the peptide by 
conjugation to lactide-capped PEG reduced CMC which reduced the peptide 
osteoinductive potential. Experimental and simulation results indicated that 
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osteoinductive potential of the BMP-2 peptide should be correlated with its 
hydrophobicity index, CMC concentration in aqueous medium, and the concentration of 





This work showed that hydrogels based on star PEG macromonomers chain extended 
with short hydroxyl acid segments (SPEXA) with a wide range of degradation rate, 
gelation kinetics and mechanical properties are potential candidates for delivery of stem 
cells to the site of regeneration in tissue engineering. Although SPEXA hydrogels were 
applied in this work for osteogenic differentiation and mineralization of MSCs, these gels 
can be utilized for a wide range of applications including vasculogenic differentiation of 
endothelial progenitor cells or chondrocyte implantation in cartilage regeneration. 
Further, results of this work demonstrated that the nano-scale characteristics of the 
hydrogels‟ precursor solutions, predicted via meso-scale molecular simulation methods, 
can be utilized for anticipating the hydrogels‟ macroscopic properties including 
degradation rate, gelation kinetics and stiffness. In addition, experimental and simulation 
results revealed that activity of a model osteo-inductive peptide in PEG based hydrogels 
is correlated with the free peptide concentration in aqueous medium and not the total 
concentration. To continue this work it is necessary to study the effect of concentration 
and hydrophobicity of other osteo-inductive peptides on the activity of peptides and 
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